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Yeast has long been the sine qua non of model organisms due to its
experimental tractability. Recent advances in biology, such as CRISPR/Cas9
editing, promise to bring this tractability to other model organism. But the
same advances have also added new dimensions to the utility of yeast, and re-
inforced its importance as a unique platform for studying basic biology, trans-
lational research and building the future of biotechnology. In this thesis I
describe (i) the use of humanized yeast to study fundamental questions about
the evolution of genetic systems, (ii) rapid and versatile techniques for lever-
aging classical yeast techniques along with cutting edge developments to solve
21-st century problems and (iii) a blueprint for transforming yeast into a vessel
for storage of digital information.
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Chapter 1
Introduction
Since the earliest days of molecular biology, the baker’s yeast Saccha-
romyces cerevisiae has enjoyed great prominence as a platform for synthetic
biology and bioengineering (indeed, humanity has used yeast for many mil-
lennia prior to the advent of biology[1]). As a unicellular organism, it can
grow prodigiously in laboratory cultures. Like many fungi, it has an excellent
capacity for artificial biosynthesis. As a eukaryote, it is often a much more
convenient vehicle for expressing systems derived from important multicellular
organisms, such as humans or crops. But last if not least, yeast has a robust
DNA repair system – as a result, countless new techniques of modifying DNA
have been pioneered in this organism. Many are still vastly more practical
in it to this day. The research presented in this thesis represents my own
efforts at expanding the capabilities of this powerful biotechnology platform
even further, to aid investigation of theory and practical technology alike.
1.1 Genetic Modification in Yeast
Even before modern biology, humanity modified the yeast genome
through selective breeding[2]. Likely, this modification continued unwittingly
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for many centuries before humanity even became aware that microorganisms
exist[3]. Likewise, since the dawn of the modern era, it was very actively
studied[4]. As such, techniques of yeast modification are legion, and I trust
the reader to kindly excuse me for eschewing to attempt a comprehensive
inventory of them in this dissertation.
Yeast genetic engineering was already quite advanced before the ad-
vent of CRISPR. The state of the art was the delitto perfetto1 method[5].
This method joined two families of genome editing techniques to provide the
ultimate editing method: Before, there were methods that could make any
edit, but only at certain loci. For instance, the I-SceI endonuclease could
cleave DNA effectively, which triggered homologous recombination (HR) and
could be used to incorporate a new sequence replacing the old one. But I-SceI
targets only a specific sequence. There were also methods that could edit
any locus, but the efficiency was low and required selection, which in turn
required introducing a selectable marker in the edit. In delitto perfetto, the
latter approach is used to first introduce a cassette into the target site. Clones
are isolated by selection. Besides a selectable marker, the cassette carries a
recognition site for I-SceI, which is then expressed in the clones. This leads to
1 This method is remarkable in that it is not just brilliantly conceived, but also brilliantly
named. The term is Italian for “perfect murder”. One of the chief uses of genome editing
techniques is to delete sequence (such as genes of interest), but prior techniques would always
introduce some extraneous sequence at the site of editing (the so-called “scar”). Correctly
applied, the delitto perfetto leaves no scar. It was, therefore, a qualitative improvement
because it could edit so as to generate any desired sequence. Other methods could not; they
only produced sequences which include the scar. Hence delitto perfetto could delete a gene,
leaving behind no evidence of the deed.
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a second round of HR which replaces the cassette with the desired sequence.
While this method is powerful, it has two weaknesses: Firstly, the two
rounds of growth and selection are somewhat laborious in routine use. Sec-
ond, after the first part, the cassette will potentially interrupt the function
of genomic sequence it is targeting. If that sequence is an essential gene, the
clone will be inviable. Therefore, an additional layer of complexity must be
introduced in the form of a temporary complementor gene, such as a plasmid
carrying a functional version of the gene. However, when HR is triggered the
cassette site will be edited to incorporate a homologous sequence. If the com-
plementing plasmid carries the yeast gene, it will be highly homologous and
may even outcompete the repair template of interest. Therefore the comple-
menting plasmid must be carefully engineered to be similar enough to rescue
disruption by the cassette, but different enough to not be picked up by HR.
In many cases, these issues are quite tolerable. However, in more complex
and sophisticated studies they can seriously complicate experimental design.
They were a direct motivation for me to develop the CRISPR-based method
described in Chapter 3, which resolved them and enabled the work of my other
chapters.
Nevertheless, the techniques available in yeast were often far ahead
of other organisms, and yeast itself if very easy to culture and work with.
Large-scale application of the delitto perfetto method and others produced
large datasets and collections of mutant strains. Genome-wide knockout li-
braries revealed foundational insights of functional genomics[6]. This deletion
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library was then used to probe the relationship between genotype, pheno-
type, and environment with unprecedented depth and breadth[7]. This dele-
tion library was also the basis for our lab’s initial systematic humanization
study[8], which served as the foundation of my work. Mating such libraries
allowed researchers to explore combinatorial effects on a vast scale. Earlier,
the yeast-2-hybrid technique had elucidated protein-protein interaction net-
works[9, 10]. Now the development of synthetic genetic arrays[11] elucidated
gene-gene interactions[12].
1.1.1 CRISPR/Cas9 Editing
CRISPR is a system of bacterial adaptive immunity[13, 14]. Many bac-
teria contain short segments of DNA in their genomes, which match sequences
of common foreign DNA such as phage genomes. These segments are tran-
scribed as RNA, which forms a complex with other CRISPR proteins such as
Cas9. The RNA is able to insert itself into double-stranded DNA (dsDNA)
and form base pairs. Upon successful base pairing, which effectively serves
as target confirmation, the protein complex begins cutting the DNA with its
endonuclease activity. In this way, bacteria in nature can selectively destroy a
broad spectrum of harmful foreign DNA. The complementary RNA sequence
is quite short (classically 20 bp) and determines the target by matching its se-
quence. Accordingly, it is called the guide RNA. There is an additional RNA
component which does not vary between targets but is necessary for CRISPR
function, and it is termed the scaffold RNA.
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It did not take long for the scientific community to perceive the util-
ity of the CRISPR system in biotechnology applications. In many organisms,
genome editing is accomplished by relying on native damage repair enzymes
to incorporate a desired sequence into the genome. For this to be a targeted
process (which is required for true editing, rather than mere insertion), there
must be a way of preferentially inducing DNA damage at the targeted lo-
cus. Enzymes capable of targeted DNA disruption have been known since the
earliest days of molecular biology[15]. However, in many cases, each enzyme
could target only a small range of sequences. Accordingly, biologists have re-
sorted to amassing extensive libraries of enzymes for different sequences. If
no enzyme was available for a given site, it was very difficult to modify it.
Moreover, restriction enzymes were often short enough to be prolific through-
out the genome, precluding specific nuclease activity at the target site only.
Programmable nucleases have attracted much research interest as a result[16,
17]. Soon after the native function of the CRISPR system was understood,
a now-famous study showed that CRISPR can be used as just such a pro-
grammable nuclease[18]. Because CRISPR targeting is controlled by base
pairing of the guide RNA, any sequence can be targeted by simply inserting a
complementary sequence into the guide. Because the guide sequence is about
20 bp long, it has a very low probability of occurring in more than one place
(with the important exception of duplicate genes). They also fused many com-
ponents of the system, reducing it to a single protein (SpyCas9, derived from
Staphylococcus pyogenes) and a single RNA (called sgRNA, being a fusion of
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scaffold and guide) which can easily be expressed in most cells. Soon after,
systems were developed to further enhance the precision of CRISPR targeting
by increasing the number of guide basepairs that participate[19].
The earliest application of CRISPR to yeast was by DiCarlo and col-
leagues and influenced much of subsequent work[20]. They cloned the system
from [18] into yeast vectors and demonstrated proof of concept experiments for
use of CRISPR to edit yeast DNA (in conjunction with a repair template) or
mutagenize a specific site (by omitting the repair template). As it turned out,
yeast was exceptionally good at repairing double-stranded breaks by homolo-
gous recombination. This allowed very straightforward protocols for making
arbitrary edits to the yeast genome. CRISPR editing in yeast was so efficient,
that it obviated the need for selection, permitting single step genome mod-
ification[21]. A minor problem was expressing sufficient amounts of sgRNA:
Initially, its expression was driven by small nuclear RNA promoters which were
not very strong. This problem was soon remedied by introducing stronger pro-
moters[22]. Another challenge was rapid cloning of many CRISPR guides, also
resolved shortly[23].
In the context of yeast, the principle of CRISPR editing is fairly simple:
One must express the modified Cas9 protein and the appropriate sgRNA, and
cleavage will usually occur at a high rate. Both can be driven from a single
plasmid. Cas9 is modified with a nuclear localization signal to deliver it to
the nucleus. Although it is sizable (the coding sequence is about 5 kb long),
expressing it rarely poses problems. Guide RNA design is in principle simple,
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but choice of target is not. Although CRISPR activity is usually efficient
and specific, it is known to have a complex dependence on the exact sequence
context of the target[24]. Fortunately, the CRISPR site need not be exactly
at the target – induction of double-strand break in relative proximity of the
desired replacement is often sufficient. Because of this, it is worthwhile to
hedge by generating multiple guides for every genomic target and empirically
testing their activity. This is the route I have taken in my own research.
1.2 Cross-species Ortholog Complementation in Yeast
Humanization in a broad sense of simply introducing human genes into
yeast is an established research strategy. It was instrumental in revealing
the biology of key pathways[25] and proteins such as RAS[26], CDC2[27] and
PIF1[28]. Systematic, genome-scale humanization studies have opened new
horizons for this field and attracted a great deal of interest[8]. In this publi-
cation, yeasts from a deletion library were complemented with human genes
(Figure 1.2). The study focused on human orthologs of essential yeast genes
— with the surprising finding that in roughly half of the cases the yeast gene
can be swapped with its human ortholog.
When a cross-species ortholog is complementing an essential function,
disrupting that ortholog should logically bring about a phenotype correspond-
ing to disruption of that function. The phenotype of a mutant complementing
ortholog might be the same as that for mutations of the native yeast gene, or
it may be a novel phenotype. Regardless, the mere presence of the phenotype
7
is sufficient to detect disruption of function. For example, dysfunctional mu-
tants of human genes can be compared to their wild types on the basis of their
phenotype in humanized yeast, even if the phenotype does not match or even
resemble that of the dysfunctional mutant in humans. This recalls the concept
of phenologs[30, 29] wherein conserved and related genetic modules, many of
their constituents orthologous will also have conserved molecular responses to
genetic disruption. This response may be manifested in very different ways
according to the physiology of each organism. However, disruption of a con-
served genetic element in a pair of species would similarly induce a phenotype
for both species, even if it is not the same phenotype. Phenologs have been
used to identify human drugs in the context of very dissimilar organisms[31].
Humanoid yeast can be regarded as a case of augmented phenologs, where
the introduction of human genes enables a higher degree of correspondence to
human physiology. Humanized genes in yeast would not generate the same
phenotype as in humans, but mutations and active drugs identified through
screens for phenotypes in yeast would be high-value targets to investigate for
the same activity in humans[32]. There have been recent pioneering studies
demonstrating that humanized yeast is a viable platform for screening human
alleles[33]. Such humanization assays can identify deleterious mutant alle-
les with considerably better performance than computational methods, while
still recapitulating many computational findings [34]. There are thousands of
yeast-human orthologs[35]; but in cases where suitable ortholog pairs are not
available, it is still feasible to apply humanization assays via paralogs[36].
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1.3 This Thesis
In Chapter 2, I will present research involving systematic swapping of
several yeast genes with their orthologs from humans, bacteria, plants, and
archea[37]. This research yielded interesting insights into evolution (such as
localization of metabolic activity) and also expanded on the general results
of a similar earlier study[8]. The work described here gives particular atten-
tion to the heme biosynthesis pathway in yeast, which is has a very universal
role across the tree of life. In yeast, it participates in respiration and main-
tenance of the cellular envelope. In humans, orthologs of these genes are
involved in the production of hemoglobin and are implicated in porphyria dis-
ease. In plants, they are involved in chlorophyll production and are frequently
targeted by pesticides. An interesting finding was that the bacterial orthologs
mislocalize in yeast and cause significant impairment, with a phenotype highly
reminiscent of human porphyria. This serendipitous discovery is an excellent
demonstration of how ortholog swapping in yeast can help us understand the
phenotype-genotype relationship even in organisms very distantly related to
yeast.
In Chapter 3 I present a detailed protocol for CRISPR-mediated yeast
humanization and genome editing, which was developed alongside the work
in Chapter 2 and contributed to that work as well. The exciting findings we
observed for heme are only the beginning: There is a wealth of biology to be
learned from expanding this approach to more pathways and complexes. My
hope is that the protocol we developed will serve as a foundation for ortholog
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swapping experiments on a massive scale.
In Chapter 4 I describe my latest work in building upon and expanding
on the two previous chapters. I have endeavored to find the limit of humaniza-
tion of the heme pathway and explore the idea of whole-pathway humanization.
I describe using these humanized strains to survey epistasis and evolution of
genetic modules.
Chapter 5 takes a different turn into the interface of digital storage and
biotechnology. Here I propose a system for encoding digital data as DNA which
can be stored in living cells such as yeast. With the invention of computers,
electronic data storage rapidly displaced paper due to its many advantages.
However, it has a significant disadvantage: Longevity. Conversely, billions of
years of evolution have molded DNA into the ultimate information store. It
also enables storage densities higher than what is possible with digital circuits.
Lastly, every new storage technology necessarily requires the establishment of
new infrastructure[38]. DNA is the exception, the tools for reading and writing
it already exist, and will conceivably continue to exist so long as civilization
endures. Even after our civilization ends, any future civilization will almost
certainly rediscover them. In this sense, DNA seems a poetic solution to the
data storage problem. This work also continues my theme of exploring the
frontiers of synthetic biology in the 21st century.
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Figure 1.1: The delitto perfetto method of yeast genome editing[5]. (Continued on next
page.)
11
Figure 1.1: The delitto perfetto method is a two stage process. First, homologies to the target region of
the genome are added to a selectable cassette. The cassette is transformed into yeast cells, and selected
for. Yeast has a very low background rate of DNA breakage, on the order of 10−6. When a large number
of cells is transformed, DNA breakage will appear close to the target site in some cells, and its repair will
result in incorporation of the cassette. Though these cells are a tiny minority, they can be selected via the
marker in the cassette (e.g. URA3, selected for with -Ura medium). The marker also carries a recognition
site for the I-SceI endonuclease. Once clones carrying the cassette have been isolated, they can be taken
through the second step: I-SceI is expressed (e.g. from a plasmid) while the actual repair template carrying
the desired sequence is introduced. I-SceI begins to cleave the genome at the cassette, which triggers the
DNA repair once again, and this time results in replacement of the cassette with the desired sequence.
Because URA3 is counter-selectable by culture on 5-FOA, its elimination can also be selected for.
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Figure 1.2: Overview of the humanization method in [8]. In this
study, heterozygous deletion strains of essential yeast genes with 1:1 human
orthologs were obtained from a deletion library. The human ortholog, under
control of a constitutive promoter, was introduced into these yeasts. After-
wards, they were sporulated and tetrads were dissected to obtain haploid cells
which have the null allele. Because the gene is essential, all 4 spores can be
obtained only if the human gene was able to complement the deletion. If the
gene was not replaceable, only 2 spores (with the wild type allele) would be
obtained.
13
Chapter 2
Systematic Bacterialization of Yeast Genes
Identifies a Near-universally Swappable
Pathway
After the surprising discovery that a large number of yeast genes can
be successfully humanized, I became interested in the extent to which com-
plementation is still viable across the tree of life. To this end, I collaborated
with Aashiq Kachroo and Jon Laurent on a project where we used genomic
editing to attempt replacement of yeast genes with not just human, but also
plant and bacterial orthologs.
The biosynthesis of heme stood out as a striking example of universal
replaceability. This pathway is known for its role in human biology because
it produces a porphyrin molecule, which is complexed to iron in the final step
of the pathway and becomes a component of hemoglobin. However, heme it-
self also has other roles, such as participating in the cellular respiration as an
electron acceptor, which is why it is found in many other organisms that do
not have blood, like yeast or bacteria. In yeast, the pathway is also neces-
This chapter was previously published in Kachroo AH, Laurent JM, Akhmetov A, et al.
(2017) Elife, 6:e25093. I contributed to conducting the initial replacement experiments,
validation of the results, follow up work, analysis, and writing.
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sary for the synthesis of ergosterol, which is unique to fungi and an essential
component of their cellular membrane. In plants, one of the intermediates
in this pathway is the precursor of chlorophyll synthesis. In sum, heme and
therefore its biosynthesis, have a central and fundamental role in almost all
living organisms. It also has similarly critical secondary roles across kingdoms
and domains of life. Because of this, that it can be swapped at all between
organisms as divergent as S. cerevisiae, E. coli, A. thaliana and H. sapiens
is in itself startling. But furthermore, in-depth analysis of these swaps can
shed new light on key evolutionary questions. This is elaborated in detail in a
report describing our work, which was published in the journal eLife[37].
15
2.1 Abstract
Eukaryotes and prokaryotes last shared a common ancestor 2 billion
years ago, and while many present-day genes in these lineages predate this di-
vergence, the extent to which these genes still perform their ancestral functions
is largely unknown. To test principles governing retention of ancient function,
we asked if prokaryotic genes could replace their essential eukaryotic orthologs.
We systematically replaced essential genes in yeast by their 1:1 orthologs from
Escherichia coli. After accounting for mitochondrial localization and alterna-
tive start codons, 31 out of 51 bacterial genes tested (61%) could complement
a lethal growth defect and replace their yeast orthologs with minimal effects on
growth rate. Replaceability was determined on a pathway-by-pathway basis;
codon usage, abundance, and sequence similarity contributed predictive power.
The heme biosynthesis pathway was particularly amenable to inter-kingdom
exchange, with each yeast enzyme replaceable by its bacterial, human, or plant
ortholog, suggesting it as a near-universally swappable pathway.
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2.2 Introduction
Despite over 2 billion years of divergence, eukaryotes and prokaryotes
still share hundreds of genes[41, 35, 39, 40]. Though these ancient genes
are identifiable as orthologs at the sequence level, the preservation of origi-
nal protein function across such deep timescales has not been systematically
explored. The function of certain genes could potentially become frozen in
place in the course of evolution, sheltered from lineage-specific functional al-
terations introduced by mutations, gene fusions, and non-orthologous gene
displacements. Such functionally frozen genes would in principle be able to
substitute for their least-diverged ortholog in any other species. Searching for
such gene replaceability between species thus serves to test a core assump-
tion of the ortholog-function conjecture: that orthologs retain ancestral func-
tion[42]. This conjecture forms the basis of most modern biomedical research
and is widely used to predict new gene function across organisms[43].
There are many individual examples of genes from one species func-
tioning for their orthologous counterparts in a different species[44, 45], but
this trend has only recently begun to be explored systematically, with several
large-scale studies substituting human genes for yeast genes and confirming
that many human orthologs can successfully replace their yeast counterparts[8,
34, 33]. At the level of evolutionary divergence of yeast and humans, such data
demonstrate widespread functional conservation, even after 1 billion years of
divergence. The ability of human genes to functionally replace their yeast or-
thologs is not strongly predicted by the similarity of sequences, but rather at
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the level of specific pathways or processes, wherein all genes in a process or
pathway tend to be similarly replaceable, or not[8].
However, in the timescale of evolution, yeast and humans are relatively
similar – both eukaryotes that share thousands of genes and the majority of
their core biological processes. Data on eukaryote – prokaryote functional
gene replacement are sparse[45]. These cross-domain replacements represent a
maximum test of the ability of genes to retain their ancestral function across
time. Eukaryotic and bacterial genes have been, for the most part, evolving
independently since at least the archaeal ancestor of eukaryotes endosymbi-
otically acquired its bacterial mitochondrion. In eukaryotes, the function of
these genes would have had to survive the development of vastly different
genome structures, cell division modalities, cell wall compositions, and subcel-
lular compartmentalizations which occurred during eukaryogenesis. Prokary-
otic and eukaryotic orthologs also diverged significantly at the amino acid se-
quence level[35] and evolved distinct expression patterns and codon usages[47,
46]. Nonetheless, eukaryotes and bacteria are known to use many of the same
orthologs to perform the same metabolic enzymatic reactions[48, 49].
Thus, in order to more systematically determine the replaceability of
orthologs across such deep timescales, we asked in this study how many con-
served E. coli genes can successfully substitute for their yeast orthologs. We
focused on those genes that are essential for viability in yeast, allowing us to
assay for the complementation of otherwise lethal growth defects. We analysed
many features of the proteins and ortholog pairs to identify which properties
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best explained replaceability, finding that replaceability was often determined
at the level of specific pathways and processes, with all genes in a pathway
or process similarly replaceable. Start codon choice and eukaryote-specific
subcellular localization were also critical determinants of replaceability. We
discovered that certain core biological processes have remained largely un-
changed since the last common ancestor of bacteria, yeast, and humans. In
particular, heme biosynthesis pathway enzymes appear to be generally ex-
changeable between prokaryotic and eukaryotic organisms, broadly retaining
ancestral functions across the tree of life over 2 billion years of independent
evolution, even when accompanied by evolved changes in enzyme subcellular
localization.
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2.3 Results and discussion
2.3.1 Many E. coli genes successfully complement lethal defects in
their yeast orthologs
Many E. coli genes successfully complement lethal defects in their yeast
orthologs We focused our efforts on the set of genes with 1:1 orthology be-
tween E. coli and yeast and that are known to be essential for yeast growth
in standard laboratory conditions (Figure 2.1A). Each E. coli open reading
frame (ORF) was cloned into a single-copy yeast centromeric (CEN) plasmid
under the transcriptional control of a constitutive GPD promoter. Comple-
mentation assays were carried out using two types of conditionally essential
yeast alleles, consisting of temperature-sensitive (TS) haploid and heterozy-
gous diploid deletion strains. In the case of the heterozygous diploid deletion
strains, the respective yeast gene null allele could be genetically segregated
via sporulation, allowing selection for haploid yeast with the null allele (se-
lected for in the presence of the antibiotic G418) or the wild-type yeast gene
(in the absence of G418) (Figure 2.1B, top panel). In the case of TS haploid
yeast strains, the temperature sensitive yeast proteins functioned normally at
the permissive temperature (25◦C) but could be conditionally inactivated at
the non-permissive temperature (36◦C) in order to test for gene replaceability
(Figure 2.1B, bottom panel). Overall, we could perform informative comple-
mentation assays for 51 of the 58 orthologs, as shown for the examples in
Figure 2.1B.
Of the 51 E. coli genes tested, 25 successfully complemented lethal
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growth defects in the corresponding yeast strains (Figure 2.2A, B and C;
Supplementary file 1). In nearly all cases, despite plasmid-based expres-
sion of the complementing genes, the bacterialized strains grew comparably
to the parental, wild type yeast strain, in both synthetic defined medium
(SD-Ura+G418) (Figure 2.1C) and rich medium (YPD+G418a) (Figure 2.2D).
We further verified complementation specificity by testing for plasmid loss (see
Materials and methods and supplementary file 1) and sequence verifying all
clones. We have previously demonstrated that plasmid-borne copies of yeast
genes complemented their corresponding heterozygous diploid deletion alleles
at a high rate (100% for 29 strains tested in [8]), but as an additional con-
trol, we repeated this test for six yeast strains where the E. coli gene failed
to rescue, confirming that the corresponding yeast genes were able to comple-
ment the growth defect when expressed on a CEN plasmid under the control
of the constitutive GPD promoter (Figure 2.3 and Sc-HEM1 as reported in
Figure 2.8).
2.3.2 Mitochondrial localization and start codon choice both affect
replaceability
Many eukaryotic orthologs of prokaryotic genes function in specific
subcellular compartments absent from prokaryotes, and consistent with this
trend, 15 of the 51 tested E. coli genes have mitochondrially-localized yeast or-
thologs[44]. Because all but one of these 15 genes were unable to replace their
yeast ortholog, we reasoned that lack of mitochondria targeting might account
for their failed complementation. We added the mitochondrial localization sig-
21
nal (MLS) from the yeast MIP1 gene to each of the 14 non-replaceable E. coli
genes and repeated the complementation assays. Four genes could now func-
tionally replace their yeast equivalents (Figures 2.4A, 2.5), restoring growth
rates to be nearly or fully comparable with the parental strain (Figure 2.4B).
We verified mitochondrial localization by fusing the E. coli Ec-MLS-HscB and
Ec-MLS-IlvD proteins with enhanced green fluorescent protein (EGFP) and
confirming correct trafficking of the EGFP-tagged proteins to yeast mitochon-
dria (Figure 2.4C).
Bacterial genes also occasionally lack a standard ATG start codon, with
∼14% of all E. coli ORFs employing an alternative start codon[50]. Three of
the tested non-replaceable E. coli genes used a GTG start codon while one
used ATT. We therefore used site-directed mutagenesis to introduce canonical
ATG start codons, then re-assayed for complementation. After changing their
start codons to ATG, two of these four E. coli genes, Ec-rcsC and Ec-tadA,
could now replace their yeast orthologs (Figure 2.4B).
Overall, after accounting for mitochondrial localization and alternative
start codons and combining results from all assays, a total of 31 out of 51
tested E. coli genes could successfully replace their essential yeast orthologs
(Figure 2.4). Thus, in a majority (61%) of our tests, both the current day
prokaryotic and eukaryotic proteins must have retained their critical ances-
tral functions such that the prokaryotic proteins could carry out the essential
roles of their eukaryotic orthologs well enough to support yeast cell growth.
In one-fifth of the cases, replaceability depended on proper subcellular local-
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ization or start codon choice to express the prokaryotic gene in the proper
eukaryotic context.
2.3.3 Replaceability varies strongly across different biological pro-
cesses
Given that we observed both replaceable and non-replaceable genes, we
sought to determine properties of the tested genes that best explained success-
ful replacements. We considered 22 features of the tested genes, including pro-
tein lengths, interactions, sequence similarities, codon usages, and expression
levels. We calculated the predictive utility of each feature as the area under a
Receiver Operating Characteristic curve (AUC) (Figure 2.6A; supplementary
file 2). Notably, the extent of protein sequence similarity between orthologs
was not a highly predictive feature. A large portion of the tested E. coli
and yeast orthologs showed only 20-30% identical amino acid sequences and
roughly half of these genes were replaceable; in contrast, the three most diver-
gent orthologs replaced, each showing less than 20% identity (Figure 2.6B). As
we observed a non-monotonic relationship between sequence identity and re-
placeability, potentially explained by replaceability differences among different
functional categories of genes, we tested for the enrichment of particular GO
Biological Process (defined by Gene Ontology Slim annotations[51] or KEGG
categories[52] within the individual bins of sequence identity in Figure 2.6B.
Aside from an enrichment in glucose metabolism genes (3 of the 7) in the
40-50% identity range, we did not find evidence for strong pathway-specific
biases that would explain the observed relationship between sequence identity
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and replaceability. We did observe moderate predictive power for some mea-
sures of codon bias, especially those related to codon optimality within E. coli,
and less so for codon optimality within a yeast context; more highly optimized
E. coli codon usage correlated with a lower replaceability rate.
Instead, the strongest predictive features related to specific pathways
and processes, much as we and others have observed for successful humaniza-
tion of yeast[8, 34, 33]. This trend was most evident in the observation that
a gene was more likely to replace (or not) if it had a higher fraction of inter-
action partners that also replaced (or not). Consequently, different biological
processes (as defined by GO) displayed varied replaceability, with metabolic
processes being largely replaceable, while processes known to be divergent, in-
cluding ribosomal processing, were much less replaceable (Figure 2.6C). This
trend suggests an explanation for why optimized E. coli codons predicted
worse replaceability, as E. coli genes with optimized codons predominantly
tend to be highly expressed ribosomal and translational proteins[53]. This is
thus consistent with the notion that replaceability is determined at the level of
the pathway or process, with codon choice and gene expression levels reflecting
functional constraints of that process. Combining all of these features into a
single predictor (after accounting for mitochondrial localization and alternative
start codons), using a random forest classifier, improved our predictive power
to a 0.79 AUC (Figure 2.6A), demonstrating that the features we investigated
provide moderately orthogonal predictive information.
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2.3.4 Each yeast heme biosynthesis enzyme can be replaced by its
E. coli equivalent, irrespective of orthology or localization
Nearly all the genes that we tested from the heme biosynthesis path-
way were replaceable by their E. coli orthologs, which in combination with the
evidence that replaceability was determined at the level of processes, led us to
investigate the heme pathway in more depth. Most of the enzymatic reactions
in the heme biosynthesis pathway are identical between E. coli and yeast,
but there are clear differences in the way this pathway functions between the
species[54]. First, heme biosynthesis pathway precursors differ: Yeast condense
succinyl-CoA and glycine to produce delta-aminolevulinate in a single enzy-
matic step catalyzed by Sc-Hem1, while E. coli produces delta-aminolevulinate
in two steps using glutamyl-tRNA as a precursor[55]. Second, the bacterial
heme pathway is largely cytosolic but in yeast it is partitioned between the
mitochondria and cytosol (Figure 2.7A). We thus next considered these two
key pathway differences in more detail. As a control, we first expressed the
corresponding yeast genes on plasmids either under the control of constitutive
GPD or the native yeast promoter[56] to test the effect of constitutive expres-
sion on functional replaceability. Except for Sc-HEM4, which showed toxicity
when expressed constitutively, all the other yeast genes showed functional re-
placeability irrespective of the mode of expression (Figure 2.8).
In our initial screen, the E. coli ortholog of Sc-HEM1, Ec-kbL, failed
to replace the yeast gene, an observation consistent with prior data showing
that Ec-kbL does not take part in E. coli heme biosynthesis, but rather carries
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out an unrelated but mechanistically-similar oxido-reductase reaction involved
in L-threonine degradation ([58, 57]). Instead, a two-step enzymatic reaction
by E. coli proteins Ec-HemA and Ec-HemL produces the heme precursor,
delta-aminolevulinate ([60, 59]). Since the initial steps of the pathway are lo-
calized to the mitochondria, we added the Sc-MIP1 MLS to the 5’ ends of these
genes and expressed them simultaneously in the Sc-HEM1 heterozygous diploid
deletion strain. Co-expression of the two E. coli genes successfully replaced
yeast gene function (Figure 2.9A). Additionally, two enzymes, Ec-HemD and
Ec-HemG, were not identified as orthologs between E. coli and yeast, despite
carrying out identical reactions to Sc-Hem4 and Sc-Hem14, respectively. Ex-
pression of these non-orthologous but functionally analogous E. coli genes in
the respective yeast deletion strains showed that they were indeed able to suc-
cessfully replace the yeast genes (Figure 2.9B). For these enzymes, the key
determinants for successful replacement are thus their enzymatic reactions,
rather than any other aspects of the genes.
Sc-Hem14 and Sc-Hem15 carry out the final two steps in yeast heme
biosynthesis and are localized to the mitochondria ([44, 61]) (Figure 2.7A).
Both genes were replaceable by the E. coli genes carrying out the analogous
reactions, Ec-HemG (Figure 2.9B) and Ec-HemH (Figure 2.1C), despite the
lack of targeting sequences for mitochondrial localization. As E. coli lack mi-
tochondria, and Ec-HemG and Ec-HemH are both predicted to localize to the
plasma membrane in E. coli [62], we thus assayed their localization in yeast
when expressed as EGFP-fusion proteins. Strikingly, both localized to the
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yeast plasma membrane (Figure 2.10). In spite of failing to localize to the
yeast mitochondria, the bacterialized strains grew well compared to wild type
yeast (Figure 2.10), suggesting that mitochondrial localization is not an abso-
lute requirement for their functions, as many heme pathway intermediates are
cytosolic. However, concurrent bacterialization of both yeast genes resulted
in a viable but defective yeast strain (Figure 2.9C), suggesting that the fit-
ness cost of mis-localizing both proteins is not tolerated well, potentially due
to cumulative effects of reduced efficiency of the bacterial proteins, altered
allosteric regulation in yeast, or the accumulation of heme precursors in the
wrong compartment (cytosol)[55].
Because heterologous expression using a constitutive promoter could
be compensating for more subtle functional differences, we also wished to
measure complementation after placing the bacterial orthologs under control
of the native yeast gene regulation. We thus used CRISPR/Cas9-based
precision genome engineering to genomically replace each of the heme
biosynthesis pathway genes in turn in yeast (except Sc-HEM12) with its
respective E. coli counterpart, from start to stop codon, while retaining
the native promoters, terminators, and chromosomal context of the yeast
genes (Figure 2.7B, 2.11). All strains but two grew comparably to the
wild-type; the Sc-hem14Δ::Ec-hemG and Sc-hem15Δ::Ec-hemH strains
showed modest growth defects (Figure 2.7B). Because these two yeast
proteins are known to be mitochondrially localized[44], we re-engineered
each of the Ec-hemG and Ec-hemH ORFs into the yeast chromosome such
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that each gene’s native yeast MLS was retained (Sc-hem14Δ::Ec-MLS-hemG
and Sc-hem15Δ::Ec-MLS-hemH). The addition of the yeast MLS to each
E. coli ORF completely ameliorated growth defects from the ORFs alone
(Figure 2.7B).
Thus, the yeast heme biosynthesis pathway appears entirely replace-
able, one gene at a time, by their corresponding bacterial genes, whether ex-
pressed constitutively from plasmids or directly integrated into chromosomes
under native yeast transcriptional regulation. The extent of replaceability
strongly suggests that ancestral functions in these genes (with the obvious ex-
ception of the non-orthologous steps) have remained intact and unaltered, at
least in terms of critical, enzymatic functionality. Mitochondrial localization
of several of the enzymes, while needed to fully recover growth rates, is not
essential for viability.
2.3.5 Bacterialization with the E. coli ferrochelatase induces a
yeast phenotype resembling human porphyria
Ec-hemH and Sc-HEM15 encode ferrochelatase, the enzyme responsible
for adding iron to the porphyrin ring of protoporphyrin IX to produce proto-
heme (Figure 2.7A). In the course of constructing the CRISPR-edited yeast
strains, we noticed that the Sc-hem15Δ::Ec-hemH yeast strain turned pink on
a standard YPD agar medium upon prolonged incubation of 3–4 days (Fig-
ure 2.12A). This phenotype was consistent across all independently obtained,
sequence verified yeast clones. The pink phenotype decreased dramatically
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in the Sc-hem15Δ::Ec-MLS-hemH strains in which Ec-HemH was correctly
localized to the mitochondria by addition of an MLS.
We speculated that the pink phenotype was likely due to aberrant
accumulation of porphyrin intermediates, presumably leading to their secre-
tion, as we observed that the pigment could be washed off the cells. There-
fore, we chemically extracted the pink pigment from Sc-hem15Δ::Ec-hemH,0
Sc-hem15Δ::Ec-MLS-hemH and wild type yeast cells (Materials and methods)
and performed fluorescence spectroscopy to determine that the pigment likely
corresponds to protoporphyrin IX (Figures 2.12B, 2.13).
In order to determine whether protein mis-localization contributed to
the phenotype, we removed the MLS from the native yeast gene. Several
clones of the Sc-ΔMLS-HEM15 yeast strain displayed similar extracellular
pigment (Figures 2.12B, 2.13). These results suggest that mislocalized plasma
membrane-bound Ec-HemH in yeast does not convert protoporphyrin IX to
protoheme efficiently, resulting in the accumulation and secretion of proto-
porphyrin IX. We further tested this line of reasoning by deleting the gene
for the preceding step in the pathway, Sc-HEM14, which encodes the enzyme
protoporphyrinogen oxidase and is responsible for making protoporphyrin IX.
Using CRISPR, we deleted the Sc-HEM14 ORF in wild type BY4741,
Sc-hem15Δ::Ec-HemH, and Sc-hem15Δ::Ec-MLS-HemH strains. Consistent
with protoporphyrin IX being the pink pigment in the Sc-hem15Δ::Ec-HemH
strain, the Sc-hem15Δ::Ec-HemH hem14Δ strain lost the pink phenotype,
even after growing for 6 days. Moreover, we observed that all strains carrying
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the hem14Δ allele were in fact significantly paler than even wild type BY4741
cells, presumably reflecting extensive protoporphyrin IX depletion in these
cells (Figure 2.14).
In humans, disrupting heme biosynthesis leads to the disease porphyria,
and the secretion of porphyrin intermediates is specifically observed in a sub-
type known as protoporphyria[63], wherein reduced activity of the human
heme pathway protein Hs-FECH leads to accumulation and subsequent secre-
tion of protoporphyrin IX into surrounding tissues. Our data suggest that
yeast protein localization and protoporphyrin secretion phenotypes might in
the future be exploited to investigate disease-causing mutations in human
Hs-FECH, even in cases where disease variants do not show any discernible
growth defect in yeast.
2.3.6 Most yeast heme biosynthesis enzymes can also be success-
fully plant-ized
The data above show that genes in the yeast heme biosynthesis path-
way can be replaced by their bacterial counterparts, extending earlier studies
demonstrating that some heme biosynthesis genes can also be humanized ([8,
34, 64]). Given the ancient conservation of this pathway, we sought to further
expand our investigation of its replaceability by swapping the corresponding
genes from the plant Arabidopsis thaliana into yeast. In plants, heme biosyn-
thesis enzymes form precursors for chlorophyll, and the pathway is largely
chloroplast-localized, in contrast to compartmentalization of the heme biosyn-
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thetic pathway between the mitochondria and cytosol in many other eukary-
otes ([58, 51, 65]). Nonetheless, the fact that Arabidopsis ferrochelatase was
cloned by complementing a mutant yeast phenotype suggests that other heme
pathway genes might also successfully replace the yeast genes[66].
The first enzymatic step in the plant heme biosynthetic pathway is sim-
ilar to bacteria, a two-step reaction using glutamyl-tRNA as a substrate (Fig-
ure 2.15A,B)[67]. We expressed both plant genes, At-HEMA1 and At-GSA2,
simultaneously and were able to functionally replace the corresponding yeast
gene function. Neither protein, when individually expressed, could function-
ally replace the yeast gene (2.16A).
In Arabidopsis, unlike for the case of E. coli, a majority of genes in
the heme biosynthesis pathway have acquired lineage-specific amplifications,
resulting in two co-orthologs for each single yeast gene (Figure 2.15B). In
these cases, we tested both co-orthologs individually for replaceability; all re-
placed successfully, with the exception of one case where only one replaced
(At-CPX1 replaced while At-CPX2 did not), and one case where neither re-
placed (At-HEME1 and At-HEME2) (Figures 2.15B and 2.16B).
Because the plant heme biosynthesis pathway builds precursors for
chlorophyll synthesis[68, 69], this pathway, especially the penultimate step pro-
ducing protoporphyrin IX, is the target of many commercial herbicides. Both
Arabidopsis paralogs that we tested, At-PPOX1 and At-PPOX2, could effi-
ciently complement the yeast gene responsible for this critical step, Sc-HEM14
(Figure 2.16B). To confirm the generality of these results, we further tested the
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soybean (Glycine max) ortholog Gm-HEMG in yeast. As for each of the Ara-
bidopsis paralogs, the single soybean ortholog also successfully complemented
the Sc-HEM14 deletion growth defect (Figure 2.16B).
It is noteworthy that plant heme biosynthesis genes harbor chloroplast
localization sequences[58], and we did not remove these for our complementa-
tion experiments. We speculated that the chloroplast leader peptides might
be recognized and localized by the yeast mitochondrial localization machinery,
so we constructed EGFP-fusions of the plant enzymes and assayed their local-
ization by fluorescence microscopy. EGFP fusions of At-PPOX1 and At-FC1
showed clear mitochondrial localization in yeast (Figure 2.17A). At-FC1 ad-
ditionally showed amorphous aggregates in some yeast cells, suggesting lo-
calization might occasionally be imperfect. Nonetheless, both EGFP-tagged
genes were able to efficiently rescue the growth defect of the corresponding
yeast gene deletion (Figure 2.17A). Thus, these plant chloroplast localization
signals appear to be recognized and processed as mitochondrial localization
signals in yeast.
These findings suggested that plant versions of cytosolic yeast heme
biosynthesis pathway proteins could potentially be mis-localizing to the mito-
chondria in yeast (Figure 2.7A). Indeed, At-HEMC only weakly replaced the
yeast gene, Sc-HEM3. We found that removing the chloroplast localization
signal (CLS) from At-HEMC markedly enhanced its ability to functionally re-
place its yeast ortholog (Figure 2.16B). In contrast, neither of two Arabidopsis
paralogs, At-HEME1 and At-HEME2, could functionally replace their yeast
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ortholog, Sc-HEM12, even after removing their CLS sequences, or even when
co-expressed in the yeast strain (Figure 2.16B). We speculate that there could
be several other reasons why complementation failed, including unknown inter-
mediate reactions, required localization in a special compartment (e.g. chloro-
plast) or different transcriptional/translational regulation in plants that might
contribute to the lack of functional replaceability.
2.3.7 Each yeast heme biosynthesis enzyme can be replaced by its
human ortholog
Earlier studies have shown successful replacement of the yeast heme
biosynthesis genes by their human orthologs Hs-ALAD ([64]), Hs-HMBS,
Hs-CPOX and Hs-FECH[8], while Hs-UROS expression resulted in toxicity
and Hs-UROD failed to replace its yeast ortholog[8, 34]. We, therefore,
sought to complete tests of the remaining human genes in the pathway. In
the case of Hs-UROS, we reasoned that toxicity was due to expression from
the heterologous constitutive promoter (2.18A). Indeed, similar to the results
obtained with the yeast version of this gene (Figure 2.8, Sc-HEM4), we found
that toxicity could be abrogated by inserting the human gene at the native
yeast chromosomal locus, thus providing native yeast gene expression and
regulation for the human ORF (2.18B). This suggests that, at least in yeast,
this step is regulated transcriptionally for optimal function. We also found
that the human ORFeome clone of Hs-UROD contained a mutation (G303V)
that when reverted to wild-type sequence allowed it to replace the yeast gene
(Figure 2.18C,D), and we additionally confirmed that human Hs-PPOX could
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complement the severe growth defect of the yeast Sc-HEM14 deletion strain
(2.15C, 2.18D). Finally, in humans, the initial step of heme biosynthesis is
identical to that of yeast (Sc-HEM1) but is encoded by two co-orthologs,
Hs-ALAS1 and Hs-ALAS2. We found that both of these human genes could
individually replace the yeast gene function (2.15C, 2.18D).
The subcellular localization of heme biosynthesis differs slightly be-
tween humans and yeast, such that the last three proteins in the human heme
biosynthesis pathway are mitochondrially localized, as opposed to only the last
two in yeast[71, 70]. As all three of these genes replaced, we tested if the hu-
man genes were localized to the mitochondria in yeast. Indeed, EGFP-tagged
Hs-FECH, Hs-PPOX, and Hs-CPOX all localized to mitochondria in yeast
(2.17B) and efficiently rescued the growth defect of the corresponding yeast
gene deletion (2.17B), confirming that the human mitochondrial localization
signal is recognizable by the yeast localization machinery. Thus, across our
attempts to humanize, plantize, and bacterialize this pathway, the presence
of mitochondrial leader peptides from the human genes and the chloroplast
leader peptides from the plant genes, as well as the absence of bacterial lead-
ers, all overrode the native yeast localization of the heme biosynthesis pathway.
However, the pathway function was largely resilient to these effects, with the
exception of protoporphyrin IX accumulation in the mislocalized bacterialized
strains (2.12).
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2.3.8 Heme biosynthesis is a near-universally swappable pathway
As illustrated in 2.19, the heme pathway has had a complicated evo-
lutionary trajectory in eukaryotes due to endosymbiotic events, which has
served to increase its similarity between bacteria and eukaryotes[72]. During
eukaryogenesis, early eukaryotes adopted a large portion of the bacteria-like
heme biosynthesis pathway of their endosymbiont mitochondria. The sub-
sequent endosymbiotic acquisition of chloroplasts along the plant lineage[73]
resulted in redundancy between mitochondrial-origin and chloroplast-origin
portions of their heme biosynthesis pathways, a state that can be observed
today in Euglena, a non-plant, photosynthetic eukaryote with more recently
acquired chloroplasts[72]. Over time, plants kept the chloroplastic system and
lost most of the mitochondrial system. These evolutionary transfers may have
been possible due the apparent modularity of the heme pathway, which we ob-
serve in its high tolerance for substituting genes or enzymatic functions across
species.
Our data demonstrate that despite 2 billion years of divergence from
their last common ancestor, heme biosynthesis genes are still carrying out a
conserved and necessary function that can be swapped into yeast with mini-
mal effect on growth and irrespective of orthology and subcellular localization.
Taking these data together with literature studies showing successful replace-
ment of the E. coli Ec-hemG gene by the plant or human Hs-PPOX gene[75,
74, 76], and that introducing the protoporphyrinogen oxidase from Bacillus
subtilis into plants improves yields[77], heme biosynthesis thus appears to be
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a pathway whose genes are freely exchangeable between bacteria, plants (with
the exception of At-HEME), humans, and yeast2.19.
2.3.9 Conclusions
In conclusion, in order to discern whether orthology strictly confers
function across deep evolutionary distances, we systematically tested E. coli
genes with 1:1 orthology to essential yeast genes for their ability to func-
tionally replace their yeast counterparts. We discovered that ∼61% (31/51)
of the tested E. coli and yeast genes still retain ancestral function to a suf-
ficient extent that the bacterial genes efficiently replace their yeast equiva-
lents. Eukaryote-specific features such as subcellular localization (4 of 14) and
proper start codon usage (2 of 4) were critical for swappability for some of
the E. coli orthologs. Our analysis of replaceable/non-replaceable orthologous
pairs revealed that amino acid sequence similarity was not the most impor-
tant property, consistent with a general trend for sequence conservation to
often more strongly reflect other attributes of protein function (e.g., abun-
dance and protein-specific functional constraints) ([78, 79]). Rather, the top
predictors of replaceability were features attributed to specific gene modules.
These results largely agree with previously published work on humanization
of yeast genes[8, 33, 34], suggesting that functional replaceability is predom-
inantly determined at the level of pathways and processes, even across very
large evolutionary distances. As our assays can be considered a form of forced
horizontal gene transfer, our results provide support for the “complexity hy-
36
pothesis”[80], which posits that informational (transcription, translation, etc.)
genes are less likely to be horizontally transferred than those genes that are op-
erational (metabolism, housekeeping, etc.). Consistent with this expectation,
we see metabolism-associated genes replacing more often than those involved
in “informational” processes like transcription or translation.
In the course of these studies, we found that heme biosynthetic reac-
tions were entirely replaceable across the prokaryote-eukaryote divide, despite
non-orthologous functional displacement and lack of eukaryotic subcellular lo-
calization by native E. coli genes (2.19). Although the archaeal pathway is
considerably diverged, our studies across bacteria and eukaryotes showed a
high degree of replaceability: Plant heme biosynthesis enzymes functionally
replaced yeast enzymes in all but one reaction. Swaps of the corresponding
human enzymes into yeast in this and prior studies all suggest that heme
biosynthesis is a near universally replaceable pathway.
Our results thus demonstrate that orthologous genes carry out similar
functions that allow for their ability to functionally replace each other across
even the 2 billion year evolutionary rift separating prokaryotes and eukaryotes
from their last common ancestor. These swaps allow engineering of orthologous
pathways in model organisms highly amenable to genetic perturbations, like
yeast and bacteria, for further characterization.
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2.4 Materials and methods
2.4.1 Construction of ORFs from bacteria, plants, and humans in
yeast expression vectors
Refer to Supplementary file 3 for all the primers used in this study.
2.4.1.1 E.coli ORF yeast expression vectors
Initial E. coli ORF primers were designed such that the 3’ ends of the
primers had homology to E. coli genes and 5’ ends contained a universal flank-
ing sequence. A second round of PCR was performed with primers recognizing
the universal flanking sequence and also having 5’ ends corresponding to gate-
way compatible attL1 (or attB1) and attL2 (or attB2) sequences on the for-
ward and reverse primers, respectively. Resulting PCR products from attL se-
quence containing primers were directly cloned via gateway LR cloning (Ther-
moFisher Scientific) into yeast destination vector pAG416GPD-ccdB (Ad-
dgene) to create expression clones. PCR products from attB primers were
subcloned via gateway BP cloning into vector pDONR221 (ThermoFisher Sci-
entific) to create entry clones. These entry clones were then cloned via gateway
LR to the pAG416GPD-ccdB destination vector to create expression clones.
Some E. coli genes were synthesized as gBlocks from IDT and made gateway
compatible by adding attL1 and attL2 sequences at the 5’ and 3’ ends, re-
spectively, making them compatible for direct LR cloning to create expression
vectors.
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2.4.1.2 Plant ORF yeast expression vectors
Arabidopsis thaliana ORFs were PCR amplified from cDNA obtained
as a kind gift from Dr. Jeffrey Chen (UT Austin), using primers specific to each
gene and containing gateway compatible attL1 and attL2 sequences at the 5’
and 3’ ends respectively (Supplementary file 3). PCR products were directly
cloned into the yeast expression vector pAG416GPD-ccdB by LR gateway
cloning (using LR clonase II from Invitrogen). At-HEME1 and At-HEMB2
were synthesized as gBlocks from Integrated DNA Technologies (IDT).
2.4.1.3 Plant ORF yeast expression vectors without the chloroplast
localization signal
In order to remove the chloroplast localization signal from the plant
proteins At-HEMC, At-HEME1 and At-HEME2, we first performed amino
acid sequence alignment with the bacterial and yeast orthologs to identify
unaligned N-terminal sequence. We attributed the non-alignment to the pres-
ence of chloroplast localization signal (CLS) sequence. We also used the Tar-
getP 1.1 signal peptide predictor[81] to corroborate the sequence alignments.
In the case of At-HEMC, 68 N-terminal amino acids were deleted while retain-
ing ATG start codon. Similarly, in the case of At-HEME1 and At-HEME2, 47
N-terminal amino acids were deleted while retaining the ATG start codon. We
synthesized these genes as gBlocks (IDT) with attB1 and attB2 attachment
sites flanking their 5’ and 3’ ends, respectively, then subcloned the gBlocks
into the entry clone pDONR221, sequence-verified the clones, and LR cloned
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the genes into yeast expression vector pAG416GPD-ccdB.
2.4.1.4 Plant ORF yeast expression vectors for co-expression of
At-HEME1 and At-HEME2
At-HEME1 and At-HEME2 were cloned (with or without CLS)
into the destination vectors pAG416GPD-ccdB and pCMY41 (kind gift of
Christopher Yellman; pCMY41 is identical to pAG416GPD-ccdB but carries
a hygromycin-resistance cassette), allowing us to co-transform two plasmids
and select for the double plasmid transformants on synthetic defined medium,
-Ura+Hyg (200 µg/ml).
2.4.1.5 Human ORF yeast expression vectors
Human ORF’s were obtained from the ORFeome collection (GE Dhar-
macon) and sequenced to verify correct, full-length clones. In the case of
human Hs-UROD, the ORFeome clone contained a loss-of-function mutation
(G303V), so wild-type human Hs-UROD was synthesized as a gBlock frag-
ment (IDT) and used as a PCR template, amplifying the gene using primers
with flanking gateway compatible sites attL1 and attL2 at the 5’ and 3’ ends
respectively (Supplementary file 3). The PCR product was subcloned by LR
reaction into the yeast expression vector pAG416GPD-ccdB.
2.4.1.6 Yeast ORF yeast expression vectors
Yeast ORFs were amplified using PCR from genomic DNA of yeast
strain BY4741, and gateway compatible attL1 and attL2 sequences added
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by PCR to the amplicons 5’ and 3’ ends, respectively (Supplementary file
3). The resulting PCR products were subcloned by LR reaction into the
yeast expression vector pAG416GPD-ccdB. Several yeast heme biosynthesis
genes were first cloned in pENTR/SD/D-TOPO plasmid (Invitrogen) to obtain
gateway entry clones (refer to Supplementary file 3 for primers). These clones
were sequence-verified and then used to generate yeast expression vectors by
LR reaction into the vector pAG416GPD-ccdB.
2.4.1.7 Mitochondrially-localized E. coli ORF yeast expression
vectors
We added the MLS from the yeast MIP1 gene to the 5’ end of selected
E. coli ORFs via PCR, using an ORF-specific ultramer containing the full
MLS-coding sequence at the 5’ end such that MLS was in frame with the
coding sequence of the E. coli gene while removing the E. coli gene start codon
(Supplementary file 3). Each PCR product was then used as a template to add
gateway cloning attachment sites attL1 and attL2, followed by LR gateway
cloning into pAG416GPD-ccdB to generate yeast expression vectors.
2.4.1.8 EGFP tagged E. coli/plant/human ORF yeast expression
vectors
Using PCR, we amplified E. coli/plant/human ORFs without their
respective stop-codons while also adding attB1 and attB2 gateway attachment
sites at the 5’ and 3’ ends of each PCR product (Supplementary file 3).
The resulting PCR fragments were subcloned into plasmid pDONR221
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to generate gateway entry clones using the BP gateway cloning reaction.
Each entry clone was subjected to the LR cloning reaction in order to
generate a carboxy-terminal EGFP-tagged yeast expression clones in the
pAG416GPD-ccdB-EGFP destination vector.
2.4.1.9 Converting E. coli ORF yeast expression vectors with al-
ternative start codons to ATG start codon
We introduced ATG start codons by PCR mutagenesis, employing
ATG-containing primers (Supplementary file 3) to amplify and simultaneously
add gateway cloning attachment sites attL1 and attL2 to the 5’ and 3’ ends
of the PCR products, respectively, then subcloning these products by the LR
gateway cloning reaction into the pAG416GPD-ccdB plasmid in order to con-
struct yeast expression vectors.
2.4.1.10 E.coli and Arabidopsis two-gene expression vectors for
complementing a yeast Sc-HEM1 deletion
E. coli genes Ec-hemA, Ec-hemL and plant genes At-HEMA1, At-GSA2
were PCR amplified from genomic DNA (E. coli) or gBlocks obtained from
IDT (Arabidopsis). For E. coli genes, we also added an MLS at the 5’
end of the PCR products. These PCRs were made Golden Gate compati-
ble by introducing Bsmb1 sites and cloned individually in pYTK001 (Sup-
plementary file 3). In the case of At-HEMA1, the gBlock was synthesized
to mutate an internal BsmBI site such that it doesn’t affect the protein se-
quence. Clones were sequence verified prior to assembly ([23]). Individual
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transcription units for each of the genes were obtained by Golden Gate as-
sembly using the pYTK001-entry clone containing the E. coli or plant gene,
along with pYTK vectorscontributing promoters and terminators. In the case
of Ec-hemA and At-HEMA1 transcription units (TU1’s), the pHHF2 pro-
moter was contributed by pYTK012 and tADH1 terminator by pYTK053. In
the case of Ec-hemL and At-GSA2 transcription units (TU2’s), the pTEF1
promoter was contributed by pYTK013 and tSSA1 terminator by pYTK052.
Unique contigs for directional assembly were obtained from pYTK002 (ConLS)
and pYTK067 (ConR1) for TU1. For TU2, the unique contigs were obtained
from pYTK003 (ConL1) and pYTK072 (ConRE). The individual transcrip-
tion units (TU1 and TU2) were then assembled in a single yeast CEN6-URA
vector via Golden Gate assembly with BsmbI.
All clones were sequence-verified using the University of Texas Genomic
Sequencing and Analysis Facility.
2.4.2 Functional complementation assays
Gene replaceability was tested using available yeast strains from two
yeast strain collections, the temperature-sensitive (TS) collection ([82]) and
the heterozygous diploid deletion magic marker collection ([83]), as follows:
2.4.2.1 Temperature-sensitive (TS) collection assays
Typically, yeast strains in this collection grow at permissive temper-
atures (22–26◦C) but cannot grow at restrictive temperatures (35–37◦C).
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Growth at restrictive temperatures thus allows for the identification of foreign
genes that complement the yeast defect. We tested for replaceability in
temperature-sensitive yeast strains as follows:
The strains were transformed with either an empty vector control
(pAG416GPD-ccdB) or with the clone expressing the foreign gene. The
transformants were plated on:
1. Ura dextrose medium at the permissive temperature (25◦C), serving as a
control for transformation efficiency and/or toxicity since both the yeast
and the human gene are expressed.
2. Ura dextrose medium at the non-permissive temperature (36◦C), testing
for functional replacement under conditions in which the corresponding
yeast gene is non-functional.
2.4.2.2 Heterozygous diploid deletion magic marker collection as-
says
The yeast heterozygous diploid deletion magic marker collection com-
prises yeast strains that harbor a deletion of one copy of a yeast gene re-
placed with a KanMX cassette. The strains also carry a magic marker or
synthetic genetic array (SGA) cassette at the can1 locus, which enables selec-
tion for haploid cells on magic marker (MM) medium (-His -Arg -Leu +Can)
post-sporulation with or without antibiotic G418 (200 µg/ml). Haploid a-type
spores that harbor a wild type gene grow normally on magic marker (MM)
medium without G418 and provide a test of sporulation efficiency and toxic-
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ity, if any, associated with heterologous expression of the foreign gene (using a
-Ura selection marker in this study). Growth of haploid spores on MM medium
in the presence of G418 selects for yeast cells that harbor the relevant gene
deletion while testing for complementation by the foreign gene.
Expression clones or empty vector controls were transformed into ap-
propriate strains and selected on -Ura G418 medium in a 96-well format. (Tox-
icity was inferred from a repeated failure to obtain transformants in the case of
expression clones compared to the empty vector control) Transformants were
re-plated on GNA-rich pre-sporulation medium containing G418 (200 µg/ml)
and histidine (50 mg/l). Individual colonies were inoculated in liquid sporu-
lation medium containing 0.1% potassium acetate, 0.005% Zinc acetate, and
incubated with vigorous shaking at 25◦C for 3–5 days, after which sporulation
efficiency was estimated by microscopy, and the mixture re-suspended in water
and equally plated on two assay conditions:
1. “G418 minus” magic marker dextrose medium (-His-Arg-Leu+Can-Ura),
incubated at 30◦C. The haploid spores that carry the wild-type yeast
gene grow in this medium acting as a control for sporulation efficiency.
This condition also assays for toxicity if the haploid spores carrying ex-
pression vectors fail to grow.
2. “G418 plus” magic marker dextrose medium (-His-Arg-Leu+Can-Ura)
containing 200 µg/ml G418. The resulting haploid deletion strain is
expected not to grow, providing an assay of replaceability for strains
carrying the expression vector. Cases with approximately equal num-
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bers of cells growing in the absence or presence of G418 were considered
functional replacements.
Positive assays were verified independently. Individual colonies were
isolated from selective plates and used for growth assays on YPD or magic
marker medium with G418 (Figure 2.1B, 2.2A). After growth on YPD with
G418, each strain was spotted on 5-FOA agar to test plasmid dependency
(Supplementary file 1). Only one strain (Ec-valS) failed that test.
2.4.3 Ortholog inference
Genes with 1:1 orthology between yeast and E. coli were obtained from
the Inparanoid 8 webserver ([84]) and filtered to an only yeast-essential set.
Orthologs to these selected yeast genes in human and Arabidopsis were down-
loaded from Inparanoid 8 and further refined by comparison to orthology cal-
culations by eggNOG4.5 ([85]), OMA ([86]), and reference to the evolutionary
history of the heme pathway in photosynthetic organisms ([73]).
2.4.4 Computational analyses of replaceability
2.4.4.1 Feature assembly
• Sequence features. Protein sequence features were calculated using
UniProt[58] proteomes from the respective species downloaded in
March 2015. E. coli nucleotide sequence features were calculated using
EcoGene ([87]) sequences downloaded April 2015.
– The number of amino acids in the respective protein.
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[Sc|Ec] Length
– Calculated as the difference of the amino acid length of the E. coli
protein subtracted from the length of the S. cerevisiae ortholog.
Sc-Ec LengthDifference
– Calculated as the absolute value of the above length difference.
Sc-Ec AbsLengthDifference
– The fraction of identical residues (PercentID) or similar
residues (PercentSimilarity) in a global alignment (NWalign,
http://zhanglab.ccmb.med.umich.edu/NW-align/) of the re-
spective orthologs, as a function of the longest of the two (Longest)
or the length of the aligned region (Aligned).
Sc-Ec PercentIDAligned
Sc-Ec PercentIDLongest
Sc-Ec PercentSimilarityAligned
Sc-Ec PercentSimilarityLongest
– The Codon Adaptation Index (CAI), Codon Bias Index (CBI),
or Frequency of OPtimal codons (FOP) for the respective E. coli
gene, calculated using the E. coli optimal codon table (Ec ) or
S. cerevisiae optimal codon table (Ec Sc) using codonw (http:
//sourceforge.net/projects/codonw/).
Ec CAI
Ec CBI
Ec FOP
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Ec ScCAI
Ec ScCBI
Ec ScFOP
• Abundance features.
– Yeast (Sc) protein abundance data was taken from [88]. Yeast Tran-
script and RPF abundance were taken from [89]. Yeast RPF abun-
dance is calculated as the ratio of RPF reads to Transcript reads
for a given gene. E. coli data was taken from [90] (average iBAQ
abundance only).
Sc TranscriptAbundance
Sc ProteinAbundance
Sc RPFAbundance
Sc TranslationEfficiency
Ec ProteinAbundance
• Network features.
– Calculated from interactions present in BIOGRID 3.1.93 ([91]). ‘BI-
OGRID’ was calculated using only those interactions annotated as
‘physical interactions’, while ‘BIOGRID-LT’ was calculated using
the subset of physical interactions found only by low-throughput
experiments.
Sc BIOGRID-Betweenness
Sc BIOGRID-Clustering
Sc BIOGRID-Degree
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Sc BIOGRID-SumLLS
Sc BIOGRID-LT-Degree
Sc BIOGRID-LT-SumLLS
Sc BIOGRID-LT-Betweenness
Sc BIOGRID-LT-Clustering
– Calculated using the ‘All Pathways’ table from EcoCyc
(https://ecocyc.org) downloaded in September 2016. To cre-
ate the network, all pathways were considered ‘cliques’ so that
all members of the pathway were annotated as interacting with
all other members of the pathway. FractionComplementing is the
fraction of interacting partners tested in our assays that were able
to replace.
Ec EcoCyc FractionComplementing
2.4.5 Calculating the predictive strength of features
The predictive power of each feature was calculated as the area under
the receiver-operator characteristic curve (AUC) while treating each feature
as an individual classifier. Each feature was sorted in both ascending and de-
scending directions, retaining the direction providing an AUC>0.5. To assess
significance, a shuﬄing procedure was performed as follows: For each feature,
the replaceable/non-replaceable status of each ortholog pair was shuﬄed (re-
taining the original ratio of replaceable to non-replaceable assignments), and
the AUC was calculated. The shuﬄing procedure was carried out 1000 times
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for each feature, and the mean AUC values and their standard deviations are
reported.
2.4.6 Combined classifier
A Random Forest classifier was constructed using all features and eval-
uated using 10-fold cross-validation. The random forest was constructed to
have no maximum tree depth, and ties between similarly good attributes were
broken randomly. The combined classifier was implemented using the Weka
data-mining software ([92]).
2.4.7 Confocal microscopy
Yeast cultures expressing GFP-tagged bacterial, plant, or human genes
were grown to an optical density (OD) of ∼1, then 500 l of the culture
washed with 1X PBS, and mitochondria fluorescently labeled by adding 100
nM MitoTracker Red CMXRos (Invitrogen). The cells were incubated in the
dark on a mildly shaking platform for 20 min at room temperature, then
washed twice with 1X PBS and resuspended in 15 µl of 1X PBS for imaging
by confocal microscopy, using a Zeiss LSM 710 confocal microscope with a
Plan-Apochromat 63x/1.4 oil-immersion objective.
2.4.8 Quantitative growth curves
Yeast strains were either pre-cultured in liquid YPD or -Ura Dextrose
selective medium for 2 hr or overnight respectively. The culture was diluted in
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YPD or -Ura Dextrose medium to an OD of ∼0.1 in 100 or 150 l total volume
in a 96-well plate. Plates were incubated in a Synergy H1 shaking incubating
spectrophotometer (BioTek), measuring the optical density every 15 min over
48 hr. Growth curves were performed in triplicate for each strain by splitting
the pre-culture into three independent cultures for each 48–60 hr time course.
2.4.9 Detection of heme pathway intermediate metabolites
Bacterialized Ec-hemH yeast strains were grown on YPD as lawns or
large patches for 5 days (the phenotype manifests after several days of growth).
Clumps of cells about 5–7 mm in diameter were collected with a toothpick and
first suspended in water, then pelleted at 15,000 g for 30 s. This created a
distinctive pale yellow yeast pellet, with the red pigment appearing in a small
clump on top. The water was removed while carefully avoiding disruption of
the red pigment pellet, after which we performed extractions with two different
methods. The first method, based on [93], was to add 1 ml pyridine to each
pellet, spinning down at 15,000 g for 30 s and recovering only the liquid fraction
(cell debris would pellet down while the red pigment migrated into the liquid
pyridine phase). The second referred to as “acetate extraction” in this text,
was to extract with a 3:1 ethyl acetate:glacial acetic acid solution as described
in [94].
We then measured the absorbance of the extractions in a transparent
plastic 96-well plate on the (Synergy H1 from BioTek) on wavelengths from
223 nm to 998 nm, with 1 nm steps. We measured fluorescence on the same
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instrument by exciting at 399 nm and measuring emission at 450 nm to 699
nm with 1 nm step. The spectra were compared with those shown in [95].
We also obtained protoporphyrin IX (Sigma-Aldrich, P8293-1G) and
hemin B (Sigma-Aldrich, 51280–1G) and suspended these in acetate and pyri-
dine to closely resemble the chemistry of our extractions. These solutions
were measured alongside the extractions themselves as standards, in order to
further confirm the identity of the molecules we detected.
2.4.10 Replacement of bacterial and human genes at their native
yeast loci using CRISPR-Cas9
Genomic editing and replacement of yeast ORFs is described in greater
detail at Bio-protocol[21].
2.4.10.1 Bacterializing yeast strains at native genomic loci using
CRISPR
We inserted E. coli ORFs at their native yeast loci using
CRISPR/Cas9-mediated double strand breaks (DSB) and homologous
recombination. The integration was performed by chemically co-transforming
yeast with a linear template DNA (Zymo Research - #T2001) and a plasmid
carrying Cas9 and gRNA targeting the desired locus of integration (refer to
Supplementary file 3). The transformed cells were plated on SD-Ura medium
to select for successful transformation of the plasmid (CRISPR-induced DSBs
act as partial selection against background), and screened for successful
integration of the template via colony PCR using primers flanking the start
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codon of the ORF (a forward primer annealing to the promoter and a reverse
primer annealing to the E. coli ORF) (Figure 2.11).
The template DNA is a linear sequence containing the E. coli ORF,
flanked by the yeast promoter and terminator which act as homology. In order
to produce this template DNA, we designed primers for each gene that amplify
the entire coding sequence of the E. coli ortholog, while also inserting flanking
homologies to the yeast locus targeted. In most cases, we used primers 120
bp long, with about 20 bp shared with the E. coli gene and 100 bp of yeast
homology. In cases where this template failed to integrate (such as Ec-hemC)
we designed 200 bp primers with about 180 bp homology. For chimeric ORFs of
E. coli genes Ec-hemG and Ec-hemH that retained the native yeast MLS, the
template was produced by including the MLS in the forward primer sequence.
We amplified the template DNA with PCR, purified it using the DNA Clean
and Concentrator-25 kit (Zymo Research - #D4006); final elutions were done
with water. We used 5 g DNA template per transformation, in cases where
this failed we attempted it again with 10 g.
CRISPR plasmids were constructed using a Golden Gate-based cloning
strategy as described in [23]. Briefly, for each yeast gene we designed two
gRNA sequences using Geneious v9[96]; both sequences were selected from
within the yeast ORF so as to exhibit high predicted efficiency with a low
background activity for the rest of the yeast genome. We performed integration
experiments separately for each gRNA, as often one of the gRNA sequences
would have substantially lower efficiency than predicted. As per [23], each
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gRNA sequence was first synthesized as an oligonucleotide (IDT), subcloned
into intermediate plasmids, and eventually into a Cas9 plasmid carrying a
Ura selectable marker, finally transforming 500 ng into yeast cells for the
integration assay.
In order to construct yeast strain Sc-ΔMLS-HEM15, we started with
Sc-hem15Δ::Ec-hemH yeast which had lost their CRISPR plasmid, and
co-transformed them with CRISPR plasmids carrying gRNA that targets
the Ec-hemH sequence, as well as template DNA created by amplifying the
yeast Sc-HEM15 sequence from yeast genomic DNA. The MLS was deleted
by designing template amplification primers which leave it out. This was
necessary since the MLS sequence did not contain unique CRISPR targets,
thus it was not possible to construct a CRISPR system that would cleave
wild type Sc-HEM15 but not the desired Sc-ΔMLS-HEM15.
2.4.10.2 Humanizing Hs-UROS gene at the native yeast locus
We co-transformed the plasmid expressing Cas9 and gRNA targeting
yeast Sc-HEM4 gene and repair PCR template that contains human Hs-UROS
gene flanked by 100 bp of homologous sequence to the yeast Sc-HEM4 pro-
moter and terminator region. The colonies that grew after the transformation
of CRISPR plasmid and the repair template were verified for the human gene
insertion using a forward primer outside the region of homology and reverse
primer specific to the human gene. The positive PCR reaction with appropri-
ate size (375 bp) confirmed the right clone.
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2.4.11 Generation of Sc-HEM14 yeast deletion strains
Using CRISPR, we deleted the Sc-HEM14 ORF in wild type BY4741,
Sc-hem15Δ::Ec-HemH, and Sc-hem15Δ::Ec-MLS-HemH strains. Specifically,
we co-transformed the plasmid expressing Cas9 and gRNA targeting the yeast
Sc-HEM14 gene with a 200 bp oligonucleotide repair template comprising 100
bp each of sequence matching the 5’ and 3’ UTRs of the Sc-HEM14 gene and
selected for growth on SD-Ura medium. The resulting hem14Δ strains were
confirmed by PCR using primers outside the region of homology. Supplemen-
tary file 3 provides relevant primers and oligos.
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2.5 Supplementary material
2.5.1 Supplementary file 1
This file is a spreadsheet containing detailed results of complementation
assays. It is available online at https://dx.doi.org/10.7554/eLife.25093.
022.
2.5.2 Supplementary file 2
This file is a spreadsheet containing data used to calculate predic-
tive features. It is available online at https://dx.doi.org/10.7554/eLife.
25093.023.
2.5.3 Supplementary file 3
This file is a spreadsheet containing primers used in this study. It is
available online at https://dx.doi.org/10.7554/eLife.25093.024.
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2.9 Conclusion
This chapter describes our work in humanizing, plantizing and bacte-
rializing evolutionarily related genes in yeast. The first major result is that
despite much greater evolutionary divergence, the earlier finding that roughly
half of genes can be replaced by cross-species orthologs[8] holds – despite bac-
teria being almost 4 times more distant to yeast than humans. In fact, after
accounting for certain general peculiarities of bacterial genetics, more than half
of the genes tested could be bacterialized. Among these, the heme biosynthesis
pathway has proven strikingly universal: It can be effectively complemented
by genes from all three tested species. Moreover, we observed a very distinct
color phenotype owing to protoporphyrin secretion from yeast cells as a re-
sult of disruptions to pathways flux. The phenotype is readily quantifiable
with chemical means, and is also apparent to even the naked eye. The step
which generated this phenotype is the final iron chelation reaction, which is of
particular interest: Mutations in it are associated with porphyria in humans,
therefore the pink humanized yeast is potentially an excellent model for study-
ing mutations and drugs of human porphyria in the much more experimentally
tractable yeast system. Moreover, because heme is a crucial precursor to pro-
duction of chlorophyll, a similar system could be investigated for studying
herbicides.
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2.9.1 Diverse Biochemistry of Heme Production
The results from the replacement of the first step of heme biosynthesis
are particularly remarkable. While most of the pathway involves identical
intermediates across species, the first step is notably different in plants and
bacteria as compared to yeast and humans[54]. In all organisms the first step
produces delta-aminolevulinic acid (ALA) which then becomes the substrate
of the second step (ScHEM2, EcHemB, At-HEMB1/2 and HsALAD). Two
distinct pathways are known for the production of ALA: The first, often called
the “Shemin pathway”, involves the condensation of succinyl-CoA and glycine,
which is done by 5-aminolevulinate synthase HEM1 in yeast and ALAS1/2 in
humans. In plants and most bacteria (including E. coli) the C5 pathway
is used instead, which involves reduction of glutamyl-tRNAGlu (Glu-tRNA)
to glutamate-1-semialdehyde (GSA) by Glu-tRNA reductase (GluTR), which
is encoded by EcHemA in E. Coli and AtHEMA1 in A. thaliana. GSA is
converted to ALA by glutamate-1-semialdehyde-2,1-aminomutase (GSAM).
Structurally, GSAM is very similar to ALAS – indeed, it is thought that ALAS
evolved from GSAM. Thus GluTR is the more unique enzyme, responsible for
the use of Glu-tRNA as the ultimate starting point for heme production.
Because the C5 pathway is not active in yeast, it is surprising that
HEM1 could be bacterialized or plantized as it did. In bacteria, there are
separate Glu-tRNAs used for protein elongation and heme biosynthesis. The
latter bears A53 ·U61 basepair where the former bears a conserved G ·C pair[97]
(notably E. coli is an exception). GluTR can recognize such features with high
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specificity. Therefore, it is on the one hand surprising that presumably un-
modified yeast Glu-tRNA was compatible with bacterial HemA, but somewhat
explained in that the E. coli GluTR is slightly less specific.
We can suspect that introducing C5 activity to yeast would might have
deleterious effects in that it creates an unnatural shunt of scarce Glu-tRNA.
Indeed, Glu-tRNA starvation can have significant impact on the fitness of
yeast, such as reducing the protein protein synthesis by 10-fold[98]. However,
our bacterialized yeasts are not actually the first case of C5 activity in yeast:
HemA has been expressed before (albeit without deleting HEM1). As such,
the fact that yeast can meet the additional demand for Glu-tRNA imposed by
GluTR activity is, though surprising, corroborated by literature. Moreover,
HemA yeast is also not the first example of both pathways being active in a
non-plant eukaryote: Euglena exhibits this phenomenon naturally[99]. Inter-
estingly, Euglena heme production is separated by final purpose: The heme
destined to mitochondria derives from the Shemin pathway while the heme
destined to plastids derives from the C5-pathway.
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Figure 2.1: Systematic functional replacement of essential yeast
genes by their human counterparts (Continued on next page.)
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Figure 2.1: (A) Yeast and E. coli share hundreds of genes, 58 of which are es-
sential in yeast and have clear 1:1 orthologs in either species. E. coli genes were
cloned into a yeast expression vector under the control of a GPD promoter.
51 of these 58 E. coli genes provided informative assays for replaceability in
yeast. Initial results from these complementation assays revealed that 25 of 51
(∼49%) E. coli genes could functionally replace their orthologous yeast coun-
terparts. (B) Complementation assays were performed in two different yeast
strain backgrounds, as shown for representative assays. In the case of a yeast
strain with a temperature-sensitive allele of the yeast gene Sc-cdc8, cells carry-
ing the empty vector control grow at the permissive-temperature (25 ◦C, yeast
protein active) but not the restrictive-temperature (36 ◦C, yeast protein inac-
tive), unlike cells expressing the E. coli ortholog (Ec-tmK), indicating that the
E. coli gene can functionally replace the yeast gene. In the case of yeast het-
erozygous diploid (Sc-ths1Δ/Sc-THS1) deletion strain, cells are sporulated and
haploid progeny grown on selective medium (-Ura-Arg-His-Leu+Can) in the
absence (yeast gene present) or presence of G418 (200 µg/ml) (yeast gene ab-
sent). Cells expressing the E. coli ortholog (Ec-thrS) grow on G418-containing
medium, unlike cells carrying the empty vector control, indicating successful
complementation. (C) Haploid yeast gene deletion strains carrying plasmids
expressing functionally replacing E. coli genes (red solid-lines) generally ex-
hibit comparable growth rates to the wild type parental yeast strain BY4741
(black dotted-lines). The empty vector control (grey solid-line) showed no such
growth rescue in the presence of G418. Mean and standard deviation plotted
with N = 3.
63
Figure 2.2: Complementation assays performed in a 96-well format
in two different yeast strain backgrounds (Supplementary file 1) (A
and B) Magic marker heterozygous diploid deletion yeast strains expressing
E. coli genes were sporulated and the sporulation mix was spotted on magic
marker agar medium (-Ura -Arg -His -Leu + Can) with (yeast gene absent) or
without (yeast gene present) G418 (200 µg/ml). (C) Temperature-sensitive
haploid yeast strains expressing E. coli genes grown at permissive temperature
(25 ◦C) (yeast protein active) and at restrictive temperature (36 ◦C) (yeast
protein inactive) on -Ura agar medium with G418 (200 µg/ml). Empty vector
containing yeast cells were used as negative control for the experiment. (D)
Haploid yeast gene deletion strains carrying plasmids expressing functionally
replacing E. coli genes (red solid-lines) generally exhibit comparable growth
rates to the wild type parental yeast strain BY4741 (black dotted-lines) as
grown in YPD liquid medium in the presence of G418 (300 µg/ml). Mean and
standard deviation plotted with N = 3.
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Figure 2.3: Constitutive plasmid expression of yeast genes
efficiently replaced the corresponding genomic copies for
6 non-replaceable alleles. Bacterial orthologs of the yeast genes,
Sc-RRP3, Sc-PGS1, Sc-SRP54, Sc-PCM1 and Sc-HSP60 did not show func-
tional replacement when expressed from a constitutive GPD promoter. We
expressed the corresponding yeast genes in a similar fashion under the control
of the constitutive GPD promoter. All the tested yeast genes functionally
replaced the corresponding yeast gene deletions. Empty vector containing
yeast cells were used as negative control for the experiment.
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Figure 2.4: The addition of a mitochondrial localization signal
(MLS) and mutation of start codons from GTG to ATG allows some
E. coli genes to swap for their respective yeast orthologs.
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Figure 2.4: (A) 14 of the 25 non-replaceable E. coli genes were predicted to
function in mitochondria in yeast. 4 of 14 were replaceable after adding the
MLS at the N-termini of the E. coli genes. Site-specific mutagenesis of E. coli
gene start codon from GTG to ATG allowed two to functionally complement
the corresponding yeast genes bringing the total number E. coli genes that
functionally replace yeast genes to 31 of 51 (∼61%). (B) Haploid yeast gene
deletion strains carrying mitochondrially localized E. coli genes rescued the
growth defect of the yeast gene (red solid-line) comparable to the wild type
yeast (black dashed-line). The empty vector control (grey solid-line) and the
yeast cells expressing of E. coli gene without MLS (blue-solid line) showed no
such growth rescue in the presence of G418. Mean and standard deviation plot-
ted with N = 3. (C) EGFP-tagged E. coli genes that functionally replaced the
yeast gene function were imaged after MitoTracker red staining. EGFP-tagged
Ec-MLS-HscB and Ec-MLS-IlvD (green) show colocalization with MitoTracker
red stained mitochondria (red).
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Figure 2.5: Some E. coli genes require a yeast mitochondrial local-
ization signal to efficiently replace. The magic marker heterozygous
diploid deletion yeast strains carrying empty vector or E. coli gene with or
without MLS were sporulated and the sporulation mix was plated on magic
marker agar medium (-Ura-Arg-His-Leu+Can) with or without G418 (200
µg/ml). E. coli genes Ec-rpiL, Ec-ilvC, Ec-ilvD and Ec-hscB without an
appropriate mitochondrial localization signal cannot complement the corre-
sponding yeast gene deletions Sc-mnp1, Sc-ilv5, Sc-ilv3 and Sc-jac1. However,
expression of E. coli genes with yeast MLS efficiently rescued the growth defect
of the corresponding yeast gene deletions.
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Figure 2.6: Replaceability of E. coli genes is a modular phe-
nomenon. (Continued on next page.)
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Figure 2.6: (A) Several quantitative properties of the tested genes were
assessed for their ability to predict replaceability, measured as the area un-
der a receiver operating characteristic curve (AUC). Having a high fraction
of interaction partners that replace was the most predictive property tested,
suggesting that the ability to replace is a modular phenomenon whereby genes
functioning together are similarly able to replace. A Random Forest classi-
fier constructed with all attributes boosted the maximum AUC to 0.79. (B)
As shown in (A), sequence similarity was not the most predictive feature.
The fraction of replaceable genes in given ranges of similarity was variable,
with the vast majority of orthologs being 20-30% identical, a range in which
roughly half of proteins replaced. (C) Mapping of replaceability status onto
yeast GO slim annotations revealed that GO categories have varying rates of
replaceability, with core metabolic processes (e.g. energy metabolism, nucle-
obase metabolism) being largely replaceable while more specialized processes
(e.g. protein assembly, membrane transport) were less so.
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Figure 2.7: Bacterialization of yeast heme biosynthesis pathway
genes at their native loci. (A) A schematic of the yeast heme biosyn-
thesis pathway shows the beginning of the pathway in mitochondria using
succinyl-CoA and glycine as precursors. The subsequent enzymatic reactions
are cytosolic up until the penultimate and ultimate reactions which are mi-
tochondrial. (B) Growth kinetics of CRISPR-Cas9 engineered yeast heme
biosynthesis pathway genes replaced with the corresponding bacterial genes
at their native yeast loci show efficient replaceability in both BY4741 (red
solid-line) and BY4742 (blue solid-line) yeast strains. The wild type BY4741
growth curve is shown as a comparison (black dotted-line). Mean and standard
deviation plotted with N = 3.
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Figure 2.8: Constitutive or native plasmid-based expression of
the yeast heme biosynthesis genes generally efficiently comple-
mented growth defects in the corresponding yeast gene deletion
strains. Heterologous expression of yeast genes Sc-HEM1, Sc-HEM2,
Sc-HEM3, Sc-HEM4, Sc-HEM12, Sc-HEM13, Sc-HEM14 and Sc-HEM15 un-
der the control of constitutive GPD promoter or native promoter efficiently
rescued the growth defect of the corresponding yeast gene deletions respec-
tively except in the case of Sc-HEM4. Sc-HEM4, when expressed constitu-
tively, resulted in toxicity in the presence of the yeast gene at the native locus
and did not complement the function in the absence of the yeast gene. This
toxicity was relieved when the yeast gene was expressed under the control of
the native yeast promoter.
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Figure 2.9: Ec-hemA and Ec-hemL carry out the initial reaction
in E. coli heme biosynthesis and are both required to complement
Sc-HEM1 deletion in yeast, and non-orthologous yeast genes are re-
placed by E. coli genes that carry out the identical reaction. (Con-
tinued on next page.)
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Figure 2.9: (A) Expression of heme pathway genes of E. coli, Ec-hemA
or Ec-hemL, individually cannot complement the lethal growth defect of the
deletion of Sc-HEM1 gene in yeast. Co-expression of Ec-HemA and Ec-HemL
efficiently rescued the growth defect of Sc-hem1 gene deletion in yeast. (B)
Growth curves of yeast strains with deletions of Sc-hem4 and Sc-hem14
genes (grey solid-line) show functional replaceability (red solid-line) by the
non-orthologous E. coli genes Ec-hemD and Ec-hemG that carry out identical
enzymatic reactions to the corresponding yeast genes. The wild type BY4741
growth curve is shown as a comparison (black dotted-line). The empty vec-
tor control (grey solid-line) showed no such growth rescue in the presence of
G418. (C) Growth curve of engineered yeast strain Sc-hem14Δ::Ec-hemG;
Sc-hem15Δ::Ec-hemH in YPD medium harboring E. coli genes at the native
yeast loci. The strain displayed a growth defect (red solid-line) compared to
the wild type BY4741 strain (black dotted-line). Mean and standard deviation
plotted with N = 3.
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Figure 2.10: The penultimate and ultimate heme pathway enzymes
in yeast are replaceable by their bacterial orthologs, in spite of
mis-localizing to the plasma membrane. EGFP-tagged Ec-HemG
and Ec-HemH localize to the plasma membrane in yeast. The EGFP-tagged
proteins do not localize to the mitochondria since no clear co-localization is ob-
served with the Mitotracker red stain. EGFP-tagged Ec-HemG and Ec-HemH
expression (red solid-line) efficiently rescue the growth defects of the respective
yeast gene deletions (Sc-hem14 and Sc-hem15) (pink dotted-line) comparable
to the wild type yeast (black dotted-line). Empty vector control is incapable
of rescuing the growth defect of the deletion strains (grey dotted-line).
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Figure 2.11: Confirmation of CRISPR-Cas9 mediated bacterialized
yeast strains. (A) Schematics of the yeast heme biosynthesis pathway gene
loci carrying functionally replaceable E. coli genes while retaining their native
promoters and terminators. The arrows indicate the primers used to confirm
the replacement (refer to Supplementary file 3). (B) PCR amplification of
expected size was obtained for each individual bacterialized yeast strains.
76
Figure 2.12: Mislocalization of the bacterialized ferrochelatase en-
zyme identifies a porphyria-like phenotype in yeast. (A) Bacteri-
alization of the ultimate yeast gene in the heme biosynthesis pathway results
in a distinct pink colony phenotype on YPD agar medium. In contrast, wild
type BY4741 strain colonies appear as creamy-white. (B) Acetate-extracted
secreted products from the pink Sc-hem15Δ::Ec-hemH strains show strongly
enhanced fluorescence at 635 nm (excitation 399 nm), comparable to a pro-
toporphyrin IX standard and unlike a heme standard or extracts from the
parental BY4741 strain. The introduction of an MLS to the bacterialized yeast
strain (Sc-hem15Δ::Ec-MLS-hemH) significantly reduced protoporphyrin IX
secretion, while deletion of the MLS from the native yeast locus in strain
Sc-ΔMLS-HEM15 caused several strains to increase protoporphyrin IX secre-
tion.
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Figure 2.13: Absorbance (top) and emission (bottom) spectra
of extracts obtained from acetate (left) and pyridine (right) ex-
traction of the wild type or bacterialized yeast colonies grown on
YPD medium. Purified protoporphyrin IX (red solid-line) or heme
(yellow solid-line) were used as standards. Extract from the bacterialized
Sc-hem15Δ::Ec-hemH yeast strain (dark blue-line) matched with that of the
protoporphyrin IX standard. Bacterialized ScHEM15Δ::Ec-MLS-hemH yeast
strain (orange solid-line) showed significantly reduced peak for protoporphyrin
IX. Extracts from wild type BY4741 (black-line) and BY4742 (light blue
solid-line) were used as controls.
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Figure 2.14: Deletion of protoporphyrinogen oxidase, Sc-HEM14, in
the Sc-hem15Δ::Ec-hemH strain suppressed the porphyria-like pink
phenotype. Top row from left show growth spots of the BY4741 wild type,
Sc-hem15Δ::Ec-hemH and Sc-hem15Δ::Ec-MLS-hemH yeast strains. Bottom
row from left show corresponding strains harboring Sc-hem14 deletion.
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Figure 2.15: Yeast heme biosynthesis pathway enzymes can
be successfully replaced by orthologs or analogs from bacteria,
plants, and humans, in spite of alterations to subcellular localiza-
tion. Enzymatic steps of extant bacterial and eukaryotic heme biosyn-
thesis pathways are identical save for the starting metabolites and conversion
to delta-aminolevulinate; bacteria also exhibit non-orthologous gene displace-
ment of several enzymes. Heme biosynthesis occurs in the bacterial cytoplasm
and inner membrane, the human and yeast in mitochondria and cytoplasm,
and the plant in chloroplast and cytoplasm. In spite of these localization
changes over evolution, most of the defects in growth rate and viability con-
ferred by heme pathway mutations in yeast can be complemented by intro-
duction of the corresponding (A) bacterial genes, (B) plant genes (except for
At-HemE), and (C) human genes. Yellow indicates a replaceable gene, blue
non-replaceable.
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Figure 2.16: Heme biosynthesis genes from Arabidopsis thaliana
and Glycine max generally efficiently replace their counterparts in
yeast, except in the case of ΔSc-Hem12.
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Figure 2.16: (A) Expression of heme pathway genes from Arabidopsis
thaliana, At-HEMA1 or At-GSA2, individually cannot complement the lethal
growth defect of the deletion of Sc-hem1 gene in yeast. Co-expression of
At-HEMA1 and At-GSA2 rescued the growth defect of Sc-hem1 gene dele-
tion in yeast. (B) Haploid yeast gene deletion strains carrying plasmids ex-
pressing functionally replacing Arabidopsis (red or blue solid-lines) and (B’)
Glycine max (Gm-HEMG) heme pathway genes (red solid-line) generally ex-
hibit comparable growth rates to the wild type parental yeast strain BY4741
(black dotted-line) as grown in magic marker liquid medium in the presence of
G418 (200 µg/ml). (B”) Native At-HEMC with chloroplast localization signal
(CLS) showed poor replaceability in yeast (red solid-line). Removal of the
CLS from At-HEMC allowed efficient rescue of the corresponding yeast gene
deletion, ΔSc-Hem3 (blue solid-line). (B”’) However, neither the expression of
Arabidopsis proteins At-HEME1 or At-HEME2 (with or without CLS) alone
nor their co-expression could functionally rescue the corresponding yeast gene
deletion, ΔSc-Hem12. Wild type BY4741 haploid strain is plotted for compar-
ison (black dotted-line). Strains carrying empty vector were used as controls
(grey solid-line). Mean and standard deviation plotted with N = 3.
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Figure 2.17: Heme biosynthesis enzymes normally localized to plant
chloroplasts or human mitochondria localize to the mitochondria
when expressed in yeast.
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Figure 2.17: (A) EGFP-tagged penultimate At-PPOX1-EGFP and ultimate
At-FC1-EGFP proteins localize to mitochondria in yeast. Green fluorescence
proteins co-localized with Mitotracker red-stained mitochondria. In certain
cases, At-FC1-EGFP formed aggregates. Expression of EGFP-tagged plant
genes, At-PPOX1-EGFP and At-FC1-EGFP (red solid-line), efficiently rescue
the growth defect of the corresponding yeast gene deletions (pink dotted-line).
The over-expression of the tagged proteins is not toxic to the wild type yeast
strain (grey dotted-line). The growth rescue by plant genes is as efficient as
the wild type BY4741 yeast strain (black dotted-line). Mean and standard de-
viation plotted with N = 3. (B) The EGFP-tagged last three heme pathway
genes from humans localize to mitochondria in yeast. The green fluorescence
co-localized with the Mitotracker red-stained mitochondria in yeast. Expres-
sion of EGFP-tagged human genes, Hs-PPOX-EGFP, Hs-FECH-EGFP and
Hs-CPOX-EGFP (red solid-line), efficiently rescue the growth defect of the
corresponding yeast gene deletions (pink dotted-line). The over-expression of
the tagged proteins is not toxic to the wild type yeast strain (grey dotted-line).
The growth rescue by the human genes is as efficient as the wild type BY4741
yeast strain (black dotted-line). Mean and standard deviation plotted with
N = 3.
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Figure 2.18: Human heme biosynthesis genes efficiently replace
their yeast counterparts.
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Figure 2.18: Functional replacement of human genes in yeast. (A) Ex-
pression of Hs-UROS in Sc-hem4 heterozygous diploid deletion yeast strain
resulted in toxicity post-sporulation as seen by the lack of growth on ei-
ther magic marker agar medium with (yeast gene present) or without G418
(yeast gene absent). (B) This toxicity was relieved by replacing the hu-
man Hs-UROS at the native yeast locus. Growth curve of the humanized
yeast Sc-hem4::Hs-UROS strain (red-solid line) showed comparable growth
to the wild type yeast BY4741 (black dotted-line). (C) Expression of hu-
man Hs-UROD (a human orfeome clone with G303V mutation) in Sc-hem12
heterozygous diploid deletion yeast strain did not complement the growth de-
fect of the yeast gene as shown by plating the post sporulation mix on magic
marker medium with or without G418. Reverting the sequence to the wild type
Hs-UROD gene resulted in efficient rescue of the growth defect of the corre-
sponding yeast gene. (D) Expression of human genes, Hs-PPOX, Hs-UROD,
Hs-ALAS1 (red solid-line) and Hs-ALAS2 (blue solid-line), efficiently rescue
the growth defect of the corresponding yeast gene deletions (grey solid-line),
Sc-hem14 and Sc-hem1, respectively. The rescue was largely comparable to
the wild type BY4741 yeast strain (black dotted-line). Strains carrying empty
vector were used as controls (grey solid-line). Mean and standard deviation
plotted with N = 3.
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Figure 2.19: The complex evolutionary history of the heme biosyn-
thesis pathway is reflected in high replaceability across species. In
eukaryotes, heme biosynthesis enzymes have been replaced historically by en-
dosymbiosis events from bacteria, leading to higher similarity across these
lineages, while the archaeal pathway appears to be more divergent[100]. Fol-
lowing the endosymbiosis of the cyanobacterial chloroplast, plants adopted
most of the chloroplast-derived heme biosynthesis genes, losing many ances-
tral eukaryotic heme pathway genes[73]. Yeast and humans both retain the
predicted ancestral eukaryotic heme biosynthesis pathway. While enzymatic
steps are mostly shared between yeast, plants, bacteria, and humans, local-
ization of individual proteins differs substantially between species. Asterisks
indicate results curated from literature.
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Chapter 3
Single-step Precision Genome Editing in Yeast
Using CRISPR-Cas9
In my initial foray into yeast humanization, a major point of interest
was the demand for sophisticated methods for probing replaceability. A very
effective method was to drive the expression of the complementing human or-
tholog from a plasmid, in a deletion strain. This approach had the advantage of
being straightforward, feasible at the time, and being able to leverage existing
deletion collections. The promoters in the plasmid were constitutive. Con-
sequently, a potential confound is introduced into every experiment, because
native transcriptional regulation is impaired and the gene is overexpressed.
A second method was knock-in/knock-out strategy based on first insert-
ing a selectable marker cassette into the target locus, and then using elements
embedded in the cassette to induce HR and implement the desired sequence
at that locus. For essential genes, this necessitated the use of temporary com-
plementing plasmids also. The state of the art in this area was developed by
Dr. Chris Yellman in our lab in the form of the IT-series of cassettes, which I
This chapter was previously published in Akhmetov A, et al. (2018) Bio Protoc.,
8(6):e2765. I contributed to the development of the technique, experiments, analysis and
the writing of the manuscript.
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have also used in my initial experiments. However, the cassette-based strategy
is somewhat time and labor intensive.
One of my first tasks as a graduate student was to identify a better tech-
nology to use for replacements. After some research, CRISPR emerged as a
promising candidate. At the time, there were very few reports of CRISPR
activity in yeast, and I made considerable progress in optimizing the ele-
ments know into a practical CRISPR-based gene replacement system. As
other groups working in parallel on similar themes published their findings, I
was able to synthesize their discoveries with mine and produce a very versa-
tile, single-step, universal gene editing strategy based on CRISPR technology.
This enabled much of the work in our eLife publication[37], and afterward,
we were invited to write a detailed protocol which is reproduced below (with
minor formatting changes).
This work was eventually published as [21]. Soon after publication,
we were serendipitously informed that another group had succeeded in repro-
ducing our results. Notably, though the protocol is written with a focus on
humanization, it is in principle equally well suited to any arbitrary genetic
editing. Due to the inherent DNA cleavage activity of CRISPR, the strains
produced by this protocol can be used as gene-drives with super-Mendelian
inheritance of the resulting edit in subsequent generations.
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3.1 Abstract
Genome modification in budding yeast has been extremely successful
largely due to its highly efficient homology-directed DNA repair machinery.
Several methods for modifying the yeast genome have previously been de-
scribed, many of them involving at least two-steps: insertion of a selectable
marker and substitution of that marker for the intended modification. Here,
we describe a CRISPR-Cas9 mediated genome editing protocol for modifying
any yeast gene of interest (either essential or nonessential) in a single-step
transformation without any selectable marker. In this system, the Cas9 nucle-
ase creates a double-stranded break at the locus of choice, which is typically
lethal in yeast cells regardless of the essentiality of the targeted locus due to in-
efficient non-homologous end-joining repair. This lethality results in efficient
repair via homologous recombination using a repair template derived from
PCR. In cases involving essential genes, the necessity of editing the genomic
lesion with a functional allele serves as an additional layer of selection. As a
motivating example, we describe the use of this strategy in the replacement of
HEM2, an essential yeast gene, with its corresponding human ortholog ALAD.
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3.2 Background
Saccharomyces cerevisiae (Bakers yeast) has a long history as a genet-
ically tractable organism, and there are an array of methodologies to manipu-
late the yeast genome. However, until recently it has been necessary to apply
selection to isolate clones possessing the desired genetic alteration [96, 20, 23,
37]. In cases where arbitrary, scar-less editing of the genome is desired, the
solution is typically a two-step process: First a selectable cassette (containing
the URA3 marker, for example), flanked by homology arms targeting the re-
gion of interest, and sometimes containing nuclease targeting sites (i.e., I-SceI
sites) to aid in the removal of the cassette at the later stage, is knocked in
via homologous recombination (HR). The small subpopulation of successful
integrants is isolated by selecting for the cassette. Second, the marker is elim-
inated through highly efficient sequence specific methods such as site-specific
recombination or endonuclease cleavage (I-SceI) to generate the desired form
of the edited genomic locus. Two steps are necessary because no method was
available which is both scar-less and efficient enough such that no selection is
required.
The development of CRISPR/Cas9 technology in yeast has eliminated
the need for this two-step process. Cas9 efficiently creates double-stranded
breaks (DSBs) in yeast DNA at virtually any arbitrary locusprovided a PAM
sequence is proximal to the desired cut site. When an appropriate repair tem-
plate is provided, these DSBs are repaired through the endogenous HR system
of yeast. Cas9 directed to the desired genomic locus via the guide RNA se-
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quence creates double-stranded break (DSB) in the genome. The CRISPR
target site is retained in cells which fail to repair the target site as expected,
which allows Cas9 to repeatedly cleave the same region until HR-mediated
editing takes place. Rarely, non-homologous end-joining (NHEJ) can gener-
ate mutations which block Cas9 cleavage despite failing to incorporate the
expected genomic alterations. More commonly, cells simply succumb to the
stress of repeated Cas9-induced genomic cleavages. In an appropriately con-
ducted experiment, the majority of the surviving population tends to be cells
which have lost their CRISPR target site by incorporating the desired ge-
nomic alteration via HR. Cas9 thus acts as a counter-selection acting directly
on genomic sequence, rather than its phenotypic manifestations.
Here, we use an approach developed by Dueber and colleagues [23] to
rapidly generate single, self-contained plasmids that express both the Cas9 nu-
clease and guide RNA required for targeting a desired locus. These plasmids,
when co-transformed with an appropriate repair template provided as a linear
PCR product, allow efficient, precise, single-step replacement of any arbitrary
yeast gene with an introduced sequence of interest. Only selection for the Cas9
and gRNA-expressing plasmid is required, which tends to select for correct ge-
nomic modification by proxy due to efficiency of targeting and repair. This
strategy was used extensively in our ortholog complementation research [37]
to rapidly humanize, bacterialize and plantize many essential yeast genes. A
CRISPR based approach is uniquely suited to this case, because it strongly en-
courages HR with functional alleles. False positives, arising from CRISPR sites
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being mutated by NHEJ without incorporation of a new allele, are minimal
because they are often not viable. Additionally, disruption of the target genes
function is brief, eliminating the need for constructing and maintaining a com-
plementing plasmid to sustain yeast through an otherwise lengthy engineering
process. Further, given that CRISPR selects against sequence regardless of
function, it is still possible and practical to alter non-essential genes (or even
non-genic regions) with this technique; indeed, we have reported successful
humanization of the non-essential yeast gene HEM14 with this method [37]
and we have used this system to incorporate site-directed changes in proteins
with high efficiency.
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3.3 Materials and Reagents
1. Pipette tips (Mettler Toledo, catalog numbers: 17005872, 17005874,
17007089)
2. 96-well plate (VWR, catalog number: 82006-636)
3. 0.2 µmfilter (Fisher Scientific, catalog number: 09-719C)
4. Petri plates (VWR, catalog number: 25384-342)
5. Yeast (BY4741)
6. MoClo Yeast Toolkit (YTK, Addgene kit, Addgene, catalog num-
ber: 1000000061). Toolkit includes plasmids pYTK050, pYTK003,
pYTK072, pYTK083, pYTK036, pYTK008, pYTK047, pYTK073,
pYTK074, pYTK081 and pYTK084
7. PCR template for the sequence which will replace the target gene (e.g.,
cDNA, plasmid-based clone, etc.)
8. Note: For demonstration purposes, this protocol will assume replacement
of S. cerevisiae HEM2 with its human ortholog ALAD.
9. NEB 5-alpha Competent E. coli (New England Biolabs, catalog number:
C2987)
10. DNA stain (Thermo Fisher Scientific, InvitrogenTM, catalog number:
S33102)
11. T7 ligase (New England Biolabs, catalog number: M0318S)
12. T4 ligase buffer (New England Biolabs, catalog number: B0202S)
13. Restriction enzymes BsaI (New England Biolabs, catalog number:
R0535S) and BsmBI (New England Biolabs, catalog number: R0580S)
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14. LB plates with antibiotic selection
(a) Ampicillin (Sigma-Aldrich, Roche Diagnostics, catalog number:
10835242001)
(b) Spectinomycin (Sigma-Aldrich, catalog number: PHR1426)
15. Chloramphenicol (Sigma-Aldrich, catalog number: C0378)
16. High-fidelity DNA polymerase for repair template PCR, such as KAPA
HiFi (Kapa Biosystems, catalog number: KK2601)
17. Zymo DNA Clean&Concentrator-25 kit (Zymo Research, catalog num-
ber: D4005)
18. Zymo EZ yeast transformation II kit (Zymo Research, catalog number:
T2001)
19. Optional: 100 mM lithium acetate can be used in place of EZ 1 solution
from the EZ competent yeast cell kit. (Lithium acetate can be obtained
from Sigma-Aldrich, catalog number: L6883)
20. Accuprime Pfx (Thermo Fisher Scientific, InvitrogenTM, catalog number:
12344024)
21. Optional: 5-fluoroorotic acid (Sigma-Aldrich, catalog number: F5013),
if counter-selection will be used (see Procedure E)
22. D-Sorbitol (Sigma-Aldrich, catalog number: S3889)
23. Zymolyase (MP Biomedicals, catalog number: 320921)
24. LB Broth, Lennox (BD, catalog number: 240210)
25. YPD powder (BD, catalog number: 242820)
26. Agarose (Thermo Fisher Scientific, InvitrogenTM, catalog number:
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16500500)
27. Agar (SERVA Electrophoresis, catalog number: 11396)
28. Yeast nitrogen base without amino acids (BD, catalog number: 291940)
29. Ammonium sulfate (Sigma-Aldrich, catalog number: A4418)
30. Dextrose (Avantor Performance Materials, catalog number: 1919)
31. SC-Ura dropout powder (Sigma-Aldrich, catalog number: Y1501)
32. Zymolyase solution (see Recipes)
33. Lithium acetate (see Recipes)
34. LB medium (see Recipes)
35. YPD agar plates (see Recipes)
36. SD-Ura agar plates (see Recipes)
3.4 Equipment
1. Thermocycler (Bio-Rad Laboratories, catalog number: 1861096)
2. Light source for visualization of DNA stain (Thermo Fisher Scientific,
InvitrogenTM, catalog number: G6600)
3. 12-channel pipette (Mettler Toledo, catalog number: 17013810)
4. Standard gel electrophoresis tank and accessories (Bio-Rad Laboratories,
catalog number: 1640302 )
5. Autoclave
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3.5 Software
1. Geneious v8.0[96] or higher, to design gRNA and repair template (re-
placement gene). Other gRNA design software can be used as well, such
as E-CRISP[101]
2. BLAT[102]
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3.6 Procedure
3.6.1 Preparation of CRISPR plasmid
For a diagrammatic overview of the cloning process, see figure 3.1.
1. Design two guide RNA (gRNA) sequences targeting the open reading
frame (ORF) for the yeast gene to be replaced using Geneious, or a
similar tool such as E-CRISP[101].
(a) gRNA sequences can often have low activity in practice, despite
being predicted to be highly efficient by software tools. In order
to minimize setbacks due to a gRNA which turns out to function
poorly, we advise designing multiple gRNAs from the outset, and
taking them through the cloning steps in parallel, up to and in-
cluding the construction of the CRISPR plasmids. Both plasmids
should then be tested for their ability to target the yeast genome
and kill cells (described in later steps) to empirically determine and
confirm their activity.
(b) We have not noticed a strong effect of the location of the gRNA
within the ORF. During homologous repair, DNA can be resected
up to several kilobases from the break site [103, 104], so the gRNA
need not be very close to either terminus of the ORF. It is however
important to select a gRNA such that the target site is not present
after replacement (i.e. the gRNA should target the yeast ORF, but
not the replacement gene).
(c) Example: For targeting HEM2, the sequences GGATTATCGGAGATGAA
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TAG (“sg1”, on the non-coding strand) and CCTGGTACCAAGGATCCAGT
(“sg2”, on the coding strand) were predicted to have high activity
(see 3.2).
2. Order forward and reverse oligonucleotides with the gRNA sequence and
Golden Gate compatible overlaps:
(a) Forward oligo consists of the 5 insert GACTTT followed by the 20 bp
guide sequence specific to the target gene. Example forward oligo
for HEM2 sg1 (underline indicates 5 Golden Gate overhang): GACT
TTGGATTATCGGAGATGAATAG.
(b) Reverse oligo consists of the 3 insert AAAC, followed by the reverse
complement of the 20 bp guide sequence, followed by AA, which
complements part of the GACTTT insert on the forward oligo. Ex-
ample reverse oligo for HEM2 sg1 (underline indicates 3 Golden
Gate overhang): AAACCTATTCATCTCCGATAATCCAA.
3. Mix forward and reverse oligos (50 µM each) for each gRNA in a total
volume of 20 µl and anneal with each other using a thermocycler with
the program below. It is unnecessary to phosphorylate the insert.
95 ◦C for 5 min
55 ◦C for 15 min
25 ◦C for 15 min
4. First Golden Gate cloning reaction to transfer into shuttle vector: Set
up cloning reaction with annealed oligos and pYTK050 (Table 3.1).
A 2:1 molar ratio of insert:plasmid is recommended for optimal
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Golden Gate cloning of linear DNA.
5. Transform the reaction into competent bacteria and plate with chloram-
phenicol selection (170 µg/ml). View colonies under UV light and pick
the white colonies (those not showing GFP fluorescence), then grow in
liquid culture and purify plasmid. The vectors used in Golden Gate re-
actions described in this protocol are all GFP-dropout vectors: They
contain a GFP gene which will be silenced upon successful cloning.
Therefore, GFP fluorescence indicates an invalid construct, while suc-
cessful constructs will lose the GFP gene and the resulting colonies will
be white.
Optionally, the plasmid can be sequenced to check for errors or mu-
tations in the gRNA sequence, such as may occur during synthesis.
6. Second Golden Gate cloning reaction to create gRNA cassette plasmid:
Set up cloning reaction which includes connector plasmids ConL1 and
ConRE (Table 3.2).
For best efficiency, all plasmids should be present at the same mo-
larity in plasmid-based Golden Gate assemblies.
7. Transform the reaction into competent bacteria and plate with ampi-
cillin selection (60 µg/ml). View colonies under UV light and pick the
white colonies (those not showing GFP fluorescence), then grow in liquid
culture and purify plasmid.
8. Third and final Golden Gate cloning reaction to construct the
yeast-compatible, complete CRISPR plasmid: Set up Golden Gate
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cloning reaction with connector plasmid from the previous step, and
yeast Ura backbone plasmid, and Cas9 plasmid (Table 3.3).
9. Transform the reaction into competent bacteria and plate with
kanamycin selection (50 µg/ml). View colonies under UV light and pick
the white colonies (those not showing GFP fluorescence), then grow in
liquid culture and purify plasmid.
The resulting construct is a self-contained CRISPR plasmid, which
when transformed into yeast will cause double-stranded breaks (DSBs) at the
locus determined by the gRNA sequence cloned into it. 500 ng of this will be
used for each yeast transformation, so if multiple replacements are planned, it
is helpful to dilute the CRISPR plasmid to a standardized concentration for
easier transformation set up later on.
3.6.2 Preparation of repair template DNA
1. Design the template DNA using Geneious or any other cloning software.
Obtain the genomic sequence of the target yeast gene (“old gene”), and
the coding sequence (CDS) of the replacing gene (“new gene”). The
CDS should not contain introns. Create a gene model for the replaced
locus by editing the sequence of the old gene so that it contains the new
gene in the correct position (i.e., the desired outcome of replacement).
We find that replacement works best if the original yeast stop codon
is left intact. Otherwise, modifying the new gene, for instance to codon
optimize for yeast, has proven unnecessary.
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2. Design template PCR primers which anneal to about 25 bp of the 5’ and
3’ ends of the new genes CDS, and also the 5’ and 3’ UTR immediately
adjacent to the ORF (the homology arms). Figure 3.3 shows an exam-
ple of primer design for replacing the yeast HEM2 gene with its human
ortholog ALAD. This process is much easier using the gene model con-
structed in the previous step: The sequence covering the junction points
between yeast genome and the new gene CDS can be used directly as
primer sequence.
(a) The length of the region complementary to the new gene CDS is
determined only by standard PCR efficiency concerns, such as melt-
ing temperature. This area will serve as a toehold for the first few
cycles of the PCR.
(b) The length of the homology arms is critical for efficient replacement.
We find that homologies of at least 70 bp are necessary (in which
case the entire primer oligo will be about 90 bp long), and for some
genes, 170 bp homologies may be necessary. For even more difficult
replacements, longer homology arms can be cloned separately, but
we have found that homologies longer than 500 bp are unlikely to
increase efficiency further.
3. Use template PCR primers to amplify a large amount of repair template
DNA using a high-fidelity polymerase.
(a) We find that it is helpful to first conduct several test PCRs with
different polymerases. Due to the particular design of the template
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primers, this PCR can sometimes run inefficiently or generate un-
wanted non-specific products. Different polymerases have different
characteristics, and often a reaction which fails with one polymerase
will run efficiently with another, rendering laborious PCR optimiza-
tion unnecessary.
(b) At least 5 µg of template DNA is needed per yeast transformation,
which can usually be obtained from a single 50 µl PCR. Difficult
replacements can often be facilitated by using more (10 µg) tem-
plate DNA, and if multiple transformations are to be performed the
amount will also need to be scaled up accordingly. Often several
PCRs are necessary to produce enough DNA.
(c) If very large amounts of template DNA are needed, or an efficient
PCR is difficult to set up, an alternative method is to clone the tem-
plate sequence onto a plasmid, which can be amplified in bacteria
with the template DNA excised using restriction enzymes.
4. Check the template PCR with agarose gel electrophoresis.
As long as a sufficient amount of the correct template is produced,
non-specific products do not necessarily constitute a problem for the re-
placement. Because the non-specific products usually lack appropriate
homologies, they will not be efficiently integrated into the yeast genome.
However, if significant amounts of them are present, they will cause
over-estimation of template DNA during spectrophotometry-based quan-
tification; thus the amount of template DNA used in the transformation
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would need to be adjusted accordingly. Alternatively, the PCR can be
optimized to reduce non-specific products, or only the correct product
can be quantified from the gel using a DNA ladder calibrated for quantity
estimation.
5. Purify template PCR using the Zymo DNA Clean&Concentrator-25 kit.
Elute in double distilled water.
Ideally, the volume of DNA included in yeast transformation should be
small, so as to not interfere with the transformation reagents. The elution
volume should be adjusted accordingly so that the resulting concentration of
DNA is not too low. In our experiments, we have found that eluting with 25 µl
double distilled water will usually yield 400-800 ng/µl DNA, which is suitable
for transformations.
3.6.3 Yeast transformation
1. Prepare competent yeast cells using the Zymo EZ competent yeast kit
according to the kit instructions.
The EZ 1 solution in this kit can be substituted with 100 mM lithium
acetate without significant change in transformation efficiency.
The amounts given in the kit manual can be slightly modified: 2 ml
yeast culture can be used to produce 100 µl of competent yeast, which
is sufficient for two transformations, 50 µl each.
2. Set up a transformation reaction: Mix 50 µl competent yeast, 500 µl EZ
3 solution, 500 ng of CRISPR plasmid and 5 µg repair template DNA
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(up to 50 µl total volume). Incubate at 30 ◦C as directed by kit manual
and plate on Ura medium.
When using a new gRNA for the first time, gRNA efficiency can be
estimated with a control transformation, which is performed as stated
but without repair DNA. When the CRISPR plasmid is introduced with-
out a repair template, it will repeatedly cleave the target locus, causing
toxicity. Very few or no colonies are the ideal outcome, since this indi-
cates highly efficient CRISPR cleavage and low background rate. Cells
can survive the CRISPR plasmid uptake without repair DNA if the
CRISPR activity is stochastically low (such as due to poor gRNA effi-
ciency) or mutations at the CRISPR target locus can be tolerated (which
produces false transformants even in presence of the repair template).
3. When colonies appear on the Ura plates, collect up to 12 of them with
a pipette tip and suspend in 50 µl water. These suspensions will be
screened for confirmed replacements. Yeast suspensions can be stored at
4 ◦C and used to start new cultures for up to 2 weeks.
(a) Typically, colonies will appear on Ura plates (Figure 3.4) after 1-3
days. In some cases, the replacement will impose a significant fitness
defect such that up to 6 days may be required for colonies to appear,
but we have not encountered cases where colonies from a successful
transformation take longer than 6 days to grow.
(b) The uracil dropout medium will select against cells which failed to
take up the CRISPR plasmid (which confers uracil prototrophy),
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but because the CRISPR plasmid is toxic to cells unless a success-
ful replacement occurs (eliminating the CRISPR target locus) only
cells which have a replaced locus are expected to survive. However,
due to spontaneous hypoactivity of the CRISPR system, mutations
in the CRISPR target locus[20], and cells which manage to sur-
vive CRISPR-associated DSBs, there will be a background rate in
the form of false transformant colonies which do not carry the cor-
rect genomic replacements. To save time, we recommend collecting
several transformant colonies and screening them in parallel.
(c) To streamline this process (especially when several replacements are
performed in parallel), pick colonies with pipette tips and manually
attach them to a multichannel pipette (Figure 3.5). The multichan-
nel pipette can then be used to suspend all 12 samples in one row
of small PCR tubes or a 96-well plate.
3.6.4 Colony screening via PCR
1. Design confirmation PCR primers: Primer pairs should be selected such
that the forward primer anneals to the yeast UTR while the reverse
primer anneals only to the new gene CDS but not the old gene’s ORF.
Thus, the product should span the junction point between foreign se-
quence and native yeast genome. The yeast UTR primer should prefer-
ably not overlap the homology region.
(a) Ideally, the product size should be small, about 300 bp, for a faster
106
and more robust PCR.
(b) It is sufficient to check only the 5’ junction point, since it is rare
for integration to proceed as expected at one end of the gene but
introduce artifacts at the other.
(c) If desired, the absence of the yeast ORF can also be tested by using
a reverse primer which anneals to yeast ORF only. However, lack
of product from such a primer pair is not sufficient to confirm a
clone, since the reaction is liable to fail for unrelated reasons (such
as poor lysis of cells).
2. Prepare lysates of harvested transformants: Mix 5 µl of each yeast sus-
pension with 15 µl zymolyase solution.
3. Incubate lysates for 30 min at room temperature, then 15 min at 37 ◦C
and 5 min at 95 ◦C.
4. Set up 20 µl colony PCRs with confirmation primers and using Ac-
cuprime Pfx as the polymerase. Use 1 µl of the lysate as template DNA.
(a) We find that other polymerases do not perform well due to impu-
rities from the yeast lysates. Due to the impurities introduced by
the lysate, the colony PCR may spontaneously fail, leading to false
negatives. To ameliorate this problem, a positive control PCR can
be performed for each lysate, which is identical to the confirmation
PCR but uses primers complementary to an unrelated, unmodified
locus in the genome. We use two primers targeting a 500 bp seg-
ment of the yeast ERG13 promoter for this purpose (forward CGA
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ACTGGATGAGATGGCCG and reverse CATGCTGCACCTTTTATAGTAATTTGG
C).
5. Check the colony PCRs for product by agarose electrophoresis. Lysates
from clones with the correct modifications should generate a product
with the confirmation primers. Background false transformants (e.g.
mutants) will not produce a band.
(a) A PCR product from the confirmation primers is sufficient evidence
of successful integration of the repair template. For further verifica-
tion, the locus can be sequenced, but we have found that dramatic
sequence artifacts rarely occur in clones confirmed by PCR, the
most common mutations are single-basepair substitutions or indels,
which typically constitute a minority of confirmed clones.
(b) Lack of product from the confirmation primers is inconclusive
per se. In such cases, it is worthwhile to consider additional
evidence, such as whether the positive control PCR worked (if not,
the lysis may have failed).
6. Confirmed clones can be propagated by starting a new culture from the
original suspensions of yeast in water.
3.6.5 Curing of the CRISPR plasmid
1. Streak original water suspensions of confirmed clones on YPD. The
CRISPR plasmid is low copy and can be spontaneously lost in absence
of selection.
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2. Pick 10 colonies from the YPD plate and patch each one on YPD and
SD-Ura plates.
3. Incubate both plates, and collect cells from patches which grew only on
YPD but not on SD-Ura. Isolates which still carry the CRISPR plas-
mid will grow on uracil dropout medium, but those which have lost the
plasmid will not. Typically, 3 days is sufficient to confirm lack of Ura
prototrophy, but if slow growth on uracil dropout is suspected, incuba-
tion can be extended to up to 6 days to definitively confirm no growth
on uracil dropout.
The plasmid can also be cured by counterselecting on 5-fluoroorotic
acid (FOA) plates[105]. However, there is a possibility that this FOA
method will generate some colonies that are not cured of the plasmid
but rather have acquired a mutation in the Ura marker (thus continuing
to express the gRNA). Thus, FOA counterselection should not be used
(as opposed to replicate patches on YPD and Ura) if it is important to
ensure curing of the plasmid, rather than simply abrogating Ura pro-
totrophy. On the other hand, the FOA method can save time if only
loss of Ura heterotrophy is desired, for instance to enable a subsequent
transformation with a different Ura-selectable plasmid.
3.7 Data Analysis
The data analysis needs for this procedure are minimal. Most im-
portantly, when using Geneious to design gRNA sequences, it is desirable to
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select gRNA sequences that have high predicted on-target activity (automat-
ically calculated by Geneious). gRNA sequences with high predicted activity
may have low actual activity, but they will be less likely to exhibit low activity
than sequences with low predicted activity. The distance of the gRNA target
site can be up to 1 kb away from either homology region without perceptible
negative consequence, thus gRNAs should be selected primarily based on high
activity rather than location (provided that they lie between the two homology
arms).
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3.8 Notes
1. We have found that even among gRNAs with high predicted activity,
some will fail to induce double-strand breaks with sufficient efficiency
for editing. It is highly recommended that for each target locus, several
gRNA are designed and tested in parallel, to ensure that at least one
will be a sufficiently good DSB inducer for purposes of genome editing.
2. If a given gRNA exhibits significant off-target activity, the likely outcome
is that off-target cleavage will kill most of the transformed yeast cells.
Successful, efficient genome editing in yeast relies on lethality associated
with DSBs at the target locus being rescued by HR (allowing efficient
repair of the DSB) and abrogation of the gRNA target site (preventing
further cleavage). In the event off-target activity, HR may likely not take
place because no repair template with homology to the off-target site has
been supplied, moreover the gRNA site will not be eliminated for the
same reason. Further, the confirmation strategy we suggest is such that
only repair at the correct locus will produce a positive result. However,
it is nevertheless worthwhile to ensure that selected gRNA target sites
do not occur at other locations in the genome, where cleavage is not
intended. Although it is very unlikely for the combined 23 bp target
sequence to appear multiple times in the yeast genome, we recommend
confirming that candidate gRNA sites appear only in the target locus
using a tool such as BLAT.
3. gRNA targets consist of a 20 bp sequence (which will also be included
111
in sgRNA sequence and become part of the Cas9 complex) followed by a
3 bp PAM sequence (which takes the form of NGG for Cas9 described in
this protocol). The PAM sequence does not become part of the gRNA,
but it must be present in the target genome for Cas9 cleavage to occur.
This can be verified by attempting to align the gRNA sequence to the
sequence of the repair template typically, CRISPR activity will be very
low with more than 5 mismatching basepairs, although mismatches in
the PAM and proximal to the PAM appear to have more significance
[106]. When replacing with very similar sequences, such that it is diffi-
cult to find good gRNA sites unique to the target locus, one strategy that
can be adopted is to introduce synonymous mutations in the repair tem-
plate sequence which alter the PAM site or PAM-proximal nucleotides.
Alternatively, recent research suggests that using shorter gRNA may in-
crease specificity, since the 8-17 PAM-proximal nucleotides contribute
disproportionately to CRISPR target recognition[107].
4. There is some variability in the yeast transformation step, and depending
on how the competent cells were prepared, and how the transformation
was performed. Most commonly, the number of resulting colonies will
vary somewhat between transformations of identical strains with identi-
cal reagents, but usually this variation will be less than tenfold. When a
transformation produces a fair number of colonies (at least 10) yet none
of them are found to be correct clones upon screening, simply repeating
the transformation is unlikely to improve results. The most straightfor-
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ward avenues of increasing the number of correct clones are to increase
the amount of repair template DNA, and to produce repair template
DNA with longer homologies.
5. If no colonies appear after transformation, the reason may be low trans-
formation efficiency. In this case, several troubleshooting steps can be
taken (described in detail in the documentation of the Zymo EZ compe-
tent yeast kit). We have found the following to be effective:
(a) Thoroughly vortexing the mixture of competent cells and DNA.
(b) Longer incubation time for the transformation (1.5 h instead of the
45 min).
(c) Including more cells in the transformation.
(d) Competent cells seem to perform slightly better when frozen once
(slowly in -80 ◦C) than freshly prepared cells.
6. When the CRISPR reagents and repair template are transformed into
yeast cells, the resulting transforming colonies will be of three kinds with
respect to the targeted locus:
(a) Correct transformants which bear the sequence of the repair tem-
plate.
(b) False transformants which bear the original, unedited sequence.
(c) Mutants.
7. In our experiments, we have found that the first two classes predominate
unless mutants are specifically selected for. Even in the absence of a
repair template, the majority of false transformants will not be mutants.
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Due to the efficient HR system of S. cerevisiae, if the conditions of the
experiment are adequate then editing will take place at a very high rate.
Thus, typically, the proportion between the first two of the three classes
listed above will be such that the transformants are either mostly correct
or all false. The third class, or mutants, we have found to be very rare in
either case unless specifically selected for. As a consequence, it is rarely
necessary to screen a very large number of colonies to determine whether
an editing experiment has succeeded. However, it is desirable to collect
several confirmed clones to minimize issues caused by artifacts, such as
mutant edited sequence caused by errors during PCR (with the reagents
and protocols described in this text, we have found clones with mutant
edited sequence also be very rare).
8. Selecting yeast transformants with a single amino-acid dropout medium
is normally a straightforward process, and colonies can be seen within
1-2 days of plating. However, occasionally the genome editing process
itself, or the resulting edited sequence, can result in a growth defect in
the resulting cells. Thus, if no colonies appear, incubating the plate
for a longer period can produce colonies. In the most extreme case
we observed, it took 6 days for colonies to appear on a uracil dropout
medium, but several clones were later confirmed by PCR and sequencing;
these clones consistently exhibited slow growth in subsequent culture on
rich medium (YPD) as well.
9. Some combinations of target locus and repair template may lead to a
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mixture of large and small yeast colonies after transformation. If this
occurs, generally it is best to screen an adequate number of colonies
for each size class. It may be that the correct edits create much slower
growing strains, thus the large colonies are false while the small ones have
the desired edit. Conversely, if the desired sequence does not interfere
with normal growth, but mutations arising from NHEJ do, then larger
colonies will tend to be the correct clones. We have observed examples of
either case when humanizing and bacterializing various loci. It is difficult
to predict a priori which case will be evident for a given transformation,
therefore it is often more practical to screen colonies and recording their
size, and also ensuring that each size is adequately represented in the
screen.
10. When picking colonies for the colony PCR screen, only a small quantity
of cells is needed. Most likely as little as 1,000 cells will be sufficient to
obtain a PCR product. We have often chosen to collect slightly larger
numbers of cells to visually confirm their suspension in water by turbid-
ity. However, too many cells lead to incomplete lysis and inhibition of the
colony PCR. With cell clumps larger than 1-2 mm the colony PCR will
often fail. So ideally, the cells collected from the colony should form only
a tiny speck, 0.5 mm or smaller in diameter. It is helpful to include the
positive control PCR when screening, to identify samples which failed
to produce a PCR product due to poor lysis. Lysis and PCR can be
repeated for these samples if needed.
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11. It is possible to adapt the protocol described here for the simultaneous
replacement of multiple genes. The Mo Clo toolkit allows for cloning
up to 4 different gRNA cassettes on the same CRISPR plasmid; for
this, the gRNAs would be captured on pYTK050 as described here, but
in the second Golden Gate reaction, instead of the ConL1 and ConRE
plasmids, the first gRNA would be cloned with ConL1 and ConR2, the
second with ConL2 and ConR3, the third with ConL3 and ConR4 and
the fourth with ConL4 and ConRE (this process is explained in detail in
[23]). All of these cassette plasmids would then be included in the final
Golden Gate reaction to assemble the CRISPR plasmid. Then, during
transformation of yeast, templates for each of the included gRNAs will
need to be co-transformed. However, multiple replacements are even
more dependent on efficient transformation, cleavage and repair than
single replacements, and some additional work may be necessary to op-
timize these parameters in practice.
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3.9 Recipes
1. Zymolyase solution (50 ml)
(a) Weigh 9.11 g D-sorbitol
(b) Dissolve in 50 ml distilled, deionized water to make 1 M sorbitol
and autoclave
(c) Weigh 0.25 g zymolyase and dissolve in sorbitol solution
(d) Aliquot and store at -20 ◦C
2. Lithium acetate, 100 mM (40 ml)
(a) Weigh 0.408 g lithium acetate dehydrate
(b) Dissolve in 40 ml distilled, deionized water
(c) Filter sterilize (0.2 µm filter) and store at room temperature
3. LB medium (1 L)
(a) Weigh 25 g LB powder
(b) For solid medium, add 15 g agar
(c) Dissolve in distilled, deionized water for 1 L total volume
(d) Autoclave and let it cool to 60-70 ◦C
(e) Pour in Petri plates so that the medium covers the visible area of
the plate
(f) Let plates cool and solidify at room temperature, store at 4 ◦C
4. YPD (1 L)
(a) Weigh 50 g YPD powder
(b) For solid medium, add 20 g agar
(c) Dissolve in distilled, deionized water for 1 L total volume
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(d) Autoclave and let it cool to 60-70 ◦C
(e) Pour in Petri plates so that the medium covers the visible area of
the plate
(f) Let plates cool and solidify at room temperature, store at 4 ◦C
5. SD-Ura (1 L)
(a) Weigh 1.5 g yeast nitrogen base w/o amino acids, 5 g ammonium
sulfate, 20 g dextrose, 2 g SC-Ura dropout powder
(b) For solid medium, add 20 g agar
(c) Dissolve in distilled, deionized water for 1 L total volume
(d) Autoclave and let it cool to 60-70 ◦C
(e) Pour in Petri plates so that the medium covers the visible area of
the plate
(f) Let plates cool and solidify at room temperature, store at 4 ◦C
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3.11 Conclusion
This work was originally published in the journal Bio-protocol. I con-
tributed to much of the development of the technique and the writing of the
manuscript. Soon after publication, we were serendipitously informed that
another group had succeeded in reproducing our results.
Though the protocol is written with a focus on ortholog swapping, it is
in principle equally well suited to any arbitrary genetic editing. In addition,
due to the inherent DNA cleavage activity of CRISPR, the strains produced by
this protocol can be used as gene-drives[108] with super-Mendelian inheritance
of the resulting edit in subsequent generations (Figure 3.6). Ordinarily, if a
haploid yeast a::B (with sequence B replacing wild-type locus A) mates with
a wild-type yeast the result will be a heterozygous A locus with AB genotype.
If the CRISPR plasmid is retained (by skipping the plasmid curing step at
the end of the protocol), then after mating the CRISPR system will cleave
the wild-type A allele coming from the unedited parent. Once a double strand
break occurs, the edited chromosome (which is immune to CRISPR cleavage by
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virtue of lacking the gRNA target site) will be used as a template for HR. The
practical result is that haploid parents of genotypes A and a::B are mated, but
instead of AB progeny, BB progeny is the result. Thus the practical function
of a CRISPR plasmid during mating is to eliminate homozygosity at a certain
locus, preferentially with respect to the wild-type allele. If such a plasmid
(often referred to as a gene drive) is maintained throughout generations, the
allele favored by it will propagate through the population rapidly and eliminate
alternative alleles. Gene-drives are therefore a powerful tool for combining a
set of different edits or propagating a single edit throughout a large population
rapidly.
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Figure 3.1: Overview of the CRISPR plasmid construction process.
In the first step Xs and Ys represent the gRNA sequence selected, and BsmBI
recognition site is indicated in bold.
121
Figure 3.2: Diagram of the native yeast HEM2 locus showing posi-
tions of the example guide RNAs sg1 and sg2.
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Figure 3.3: Diagrams of example template primer designs for the
replacement of HEM2 with hsALAD.
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Figure 3.4: Representative assay results. Yeast cells are rescued from
DSB lethality (center plate) when an appropriate repair template is provided
(right plate). The left plate is a negative control of cells carrying a control
plasmid with the same selectable marker (URA3) done to estimate the trans-
formation efficiency of the yeast strains being used.
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Figure 3.5: Demonstration of colony picking technique with
12-channel pipette.
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Figure 3.6: CRISPR/Cas9 as a gene drive. Ordinarily,
CRISPR-mediated humanization is carried out in haploid strains. A human-
ized strain is mated with another yeast of the opposite mating type, but not hu-
manized at that locus. This generates a heterozygote (yeast/human) diploid.
If the CRISPR plasmid targeting this locus is retained during the mating, it
will also cleave the wild type allele received from the other yeast. The ho-
mologous chromosome can serve as a repair template, and the yeast allele is
overwritten with the human one during homologous recombination. If the
plasmid was not preserved, or it is desirable to decouple the HR from the
mating itself, it can still be transformed later with the same effect.
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Reagent Amount
dsOligo 40 fmol
pYTK050 20 fmol
NEB T4 buffer 10x 1.0 µl
NEB T7 ligase 0.5 µl
NEB BsmBI 0.5 µl
H2O to 10 µl
Table 3.1: Golden Gate reaction for cloning into shuttle vector.
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Reagent Amount
gRNA on pYTK050 20 fmol
ConL1 (pYTK003) 20 fmol
ConRE (pYTK072) 20 fmol
AmpR-ColE1 (pYTK083) 20 fmol
NEB T4 buffer 10x 1.0 µl
NEB T7 ligase 0.5 µl
NEB BsaI 0.5 µl
H2O to 10 µl
Table 3.2: Golden Gate reaction for cloning gRNA cassette plasmid.
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Reagent Amount
gRNA cassette plasmid with connectors 20 fmol
Cen6-Ura cassette* 20 fmol
Cas9 plasmid (pYTK036) 20 fmol
NEB T4 buffer 10x 1.0 µl
NEB T7 ligase 0.5 µl
NEB BsmBI 0.5 µl
H2O to 10 µl
Table 3.3: Golden Gate reaction for cloning CRISPR plasmid.
*Cen6-Ura is constructed by assembling YTK plasmids (008, 047, 073, 074,
081, and 084).
129
Chapter 4
Multiple Humanization of the Heme Pathway
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4.1 Introduction
In past work, we observed that modularity largely determines swappa-
bility. I have also noticed that although many genes can be swapped, many of
these replacements cause slight fitness defects. Motivated by these findings, I
questioned the limits of swappability: Is it possible to replace multiple genes
within the same yeast? What are the consequences of doing so? This chapter
describes my work on investigating these questions, primarily in the context
of humanizing the yeast heme biosynthesis pathway.
Detailed consideration reveals several interesting aspects to this ques-
tion, and describes the rationale and motivation for attempting to humanize
the heme pathway of the yeast.
4.1.1 Is multiple humanization feasible?
One of the simplest naive expectations is that if many genes can be
individually humanized, then they can be humanized together as well. This
corresponds to the reductionist null hypothesis that replacements do not sig-
nificantly influence each other. It is instructive to consider a similar case in the
recent history of yeast biology: The striking discovery that most yeast genes
are non-essential[109, 6] was soon followed by the equally striking discovery
that there in many pairs of such dispensable genes are synthetic-lethal[12,
110], and become essential once one of them is deleted. In fact, the so-called
non-essential yeast genes are so considered because they are non-essential in
culture on rich medium under standard laboratory conditions. For most es-
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sential genes, there exists at least one environment where they do become
essential[7]. It appears that often, genes can appear to be dispensable because
their function is redundant, but when the redundancy is eliminated through
environmental stress or genetic disruption, they cease to be dispensable.
Analogously, we hypothesize that many cases of yeast humanizations
are not necessarily complete complementations of the native gene’s function.
Humanizing a gene only shows that the non-redundant functions of that gene
have been provided by the human ortholog. It may be that the human ortholog
lacks key functions that the yeast gene has, or has additional functions that,
in a yeast cell, would be deleterious. In single humanizations, these functional
impairments could be overcome due to other native yeast genes acting as a re-
dundancy for the same functions. Higher order humanization can conceivably
eliminate all redundant genetic providers of an essential activity, thereby pro-
ducing a “surprising” behavior of mutual exclusivity between humanizations
which are possible individual. Constructing a multiply humanized yeast helps
elucidate this hypothesis and a number of long-standing theoretical concerns.
Moreover, focusing on a single pathway increases the relevance of such an ex-
periment, as we would expect key metabolic modules to be particularly rich
in epistasis.
4.1.2 Does compatibility extend to pathways?
Past studies revealed modularity plays a large role in which yeast genes
are amenable to ortholog swapping. Genes which can be readily humanized
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often belong to pathways or protein complexes (collectively, the “modules”)
made up of other swappable genes. This was a major discovery of the initial
systematic humanization project[8]. It was also confirmed in our later work[37]
generalize across domains and kingdoms of life (Figure 2.1). It is tempting to
rationalize this phenomenon in terms of compatibility within the module: We
can expect that evolutionary divergence would introduce distinct molecular
idiosyncrasies to orthologous genetic modules[111, 112]. This would hamper
cross-species swapping, not necessarily due to a deficiency in the function of
the ortholog per se, but due to its inability to act in concert with the whole.
In the course of applying genomic editing to humanization research, it
became apparent that often humanization can lead to a modest fitness defect.
In older studies, human orthologs were often provided on plasmids, driven by
strong constitutive promoters. This likely expressed many human genes at
a much higher level than their native counterparts, and also blocked many
native regulation mechanisms. With the CRISPR-based genomic replacement
approach described in Chapter 3, the orthologous ORF directly takes the place
of the yeast ORF and is amenable to many of the same mechanisms of tran-
scriptional regulation. It is, therefore, possible to directly measure the fitness
defects associated with the swap.
If each genetic modification i results in fitness fi (relative to the wild
type) when performed individually, and if they are independent of each other,
we could expect that combining the modifications will result in fitness F =
∏
i
fi
(the “multiplicative model”). We could expect this behavior if the fitness de-
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fect of humanization is determined by interactions with the entirety of the
genome or the hypofunction of the human ortholog itself. However, if in-
teractions with other module member are more important, they will not be
disrupted by bringing an entire human module into yeast wholesale. When
humanizing the last gene in a yeast module, we would predict little fitness de-
fect as the human interaction partners of that gene would already be present.
Generalizing from this by induction, we can predict that fitness would de-
pend on how much of the module has already been humanized. The initial
humanization steps would gradually impair growth, but after the lion’s share
of the module is human, there would be a tipping point and subsequent hu-
manizations would improve fitness – for the same reason that “yeastizing” a
human cell might decrease it. Recalling our earlier formalism, the fitness cost
of humanizing each gene fi would depend on fraction r of the module that has
already humanized (the “cooperative model”). An illustration of these models
is provided in Figure 4.1.
Humanizing an entire yeast pathway allows us to directly test these
alternative explanations. Moreover, there is also a practical benefit: The
multiplicative model implies that it is possible to humanize only so much
of a yeast genome. This constrains the suitability of using humanized yeast
clinically, as a test bed for investigating the biology of human genetic modules,
because it predicts that any substantial human pathway will cause the strain
carrying it to be extremely slow-growing. As a result, strategies would need to
be developed to cull large modules to a handful of key genes in order to balance
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fidelity to human physiology with experimental practicalities. Conversely, if
the cooperative model is true, then the solution to slow growth of a humanized
yeast system is paradoxically to humanize it more rather than less.
4.1.3 Scalable probing of epistasis and allelic variation
The CRISPR-based genome editing system I am utilizing for this re-
search has a convenient side-benefit: After a humanization is finished, the
CRISPR plasmid can act as a gene drive to greatly simplify combining in-
dividual humanizations (Chapter 3, section Conclusion). When introducing
a new humanization, it is necessary to transform a linear DNA that serves
as the repair template. The success of the procedure, therefore, hinges not
just on the ability of the human ortholog to complement its function, but also
on efficient transformation and incorporation of the template. In contrast,
when inducing loss-of-heterozygosity via a CRISPR gene drive, efficiency of
the genome editing is very high: The entire chromosomes act as homology
arms, and transformation efficiency is no longer a factor. This permits reliable
humanization with not just wild type human alleles, but also allelic combina-
tion with significant deleterious epistasis.
Under the cooperative model given above, the number of humanized
strains that can be constructed for a module with n genes is given by
∑n
i=0
(
n
i
)
.
For 8 genes (as in the heme pathway), this evaluates to 255. It would be im-
practical to construct so many strains individually, but the gene drive permits
a high throughput approach, analogous to existing techniques based on large
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yeast crosses[11, 113]. Conducting an all-by-all cross of partially humanized
strains affords deep knowledge of the epistasis network inherent in the clini-
cally relevant heme pathway. Moreover, creating this system would enable its
generalization to also probe various allelic variants of human genes and pro-
vide a very practical, scalable, economical method of probing massive human
variation data.
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4.2 Higher order humanization of the yeast heme
biosynthesis pathway
I began efforts at multiple humanization with the collection of indi-
vidually humanized strains generated as part of the work described in [37]
and elsewhere. In transformation experiments, UROS, UROD, and HMBS
seemed to be the human genes that can be humanized most efficiently. In sep-
arate experiments, UROS was transformed with HMBS and UROD. UROD
was transformed with UROS and HMBS. HMBS was transformed with UROS
and UROD. The transformation was as described in Chapter 3. I was able to
confirm a large number of UROS/UROD transformant colonies, which were
afterward dubbed the “UU” strains. All singly humanized strains exhibited
a small but perceptible slowness in growth, which was evident from colony
size when they were cultured in parallel with wild type yeast. The UU strain
appeared to have a similar slight fitness defect.
The UU strain was cured of the CRISPR plasmid using the 5-FOA
counterselection method and, in separate experiments, transformed with
ALAD, HMBS, CPOX, and PPOX. Once again I obtained a large number of
transformants for ALAD/UROS/UROD (“AUU”) and HMBS/UROS/UROD
(“HUU”) and confirmed them by colony PCR. The CPOX and PPOX exper-
iments produced very few colonies (typically <5) and none were confirmed by
PCR, indicating that they likely failed to incorporate the humanized template
and repaired CRISPR-induced damage by NHEJ. It has often, though not
always, been the case that false transformants in genomic editing experiments
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will grow much slower. NHEJ is known to be mutagenic in yeast, with
mutation rates on the order of 0.1%[20]. It is possible that repeated cleavage
in these failed transformants (although the plasmid bearing their CRISPR
system was continuously selected for, the repair template is only transiently
present) induced and selected for mutations that eliminated the CRISPR
target site, but at the same time impaired the activity of an essential gene. It
is also likely that the slow growth is due to repeated CRISPR cleavage which
the clones manage to tolerate. In other experiments, Sanger sequencing has
shown that many false transformants do not have any mutations in the area
around the CRISPR target site.
Both AUU and HUU clones all showed a moderate growth defect, some-
what greater than that of UU and singles. Both clones were cured of plas-
mid, grown out and prepared for a subsequent round of transformation with
PPOX, FECH, HMBS (for AUU) and ALAD (for HUU). The transforma-
tion succeeded for ALAD, generating the ALAD/HMBS/UROS/UROD strain
(“AUUH”). I isolated several transformant colonies, confirmed them by PCR,
and selected one for further experimentation. Interestingly, the HMBS trans-
formation which would have generated the same genotype failed to produce
any confirmed clones. Moreover, it resulted in a very small number of trans-
formant colonies (<5) which has often been a hallmark of a failed replacement
in our system. A second attempt to transform HMBS into AUU also failed
in similar fashion. This somewhat paradoxical result appears to imply that
swappability can depend not merely on the set of genes being humanized, but
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also on the order in which they are humanized. I suspect that the paradox is
explained by the nature of our experimental method: The limiting factor in
our technique is transformation efficiency, as even the most successful experi-
ments will produce at most around 50 colonies transformed with the plasmid.
Typically, the number is much smaller, in the 10-20 range. There is no di-
rect selection for the repair template, so one would expect a large number of
colonies passing -Ura selection may have failed to be co-transformed with the
template as well. The lethality of CRISPR activity in absence of HR should
kill most such partial transformants, but in practice, some false transformants
are often recovered from replacement experiments. Therefore, in many cases,
the probability of recovering correct clones is not much greater than the limit
of detection. Any genetic change, such as humanization of multiple genes,
could impair cellular function just enough for transformation efficiency fall
below that limit. Given that transformation itself, as well as successful HR,
is not a trivial physiological event, it is not unrealistic to suspect that certain
combinations of humanized genes interfere with it.
The AUUH strain proved to be the most extensively humanized strain
I was able to construct. Notably, it had an extremely slow growth rate. Typ-
ically, Ura prototroph yeast will form visible colonies on -Ura medium after
1-2 days[114]. In accordance with the fitness defect imposed by humanization,
colonies from successful transformations will often grow slower, appearing only
after 2-4 days. Colonies from the AUUH strain had only reached a large enough
size to be picked (2-3 mm in diameter) after 6 days of culture at 30 ◦C. Al-
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though such slow growth is often an indicator that the colonies are false and do
not contain the humanization, we were able to definitively confirm the identity
of these clones in multiple colony PCR screens (Figure 4.2).
Transformations of AUU and HUU with either PPOX or FECH failed
to produce any confirmed clones. This result is unsurprising given the earlier
difficulties with humanizing PPOX in UU context. Despite several repeated
attempts, I was likewise unable to recover any successful clones from trans-
forming AUUH with FECH, ALAS1, CPOX or PPOX. Interestingly, when I
succeeded in obtaining single ALAS1 and FECH strains, the humanization
appeared very inefficient, generating only a few clones. The clones that were
confirmed grew very slowly, between AUUH and AUU/HUU despite being only
singly humanized. Further, the FECH clone showed a strong pink cell pheno-
type which we had earlier observed for ecolization of the same locus (Figure
2.12)
4.3 Evolutionary optimization of the AUUH strain
In order to facilitate experimental work with the quadruple strain, and
also to gain a deeper understanding of the biological basis for its slow growth,
I next conducted a suppressor screen to discern the selective consequences of
quadruple humanization.
In order to study the feasibility of obtaining suppressor mutants in
this way, I first conducted a preliminary solid culture experiment. A clonal,
validated stock of AUUH was plated on a large YPD agar plate at a sufficient
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density to generate large numbers of well-separated colonies. After 3 days of
culture, there was a clear and consistent pattern of bimodal colony sizes (Figure
4.3). To confirm that the large colonies were bona fide suppressors rather than
contaminants, I collected 12 with sterile toothpicks for a colony PCR screen.
In order to further verify the results and provide a control, I likewise collected
12 smaller colonies, which were presumably also AUUH populations that had
not acquired significant suppressors. All 24 colonies in this set were confirmed
to steal bear humanizations at all 4 loci. This demonstrated the feasibility
of obtaining much faster growing mutants of AUUH by relying only on the
background mutation rate of yeast.
I then conducted a more elaborate evolution experiment. A clonal
AUUH stock was split into 8 sister lineages, and each was passaged daily in
liquid YPD for 12 days. The final sample from each lineage was designated
A12-H12, with letters identifying the lineage and numbers indicating the day.
All 8 evolved lineages, as well as the ancestral AUUH and BY strains, were
then assayed for fitness by measuring growth rate in triplicate4.5. Although
there was substantial variation between lineages, all were significantly more
fit than the ancestral strain, with the fastest growing strain being C12 4.6.
The results of the liquid culture passage experiment corroborate the feasibil-
ity study on solid culture: The relatively consistent amount of fitness recovery
across distinct cultures, and the significant change over such a short time pe-
riod, suggests that some “low hanging fruit” must have been available in the
evolutionary landscape of the AUUH strain. Likely, all lineages were explor-
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ing a similar clique of compensatory mutations, which were also exhibited by
the colonies in my feasibility study, and help explain the bimodal colony size
distribution.
4.4 Whole genome sequencing
In order to investigate the mutations accrued by my evolved lineages,
I performed whole genome sequencing of several evolved lineages, along with
the ancestral strain to establish the baseline, and the BY4741 to control for
mutations in our lab stock. The reads were mapped to the reference genome
of BY4741.
Coverage was evenly distributed between strains and chromosomes, at
a mean of about 15x (Figure 4.7). The notable exception was chromosome
XII which was covered at 30x in the initial mapping for all strains includ-
ing BY4741. Chromosome XII contains the highly repetitive ribosomal DNA
(rDNA) sequences[115, 116], which accounts for this — there are typically more
than a hundred repeats of rDNA and collectively they make up around 60% of
chromosome XII. The reference sequence for chromosome XII (NC 001144.5,
[117]) represents rDNA as a single copy, thus all of the reads from the repeat
array were collapsed into this single locus during mapping (Figure 4.8). With
reads mapping to rDNA excluded, the chromosome is covered at a mean of
15x, which was the value used in figure 4.7. Coincidentally, chromosome XII
does not contain any of the heme loci.
Notably, there were conspicuous gaps in coverage around the cod-
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ing sequences of genes HEM2, HEM3, HEM4, HEM12 for AUUH but not
BY4741. This confirms the presence of these humanizations in AUUH (Fig-
ures 4.9–4.12).
The number of short variations was generally slightly smaller in the
ancestral AUUH than in BY. However, the evolved strains had a much higher
number of variants, confirming that substantial evolution has taken place in
the passage experiment (Figure 4.16). Interestingly, it appeared that for chro-
mosome I, the number of variants was much smaller in AUUH than in BY, but
the evolved strains appear to have accumulated a large number of variants.
Generally, chromosome I appeared to have a much higher rate of variation for
its size, followed by chromosomes III, IV and II. Notably, 3 of the AUUH genes
are on chromosome IV.
In order to observe mutations within the heme biosynthesis pathway,
I then mapped the reads to the human coding sequence of each humanized
pathway member. I repeated this mapping for genes which were not human-
ized, by using their yeast CDS as the reference. After mapping, consensus
sequences for each gene in each sample were generated. For humanized genes,
the consensus sequences of ancestral AUUH and the other 4 evolved strains
were aligned to each other. For non-humanized genes, the BY consensus was
included as well.
The alignments were largely identical to the reference sequence, with
rare exceptions: The most striking difference was in UROS of strain 12D, where
a 4 bp insertion after residue 247 causes a frameshift affecting the remaining
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17 residues at the C-terminus of the protein (Figure 4.13). The frameshift
also appears to have abrogated the normal STOP codon. Mutations at this
residue[118], and further in the disrupted region[119], are known to be associ-
ated with human porphyrias. P248Q is associated with a porphyria phenotype
in humans, where ALAS2 gain-of-function partially rescues the hypoactivity
of UROS. Therefore, it is interesting and notable that this mutation should
arise in our suppressor screen.
Another terminal mutation is observed for HMBS in strain 12C. From
residues 352 onwards, there are several ambiguous nucleotides for the rest
of the terminus (4.14). Though this could potentially indicate a significant
mutation, in every case one of the possibilities for the ambiguous nucleotides
is always the wild type. There do not appear to be prominent known mutations
in this region; the most C-terminal known mutation I could locate is at residue
343.
HEM15 in 12C has two ambiguities near the N-terminus of the protein
sequence (Figure 4.15). These are likely to be spurious. Firstly, only a few
reads report an alternate base in those positions and the ambiguity appears
to have been caused by coincidentally poor read quality and coverage in this
spot. The N-terminus of HEM15 has a very significant role - as our earlier
work demonstrates, the first 100 bp of the iron chelatase sequence contain
critically important localization signals. Disrupting localization causes slow
growth and harmful accumulation of porphyrins. However, in this case, even
if the ambiguities were indeed mutations, one would be changing a leucine
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to isoleucine, the other would be synonymous. Therefore, it appears that no
significant mutation has occurred in the 12C strain at HEM15.
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4.5 Mating array of humanized heme strains
In order to probe the epistatic landscape of the partially humanized
heme biosynthesis pathway, and demonstrate the high-throughput gene drive
cross concept, I decided to conduct a large mating array. Throughout my ex-
periments, I had performed many CRISPR transformations in duplicate, for
BY4741 as well as BY4742, thus I had humanized strains in a and α mat-
ing types. I collected 10 MATa strains (the “query strains”) and 6 MATα
strains(the “subject strains”). To these, BY4741-2 were added to serve as
controls, for a final set of 11 query strains and 7 subject strains. These were
distributed across subjects and queries of a 96-well plate to achieve an all-by-all
cross and grown on appropriate selective media to select for successful mating
on the basis of Lys and Met markers and CRISPR activity on the basis of Ura
marker (conferred by the CRISPR plasmid).
Afterward, I compared the fitness of resulting diploids with a growth
curve experiment in YPD. As a proxy for fitness, I calculated the area un-
der the curve of OD measurements relative to the wild type, BY4741 mated
to BY4742. Query strains mated to BY4742 and subject strains mated to
BY4741 were then used as the baseline for establishing baseline growth rate
for each strain. Expected relative growth rates were calculated as the product
of baselines for either parent, as per the multiplicative model (Figure 4.17).
There appeared to be substantial variations in observed growth rates. Some
individual crosses stood out:
• HMBS to UROD and UROS grew very well, which is consistent with se-
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quential transformation experiments where UU was modified into HUU.
• UROD to UROS was also a rapidly growing cross, similarly consistent
with the construction of UU.
• Crosses with HMBS generally grew well. HMBS has also been quite easy
to humanize in earlier experiments.
• Crosses to the evolved AUUHe seemed to grow slightly better than ances-
tral AUUH, which would be expected due to the higher fitness of AUUHe.
Notably, FECH x AUUHe (but not FECH x AUUH) grew slightly better
than expected, while ALAS1 x AUUH (but not ALAS1 x AUUHe) grew
worse than expected. Both FECH and ALAS1 had proved recalcitrant
to humanization in the context of the ancestral AUUH strain. However,
given the superior growth of crosses to the evolved AUUHe, humaniza-
tions might prove more successful in this more optimal genomic context.
• AUU x HMBS grew much better than HUU x ALAD, which is also
consistent with earlier observations.
• Crosses with subject strain PPOXk grew slightly better than expected,
while PPOXdel crosses grew slightly worse. HEM14 is the yeast ortholog
of PPOX, and it overlaps BUD25 on the opposite strand. BUD25 is
non-essential. We generated two versions of the replacement template
for PPOX, one which deletes part of BUD25 coding sequence (PPOXdel)
and one which attempts to leave it intact. BUD25 is not known to
interact with any of the heme biosynthesis pathway genes, but the diploid
mutant has defects in bud-site selection[120] and might plausibly impact
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the growth of diploid strains.
• Subject strain ALAD and query strain UROD generally showed poor
growth rates, which is not consistent with the generally high level of
fitness observed for these strains in earlier work. Therefore, the data for
these two strains might have an unusually high level of error.
Figure 4.18 shows some summary visualizations comparing different
groups of crosses. First, I sought confirmation of the multiplicative model
which would predict that fitness of multiple humanizations follows the product
of individual humanizations. In this experiment, the observed growth rates
varied substantially from this prediction, so it seems likely that the effects of
humanization are not independent. This supports the idea that inter-pathway
interactions are a significant determinant of swappability. I also compared
crosses with evolved AUUH and ancestral AUUH. Generally, the crosses with
evolved AUUH fared much better. This is consistent with evolved AUUH
growing better in previous experiments.
I also considered crosses with multiply humanized strains and singly
humanized strains. In sequential experiments, there seemed to be a trend of
gradually diminishing fitness as more humanizations accumulate. In this case,
growth rates of crosses between singly humanized strains were slightly higher
than with multiply humanized ones, but generally, there was not a clear ten-
dency to be greater or less than the expected value under the multiplicative
model. Lastly, comparing humanizations which I had earlier failed to obtain
in combination, and those which were part of the AUUH quarter, there was
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likewise little difference. The variation for successful genes was greater, how-
ever. This seems to recapitulate the process of building AUUH: At each step,
several genes were transformed and only some were successfully added to the
strains. Likely, these successful experiments coincided with combinations that
have unusually good fitness. This explanation would predict, then, that pos-
itive epistatic relations contributed to the viability of AUUH; even though
it grew quite slowly, other attempted quadruple humanizations could not be
obtained at all.
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4.6 Conclusion
In this chapter, I have presented my latest work on yeast humanization,
in the context of humanizing heme. Being the most recent, this work is also
in the earliest stage. Nevertheless, there appear to be some promising results:
• Construction of the quadruple-humanized heme strain was remarkably
straightforward. Though the resulting strain was slow growing, it was
amenable to manipulation and would be a suitable organism for large
assays.
• Evolving the AUUH strain has been a very effective strategy. All 8
lineages have quickly recovered more than half of their growth defect.
This is exciting for two reasons: It shows that humanization or other
swapping experiments can be greatly facilitated by simple evolutionary
approaches. The improvement in growth rate that I observed came after
only 12 passages over as many days, with only background mutagenesis
driving sequence diversity. Also, sequencing has revealed many more
genetic variants arising in the evolved lineages, demonstrating that the
suppressor screen is an effective approach to studying humanized path-
ways.
• Sequencing, in conjunction with evolution, has identified mutations as-
sociated with human disease. This underscores the clinical relevance of
humanization studies.
The compatibility hypothesis, regarding whether interactions within a
pathway or outside play a more significant role in humanization, remains elu-
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sive. Sequencing data appears to imply that human genes specifically are being
mutated, as no hint of mutation was observed in the non-humanized genes.
Meanwhile, the mating crosses show very poor correspondence to the multi-
plicative model. More precise studies are needed to answer these questions –
for example, introducing a mutagen into the evolution experiment could in-
crease sequence diversity, and perhaps bring more heme suppressors above the
detection threshold. Meanwhile, an evolved AUUH is an excellent candidate
for introducing mutant human alleles and observing their sequence changes.
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4.7 Materials and Methods
4.7.1 Strains and culture conditions
All strains were engineered from BY4741 and BY4742 strains of S.
cerevisiae[121]. When selection was not needed, cells were grown in yeast
peptone dextrose medium (BD, 242820). Selection was performed in SD-Ura,
SD-Lys, SD-Met, CSM-Lys-Met, SD-Lys-Ura and SD-Met-Ura media (Sunrise
Biosciences; 1703-500,1745-300, 1740-100, 1345-030, 1018-010, 1092-010). Me-
dia were supplemented with 2% agar for solid culture. Strains were suspended
in 20% glycerol and frozen in -80 ◦C for long term storage.
4.7.2 CRISPR transformation
Sequential construction of the AUUH strain was done with sequential
transformations of a CRISPR/Cas9 system as described in [21]. Briefly, a
linear repair template DNA was constructed by PCR amplification and column
purification (Zymo DNA Clean&Concentrator-25 kit, Zymo Research, D4005)
of the human ortholog with homologies to yeast promoter and terminator
sequences inserted via primers. A CRISPR plasmid targeting only the yeast
coding sequence (CDS) was prepared with the Mo-Clo plasmid toolkit[23].
Cells were grown to OD=1 in liquid yeast peptone dextrose medium (YPD).
Usually, overnight culture was sufficient, but for slow growing cells, sometimes
2-3 days of culture were required. The culture was made chemically competent
using the Zymo EZ Yeast Transformation II kit (Zymo Research, T2001). The
competent cells were transformed with 5 µg of the repair template and 500
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ng of the plasmid, then plated on SD-Ura agar plates and cultured at 30 ◦C
until colonies appeared. Reagents used were the same as those constructed
and described in [37].
4.7.3 Plasmid curing
Two strategies were used for curing plasmids: When rapid curing of
many strains was necessary, they were grown for 2 days on 5-FOA medium
[105] and the resulting cells were free of the Ura auxotrophy (as confirmed by
failure to grow on -Ura medium). For smaller sets of strains, the cells were
streaked out on YPD agar plates and incubated until colonies appeared. Then
12 numbered colonies were patched onto a fresh YPD agar plate as well as
-Ura plate and cultured in parallel. Colonies which failed to grow on -Ura
after 6 days were considered cured of the plasmid.
4.7.4 Colony PCR screen
Up to 12 colonies at a time were picked from transformation plates and
probed for presence of the human gene by PCR [21]. The PCR confirmation
primers were designed so that one primer anneals to the yeast promoter which
was not covered by the repair template homology, while the other binds to the
human coding sequence and not the yeast one. Expected product sizes ranged
between 200-500 bp. Primer sequences are the same as those in [37]. PCR
was analyzed by gel standard agarose electrophoresis.
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4.7.5 Agar plate suppressor screen of AUUH
A clonal stock of AUUH colony was grown overnight on YPD agar. The
cells were collected and suspended in water for OD measurement. The cells
were diluted to ∼10 million CFU/ml based on OD (0.68 OD is assumed to
correspond to 10 million CFU/ml). From this master dilution, serial dilutions
of 1:10 were made in 1 ml water each. 300 µl of cells from several dilutions
was plated on 150 mm YPD agar plates for 30, 300, 3k, 30k expected colonies,
to account for measurement and dilution error and cultured for 3 days. The
plate with the largest number of separated colonies was selected to collect
suppressors. 12 large and 12 small colonies were picked with sterile toothpicks
and confirmed for AUUH humanization.
4.7.6 Evolution of AUUH
1 µl of a clonal population of AUUH from glycerol stock was inoculated
into eight tubes with 5 ml liquid YPD media. Cultures were designated A-H
to indicate lineage and numbered 1 for day 1. After exactly 24 hours of culture
at 30 ◦C with orbital shaking at 200 rpm, each tube was removed from culture.
Cells which had precipitated to the bottom were resuspended by pipetting up
and down inside the tubes. Then, 1 µl of each tube was inoculated into a
fresh 5 ml YPD culture to create cultures A2-H2. The remainder of A1-H1
was frozen in glycerol. This process was repeated for 12 days resulting in
A12-H12. All cultures were saved in glycerol.
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4.7.7 Growth curves
Yeast strains were pre-cultured in liquid YPD or -Ura medium
overnight. 1 µl of each culture was inoculated into 200 µl liquid culture on 96
well format transparent plate. A Synergy H1 spectrophotometer (BioTek) was
used to incubate the plates, with shaking and optical density measurement
every 15 minutes for up to 72 hours. Data was analyzed in triplicate, except
in the case of the pairwise mating array.
4.7.8 Genome sequencing of AUUH
For genome sequencing, samples were grown overnight in YPD and
DNA was isolated with the Zymo YeaStar Genomic DNA Kit (Zymo Research,
D2002). 3 µg of each sample was submitted to the CSSB sequencing core in
100 µl for 250 bp paired-end Illumina reads. Data were analyzed with Geneious
v9[96] software. Reads were paired and mapped to the S288C reference genome
from SGD[44] with the Geneious mapper. Mapping statistics were exported
and analyzed in R with dplyr and ggplot2 packages. Multiple sequence
alignments were performed with the MUSCLE software[122, 123].
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Figure 4.1: Illustrative simulation of the multiplicative and cooper-
ative models for high order humanization. Each thin line shows fitness
over the hypothetical course of a whole-pathway humanization project for a
module with 8 genes. Averages of 20 runs are shown as thick lines. (Top) Un-
der the multiplicative model, fitness fi of humanizing gene i is assumed to be
independent of other humanizations in this module, thus the final fitness is
given by the product
∏
fi calculated over every i humanized in that strain.
In this simulation, fi = 1− x where x is an exponentially distributed random
variable with mean 0.05 (λ = 20). (Bottom) Under the cooperative model,
fi is strongly dependent on the whether other genes in the module have been
humanized. In reality, a complex epistatic network of n × n genes would de-
termine the fitness of every subsequent humanization. For simplicity, in this
simulation fi = 1−x ·(0.5−r) where x is an exponentially distributed random
variable with mean 0.1 (λ = 10) and r is the fraction of genes in the pathway
that are already humanized.
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Figure 4.2: Colony PCR confirmation of quadruple humanized
AUUH strain. This gel shows agarose electrophoresis and SYBR Safe
staining colony PCR for 3 different colonies from a CRISPR humanization
experiment. From top to bottom, the first row is a GeneRuler 1 kb DNA Lad-
der. The next three pairs of lanes correspond to colonies 1, 2, 3 respectively.
Bands corresponding to PCR products spanning the junction of the humanized
hem2::ALAD, hem3::HMBS, hem4::UROS and hem12::UROD and their yeast
promoter regions are shown. All 4 bands are absent when the humanization
is not present as one primer in each pair binds only the human and not the
yeast sequence (not shown). The rightmost lane is a positive control (the yeast
ERG13 locus). All bands are at their expected size range.
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Figure 4.3: AUUH suppressor screen feasibility study. AUUH cells
from a clonal population were cultured on YPD agar for 3 days, giving rise to
this pattern of colonies. Large and small colonies can be seen.
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Figure 4.4: Colony PCR confirmation of AUUH suppressor colonies.
Lanes, from left to right, are large (1-12) and small (13-24) colonies from the
AUUH suppressor screen on solid medium. Each row shows results of probing
for a different gene. All 4 humanizations are shown to be present in all 24
colonies.
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Figure 4.5: Growth curves of individual evolved AUUH lineages.
Each plot shows measurements of three parallel cultures. Black lines show
individual OD measurements, red line is the mean OD and grey bands show
standard deviation (±1σ). “AUUH” denotes the ancestral AUUH strain which
was not passaged, while plots labeled A-H are 12th day samples of each evolved
lineage.
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Figure 4.6: Comparison of mean growth curves for evolved AUUH
lineages. Red lines show 8 evolved lineages, dark red shows the ances-
tral AUUH and black lines show 3 wild type cultures (BY4741, BY4742 and
BY4743).
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Figure 4.7: Mean coverage of whole genome sequencing reads.
Mean coverage is shown across all chromosomes (top), and by individual
chromosomes (bottom). For chromosome XII, reads mapping to the highly
repetitive ribosomal DNA sequence (Figure 4.8) were excluded from coverage
calculations.
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Figure 4.8: Very high apparent coverage of ribosomal DNA on chromosome XII. Many
repeats of ribosomal DNA are represented as a single locus in the reference sequence for chromosome XII.
Shown here is coverage resulting from mapping of BY4741 reads. Coverage is on log-scale, and is about
1200x within the rDNA.
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Figure 4.9: Coverage gap around genomic HEM2 in AUUH. HEM2 was replaced by ALAD.
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Figure 4.10: Coverage gap around genomic HEM3 in AUUH. HEM3 was replaced by HMBS.
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Figure 4.11: Coverage gap around genomic HEM4 in AUUH. HEM4 was replaced by UROS.
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Figure 4.12: Coverage gap around genomic HEM12 in AUUH. HEM12 was replaced by
UROD.
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Figure 4.13: Multiple alignment of consensus UROS sequences from AUUH strains. A
4 bp insertion leads to a frameshift covering roughly the last dozen residues of the protein. Two known
disease mutations occur in this region, one of them almost exactly at the location of the insert.
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Figure 4.14: Multiple alignment of consensus HMBS sequences from AUUH strains. Am-
biguous nucleotides in the C-terminus imply a possible mutation. The individual reads have a bimodal char-
acter and seem to follow two distinct sequence patterns. The alternate pattern would cause a frameshift.
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Figure 4.15: Multiple alignment of consensus HEM15 sequences from AUUH strains. Two
ambiguous nucleotides may potentially be causing residue changes. The first, M indicating canonical C or
mutant A, would lead to an L2I mutation. The second, also an M with canonical C, would be a synonymous
substitution. However, there are not many actual reads exhibiting the alternate sequence.
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Figure 4.16: Total counts of small variations vs. reference yeast
genome. (Top) Absolute counts across entire genome. (Bottom) Counts
in individual chromosomes, normalized to chromosome size.
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Figure 4.17: Observed and expected growth rates of various crosses between humanized
strains. (Left) Heatmaps showing area under curve relative to the BY4741 x BY4742 cross. (Right)
Log-ratio comparison of expected to observed. Calculated as log2AUCobs
AUCexp
.
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Figure 4.18: Scatterplots summarising relative growth rates for
selected groupings of crosses. “Expected” refers to the growth rate pre-
dicted as the product of crosses to BY4741-2 (also shown in red). (Top left)
Overall, there was substantial variation in growth rates, with more crosses
growing better than expected. (Top right) Crosses with evolved AUUH were
more likely to have better than expected growth rate, and grew higher overall.
Bottom left Crosses with singly humanized strains were more likely to grow
better than expected as opposed to crosses to multiply humanized strains,
but generally, the difference was slight. Bottom right There was not much
difference between growth rates of crosses with humanizations that had pre-
viously been obtained in combination (ALAD, UROD, UROS, HMBS) and
those which were not (FECH, PPOX, ALAS1).
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Chapter 5
A Highly Parallel Strategy for Storage of
Digital Information in Living Cells
DNA has a long history as a medium of storing information, but hu-
manity has only began to explore this potential recently. Initial investigations
into the possibility of writing digital data into DNA sequences were confined
to theory, and it is only in the recent past that the advent of high-throughput
sequencing and synthesis technology made arbitrary reading and writing of
DNA possible. Several prominent researchers have produced systems for do-
ing this[125, 124, 126, 127], but they appeared unanimous in a key choice as
to how the information is to be partitioned.
Though modern electronic memory can fall short in very long term sur-
vivability, it has succeeded in providing vast storage space. Computer files can
often be thousands, millions or even billions of symbols long as the complexity
of software grows. Conversely, DNA synthesis technologies are limited. It is
not practical to synthesize pieces of DNA much longer than a few hundred
basepairs, especially on the vast scale needed for information storage. Thus
This chapter was previously published in Akhmetov A, Ellington AD, Mar-
cotte EM (2018) BMC Biotechnol., 18(1):64. EMM helped conduct the research. EMM
and ADE also helped me conceive the main idea and write the manuscript.
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any system for encoding information in DNA must first overcome the hur-
dle of breaking that information down into tiny pieces, and keeping track of
the pieces. Upon my first introduction into this area of research, I noticed
that all existing approaches seemed to favor a strategy of embedding individ-
ual addresses into each piece. This method has some advantages (conceptu-
ally straightforward, random-access) but also disadvantages (risk of address
corruption, complexity of implementation). My work was motivated by the
observation that it is possible to use a wholly orthogonal approach.
I developed a proof of concept codec which uses a customizable algo-
rithm to generate a codebook for a perfect code. The user is able to directly
specify a desired block size and error tolerance capacity. I further developed a
method of partitioning the resulting information without addresses, but rather
with overlaps between successive packets. As the problem of assembling many
small pieces into one long sequence has been solved extensively by traditional
de novo sequencing, my approach is very compatible with off-the-shelf sequenc-
ing software rather than requiring a specialized assembly solution. The over-
laps act as an additional protection against error. I tested the performance of
my codec by simulating a round-trip synthesis and sequencing of digital infor-
mation in DNA, with results demonstrating the feasibility and practicability
of this method. Besides performing competitively with regards to other stud-
ies, my approach has an additional advantage that is very significant from a
very long term archival perspective: It requires the storage of minimal details
regarding its operation for successful recovery to be possible. It also relies on
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technologies with inherently enduring interest to humanity, such as sequencing
of large genomes. Because of this, information encoded with my method is at
much lower risk of getting lost due to technologies needed to read it becoming
forgotten or obsolete (a common problem of many storage systems).
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5.1 Abstract
5.1.1 Background
Encoding arbitrary digital information in DNA has attracted attention
as a potential avenue for large scale and long term data storage. However,
in order to enable DNA data storage technologies there needs to be improve-
ments in data storage fidelity (tolerance to mutation), the facility of writing
and reading the data (biases and systematic error arising from synthesis and
sequencing), and overall scalability.
5.1.2 Results
To this end, we have developed and implemented an encoding scheme
that is suitable for detecting and correcting errors that may arise during stor-
age, writing, and reading, such as those arising from nucleotide substitutions,
insertions, and deletions. We propose a scheme for parallelized long term
storage of encoded sequences that relies on overlaps rather than the address
blocks found in previously published work. Using computer simulations, we
illustrate the encoding, sequencing, decoding, and recovery of encoded infor-
mation, ultimately demonstrating the possibility of a successful round-trip
read/write. These demonstrations show that in theory a precise control over
error tolerance is possible. Even after simulated degradation of DNA, recov-
ery of original data is possible owing to the error correction capabilities built
into the encoding strategy. A secondary advantage of our method is that the
statistical characteristics (such as repetitiveness and GC-composition) of en-
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coded sequences can also be tailored without sacrificing the overall ability to
store large amounts of data. Finally, the combination of the overlap-based
partitioning of data with the LZMA compression that is integral to encoding
means that the entire sequence must be present for successful decoding. This
feature enables inordinately strong encryptions. As a potential application, an
encrypted pathogen genome could be distributed and carried by cells without
danger of being expressed, and could not even be read out in the absence of
the entire DNA consortium.
5.1.3 Conclusions
We have developed a method for DNA encoding, using a significantly
different fundamental approach from existing work, which often performs bet-
ter than alternatives and allows for a great deal of freedom and flexibility of
application.
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5.2 Background
Recently, the prospect of encoding information in free nucleic acids has
attracted much interest from both academic research communities[124, 128,
125, 126] as well as the technology sector[129]. DNA offers unique potential
for storage of information, in that large amounts of information can be be
written (synthesis) and read (sequencing) at moderate, and rapidly decreasing,
cost. Ultimately, one DNA base-pair (bp) stores 2 bits of information [124],
a much more dense information storage medium than any electronic device of
comparable capacity. Moreover, the long term storage of information in DNA
is potentially very feasible, given its extremely long half-life[130] unlike digital
media which is prone to degrading with timescales on the order of decades.
As an example, it has been possible to reconstruct a mammoth genome from
remains found in the tundra[131], it is unlikely we would recover electronic
information stored in the same way. This feat was possible in part because an
exquisite molecular mechanism (base-pairing and replication) exists for making
many copies with very high fidelity.
Herein we propose a novel scheme for encoding information in DNA
and distributing this information across multiple cells, and present computer
simulations demonstrating the feasibility of our approach. We discuss three
main steps of this process (Fig.5.1): (i) A coding scheme for converting digital
information into DNA and vice versa. Our scheme has a built-in, highly general
error detection and correction capacity that can be tailored to pre-chosen
balances of redundancy versus error tolerance; (ii) A strategy for parceling long
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strings of information into smaller pieces that allows for their later re-assembly.
This strategy is completely compatible with current chemical DNA synthesis
methods that yield at most only short (2˜00 bp) oligonucleotides (oligos); and
(iii) The use of error tolerance to defeat corruption of information arising from
synthesis errors, sequencing errors, mutations and packet loss. Taken together,
these innovations allow for very long term, error-resistant storage, potentially
for thousands of years.
We also analyze the performance of our method for key trade-offs that
will be inherent in any strategy of encoding digital information in DNA.
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5.3 Results
5.3.1 Successful generation of codebook
We executed our implementation of the codebook generation algorithm
to generate a set of codewords 4 bp long, and with minimum Levenshtein
distance[132] of 3 (the full set of parameters is given in Table 5.1: Param-
eters used for codebook generation). The latter parameter was set so as to
allow recovery from up to one mutation (including substitutions, insertions
and deletions) per block of encoded DNA. Due to a codeword length of 4, the
block length is likewise 4 bp, therefore the expected theoretical upper bound
on mutation rate for error recovery is 0.25 bp-1, and the upper bound for error
detection is 0.5 bp-1.
All of the resulting code words showed a good diversity of base pair
composition, lack of repetition, sufficient sequence distance between them-
selves, and overall conformed to expectations. The list of codewords is given
in Table 5.2 along with the numeric value assigned to each codeword for the
work described here.
The theoretical upper bound on the information that can be stored
using the four nucleotides of DNA is 2 bits bp-1. Given our codebook, each
sequence of 4 bp can only have one of 8 values, therefore the information
content under our encoding scheme is only 3 bits per 4 bp, with a density of
0.75 bits/bp. Thus, the expected theoretical rate of our encoding approach
per se can be calculated as 0.75
0.375
= 0.375.
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5.3.2 Encoding of digital data into DNA
We implemented our encoding algorithm and used it to encode five
separate sets of input data (Table 5.3). Table 5.4 describes the performance of
our encoding algorithm on these test data sets. Each input file was wrapped
in a tar archive prior to encoding, and rates were calculated by dividing the
size of the tar file prior to converting (found by multiplying the size in bytes
by 8) by the information content of the resulting DNA (found by multiplying
the number of base pairs by 2).
5.3.2.1 Cat image
The realistic test input Cat.jpg (Fig. 5.2) was encoded and had an
empirical rate of 0.459, thus the redundancy and overhead introduced by our
encoding algorithm inflated the size of the data by 1.179 times. Notably, this
is a rate higher than the predicted 0.375; this is due to the Lempel-Ziv-Markov
chain algorithm (LZMA) compression step built into our method reducing the
size of the input (compression with LZMA yields only 10,028 bytes, which
would result in a rate of 0.375). After decoding, we were able to recover the
original image exactly.
The resulting DNA string appeared to be free of any major
self-similarity or repetition. We visualized the self-similarity using a
dot plot to show the extent to which the sequence matches itself (Fig. 5.3).
The most notable case of repetition was near the beginning and ends of the
sequence (Fig. 5.4). Closer inspection of the binary data after compression
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but prior to transformation into DNA revealed that there is often a short
string of zeros in LZMA-compressed data, containing header/tail information
used by the compression logic to identify the properties of a compressed data
stream. Indeed, the most commonly repeated sequence at these regions was
ACCG, which maps to 0 in our codebook.
5.3.2.2 Random data, centromere and flat file
Random data is often regarded as particularly difficult to compress, due
to a lack of statistical tendencies in it which can be exploited by compression
strategies. Indeed, upon compressing our 10 kb random file with 7zip, an open
source implementation of the LZMA algorithm, we obtained a compressed
file 10.2 kb in size. When encoded into DNA with our algorithm, the resulting
file was only 1.278 times bigger than the input tar file.
The centromere was included as an example of highly repetitive infor-
mation that has statistical properties representative of known repetitive DNA
that is considered challenging to sequence and synthesize. As seen by the high
rate, the compression step of our encoding process vastly reduced the size
needed to store this data. The resulting DNA string had very similar compo-
sition and structure to the other test data, and should be no more difficult to
synthesize or read with our approach than any other input.
Lastly, the flat file was dramatically reduced in size after compression,
as shown by the extremely high rate. Due to the very short output sequence,
the repetitive head/tail regions are clearly visible in the dot plot (Fig. 5.5), as
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the data content of the end result is relatively small.
5.3.2.3 Base pair composition
We noted that the nucleotide composition was very close to an even
split of 25% for each base in most of our encoded DNA (Fig. 5.6). The most
conspicuous exception was the flat file, which showed larger skews due to the
characteristic head and tail patterns, which do not vary in length with the
amount of data encoded, thus having a disproportionate effect.
We have also investigated the local composition to detect any small
stretches of base composition skew (Fig. 5.7). As expected, we did not observe
any regions of pronounced skew, and the distribution of nucleotides seemed
to be uniform throughout the encoded sequences. Notably the skew caused
by characteristic head and tail patterns is most noticeable in the flat file,
where several peaks of C content can be seen at the beginning and end. This
would be the expected result, since the common code word in these areas is
ACCG which has a larger proportion of Cs. After quantifying the total skew
by adding up local deviations from expected even distribution, we observed
mostly small amounts of error, with the exception of the flat file which had
larger composition imbalances, particularly in C and T (Fig. 5.8).
In order to verify that our encoding algorithm performs as expected for
larger files, we have also performed a round-trip read-write of a larger image,
Cat-big.jpg (Tables 5.3 and 5.4). The algorithm performed very well for this
larger dataset and we were able to recover the original input exactly. The
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overall error in composition was even less than smaller datasets (Figs. 5.6,
5.7 and 5.8), due to slightly better performance of the LZMA compression for
larger input data.
5.3.2.4 Open reading frames within the encoded DNA
Encoded DNA produced by our algorithm is expected to resemble ran-
dom sequence in many respects. It is possible that large stretches of such
sequence would coincidentally contain start and stop codons forming open
reading frames. Our scheme anticipates that the information-bearing DNA
would ultimately be stored in living cells, thus it is of interest whether and to
what extent open reading frames (ORFs) appear in the encoded sequence. We
analyzed the occurrence of such random ORFs, and a visualization is presented
in Fig. 5.9.
The distribution of ORF lengths follows a pattern that would be ex-
pected a priori from random sequence. The shortest ORFs are most frequent
(our ORF detection software looks for ORFs containing at least one codon be-
sides start and stop). ORFs longer than about 30 residues or 100 bp are very
rare, and none are longer than 83 residues. The start and stop codons are
evenly distributed throughout the sequence, but slightly under represented
near the ends of the DNA – possibly owing to the composition skew intro-
duced by the characteristic head and tail regions resulting from our encoding
approach. There does not appear to be any particular bias towards a single
reading frame, nor towards a particular direction.
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5.3.3 Decoding and error correction
We confirmed correct operation of our encoding approach by attempt-
ing to decode the DNA resulting from the encoding step. In every case we
were able to recover the original tar archive, which when extracted produced
the relevant file that was identical to the one encoded.
Having verified successful round-trip encoding-decoding of information
we then sought to measure the performance of the error correction function.
We simulated substitution mutations accumulating at a slow but steady rate
over many generations, by repeatedly mutating the Cat.jpg so as to correspond
to total numbers of mutations per block ranging from 0 to 2. As an indicator
of data integrity, we compared sequence identity between the simulated mu-
tant sequence and the original, before and after applying the error correction
(Fig. 5.10). For a smaller number of mutations, the error correction is able
to restore nearly the entire original sequence. As the density of mutations
increased, eventually the error correction did become overwhelmed, but the
data shows a very clear mutation buffering effect contributed by it.
As calculated in earlier sections, our error correcting code operates on a
block-wise basis. Each individual block (in our case 4 bp long) can be recovered
so long as no more than one mutation occurs within it. With larger numbers
of mutations distributed randomly throughout the sequence, it becomes more
probable that at least two mutations will fall very close to each other and co-
incide on the same block. Such an improbable event would potentially result
in the loss of that block of information. We have observed that minor pertur-
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bations to the encoded DNA do not significantly corrupt the stored data, and
do not preclude its recovery. Furthermore, our strategy anticipates that the
final encoded DNA string will be broken up into small, overlapping pieces in
practice; therefore the mutations would be further removed at the assembly
stage via a consensus mechanism.
5.3.4 Parallelized storage
We investigated the practical aspects of synthesis, storage and reading
of digital data as DNA using our approach by simulating the round trip pro-
cess. Basing our model on the assumption of DNA synthesis capability which
allows the production of a pool of oligonucleotides 200 bp each (readily achiev-
able with current technology), we generated a series of 200 bp “packets” of
information, which tile the encoded DNA with a pre-defined amount of overlap
between each two successive packets (shown in Fig. 5.11 for a 175 bp overlap).
These packets can be synthesized as a mixed pool, stored, and sequenced using
standard high-throughput sequencing technology, which would allow assembly
of the full-length DNA sequence using only the overlaps, without necessitating
the complicating addition of addresses and addressing schemes. In order to en-
sure even coverage at the termini, we generated successively shorter fragments
at these areas.
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5.3.4.1 Simulated sequencing and assembly
After generating packets with varying overlaps (75, 100, 125, 150,
175 bp corresponding to mean sampling densities ranging from 1.6 to 8) we
simulated the outcome of sequencing this pool of oligos using the ART se-
quencing simulator (details in Table 5.1) at varying read depths (1x, 2x, 5x,
10x, 50x). Afterwards we attempted de novo assembly of the resulting FASTQ
files, compared the longest resulting contig to the original sequence, and con-
sidered two key measures of sequence similarity: How much of the original
sequence was present in the resulting contig (recall), and how much of the
resulting contig matched the original sequence (precision).
Our measures of precision and recall correlated very closely with each
other: With read depths of 5x or more, assembly could easily succeed even
when overlaps between successive packets are small. Below this threshold, only
comparatively dense tilings of packets could be assembled: With 8x sampling
density, even 1x read density was sufficient to recover the original sequence.
However, lower sampling densities performed very poorly with low read depth,
and contigs assembled would be a fraction of the size of the original sequence,
as well as having little similarity to it (indicating spurious assembly becom-
ing the dominant process). A visualization of these findings is provided in
Fig. 5.12. Based on these results, we decided to use a sample depth of 8x
(175 bp overlap) and a read depth of 10x for subsequent work.
Notably, we simulated sequencing of a complex pool of short oligos.
Simulated reads obtained from this pool were assembled naively; we did not
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attempt to recover individual packets, and then assemble packets. Rather,
due to the overlaps between successive packets, our assembler was able to
seamlessly combine these reads into a single contig without additional inter-
vention. We consider this to be an advantage of our conservative overlap-based
segmentation of data.
5.3.4.2 Library construction and long-term packet-wise retention
Because the intended use of our strategy involves cloning the pool of
synthesized DNA oligos, there is a risk that not every sequence in the pool will
be represented. If too many packets “drop out”, our assembly method may
suffer catastrophic failure (a full contig will be impossible to build if a critical
number of adjacent packets are missing entirely at one or more locations).
However, with higher sampling densities, it is possible that even though one
packet is lost during cloning, the two packets adjacent to it will bridge the
gap and nevertheless rescue successful assembly. In order to investigate the
validity of this tradeoff in the practical context of our work, we performed
Monte Carlo simulations of library coverage under the assumption of a defined
number of clones being harvested (set to a constant multiple of the sequence
diversity).
In all, we conducted 20 simulations each from pools of 100 and 500
unique sequences and expected mean library sample rates ranging from 1 to
30 clones harvested per unique oligo sequence. We then looked at what fraction
of the initial set was represented in the draw (Fig. 5.13). As expected, if the
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total number of clones harvested is equal to the number unique sequences, some
sequences appear repeatedly and many are not captured at all. In our case,
about a third of the pool would be lost under this cloning regimen. Collecting
a very large number of clones virtually guaranteed that no sequence would
be lost. Interestingly, the threshold of full coverage was between 10 and 5
clones per unique oligo (cpo): The vast majority of the sequences could be
recovered with 5 cpo, but in most simulated runs there would be a few packets
missing. On the other hand, if 10 clones per oligo are considered then every
single packet was recovered in all 20 simulation runs.
Interestingly, the complexity of the pool per se does not appear to
have an effect on these boundary conditions. The most pronounced difference
between the 100 oligo and 500 oligo case was that the variation was greater with
a less complex pool, while the more complex pool behaved more predictably
in individual runs.
We concluded, based on our observations, that harvesting 10 clones per
oligo is sufficient to have a >95% confidence that all original packets will be
well represented.
5.3.4.3 Simulated recovery of information with packet loss
Having observed that harvesting roughly 10 clones for each unique oligo
should almost guarantee full library coverage, we attempted to test this infer-
ence with in silico experiments. We conducted a series of simulated experi-
ments in which the initial pool of oligos was randomly sampled with replace-
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ment (since the number of molecules in each class is typically much higher
than the number of distinct sequences in synthesized oligo pools, we regarded
the effect of replacement as negligible). These random subsamples were then
subjected to simulated sequencing with ART at 10x read depth, and then
de novo contig assembly of the resulting reads was attempted to determine
whether recovery of the original sequence is possible even with lost packets.
This was repeated 20 times to account for the influence of chance events on
recovery.
As shown in Fig. 5.14, results were in line with the expectations aris-
ing from the library-coverage experiments. We saw that with a single clone
harvested per oligo, in all 20 cases the resulting contigs do not match the orig-
inal sequence. Moreover, we have seen that due to very poor coverage of the
original pool, under this regimen the assembly suffers catastrophic collapse:
The resulting contigs do not exceed roughly a third of the original sequence
by length, and their sequence often diverges from the reference. Predictably,
applying the error correction did not ameliorate this situation.
With the previously established “safe” regimen of 10 clones per oligo,
the vast majority of the 20 experiments yielded contigs that were exactly iden-
tical to the original sequence, demonstrating successful round-trip read-write
of digital data as DNA. In two cases, the assembled contig did not match the
original exactly, but the only difference in either case was a single missing ter-
minal nucleotide. Because our error correction method is based on Levenshtein
distances, which take into account not only substitution but also deletions, it
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was possible to correct these problems and restore the original sequence ex-
actly. Thus, considering error correction as well, with a regimen of 10 clones
per oligo we could reconstruct the original sequence exactly in every single one
of our 20 experiments.
Lastly, of interest was the borderline case of 3 clones per oligo. As
expected, this regimen was occasionally able to produce exactly matching se-
quence, but often the contigs would differ slightly due to missing one terminal
nucleotide. Many such errors were readily amendable with the error correc-
tion, such that attempting to correct errors produced a dramatic improvement
in how many assembled contigs matched the original sequence exactly.
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5.4 Discussion
DNA has great potential as a medium of information storage. Indeed,
it has been used for this purpose by all living organisms for millions of years.
Molecules of DNA are much smaller than digital devices, can be easily copied
using both natural and artificial systems and they can be stably maintained
for a very long time: The half-life of DNA in solution, depending on pH,
temperature, and length, can range from a few years to hundreds of thousands
of years[133]. In nature, DNA in fossilized bone has been shown to have
a half-life as long as 500 years, implying recovery should be possible after
many thousands of years given sufficient initial copies of the DNA[130], and
useful sequence has been recovered from 450 to 800 kyr old samples encased
in ice[134]. In contrast, digital media degrades quickly over decades[135, 137,
136, 138].
Besides durability of the medium itself, DNA enjoys a unique advantage
in that the characteristics of DNA are fixed over time. In contrast, electronic
formats change frequently and require specific read/write equipment, tech-
nology that can become lost on more epochal time scales [135, 139]. This
molecular conservatism will help drive recovery irrespective of what version of
DNA sequencing technology is available even in the far future. Taken together,
these features highlight the possibilities for DNA for extraordinarily long term
archiving.
DNA-based information storage has previously been explored (Ta-
ble 5.6), as challenges with conventional digital storage methods became
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apparent. Bancroft et al. 2001 provided an early proof of concept and laid
out the theoretical framework for encoding data into DNA. They proposed
an encoding scheme that maps triplet combinations of the three nucleotides
A, C, T to ternary numbers and uppercase letters of the English alphabet,
along with a space character. The information is subdivided into segments
(called iDNAs), and each segment is prefixed with a spacer and unique primer
sequence, and then flanked with universal forward and reverse primers. An
ordered array of unique primers is also included as a “polyprimer key”, also
flanked by the universal primer. With this, they encode the famous opening
of A Tale of Two Cities by Charles Dickens in two iDNAs 232 and 247 bp
long. The iDNAs can then be individually recovered by PCR and sequenced.
Notably, this conception predates the revolution in reading DNA sequences
wrought by NextGen sequencing technology, which we extensively leverage in
our own work.
Church and colleagues reported in 2012 the storage and subsequent
recovery of a 5.27 megabit stream of information (composed of text, images
and source code)[125]. The information was encoded with a degenerate code,
mapping A or C to 0 and G or T to 1 (this provided some freedom in preventing
homopolymer runs and GC-skew). The information is partitioned into 54,898
blocks 159 bp each (which would amount to 8.7 Mbp of DNA), of which only
96 bp encodes information while 19 nt is used for address blocks and 44 bp for
universal primers (incidentally this implies a rate of about 0.3 input bits per
output bit, very close to that which we calculate for our encoding strategy).
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After sequencing and filtering for perfect reads, they obtain 3000-fold coverage
of each piece (for comparison, our simulations demonstrate data recovery with
5-fold and 10-fold sequencing). However, their demonstration still contained
22 nucleotide errors, of which 10 were also bit errors. Interestingly, this work
notes that future work could incorporate compression, redundant encodings,
parity checks and error correction - three of which are central aspects of our
own work.
Goldman and colleagues in 2013 describe the encoding and reconstruc-
tion of various computer files totaling 739 kb[126]. The digital information was
first Huffman coded (which reduces the space taken up by frequently occurring
symbols) and then converted to a ternary representation, which is encoded into
DNA at one nucleotide per ternary digit, rotating the nucleotides to prevent
sequences that are difficult to synthesize or sequence from occurring. This
single stream of DNA is broken into 100 bp fragments with 75 bp overlaps
similar to our approach, but with alternate forward and reverse complement
information in subsequent pieces. The overlaps are used only for redundancy,
not assembly, and instead an address block is added to each piece to enable
assembly. Their final encoding produces 153,335 DNA sequences that are each
117 bp long (totaling 17 Mbp), including the address information, which cor-
responds to a rate of roughly 0.17 (including the four-fold overlaps). After
sequencing and filtering, they obtained a set of reads with 1308x coverage,
from which they were able to recover the encoded digital data after applying
error correction. For comparison, in our case we simulated read depths of 5x
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and 10x, after which all of the data was recovered perfectly without need for
error correction, with the exception of a few cases in which a single terminal
nucleotide was lost. These losses could nonetheless be rectified by applying
error correction so that the original data was recovered intact.
A 2015 publication by Grass and colleagues demonstrates encoding
of 83 kB of data in DNA, using an error correction approach based on
Reed-Solomon codes[140]. In this implementation, bytes of input information
and block indices are mapped to elements of a Galois Field with an addition
of Reed-Solomon redundancy for error correction. The Galois numbers are
in turn mapped to 3 bp “codons” of DNA. Some codons are excluded from
this mapping, which ensures that homodimers in output sequence cannot be
longer than 3 bp. The output sequence is synthesized as 117 bp long pieces of
DNA and stored encapsulated in gel. From 83 kb of text, they produced via
this method 4991 pieces of DNA, for a total of 584 kbp of encoded DNA. Thus
their encoding rate was roughly 0.59. Interestingly, Grass et al. performed
experiments simulating thermal damage to the DNA in order to assess their
error correction ability, and were able to recover original information exactly
from a simulated 1% rate of per-nucleotide error; in our own simulations
we also observed a threshold of about 1% for successful recovery. However,
our simulations of error recovery did not account for error correction by
the overlapping packets, and consider only errors that are not eliminated
during the sequencing and assembly stages, so in reality our simulations
underestimate the error-correction capacity of our work (a more detailed
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discussion of estimated error rates is included in the Additional file 1).
Another recent report by Yazdi et al.[127] has made several advances
to address-based encoding schemes by demonstrating a rewritable storage sys-
tem which also supports random access. They distributed a total of 17 kB
of digital information across 32 1 kbp gBlocks produced by a DNA synthesis
technology. Using larger fragments allows for more efficient storage and re-
duces likelihood of data loss due to missing packets, both with address-based
strategies as well as in our case. However, synthesizing of large amounts of
DNA in bulk can be more economical with array based synthesis. The authors
note that the cost of DNA synthesis is rapidly decreasing as new technologies
are developed; should gBlocks or another method for synthesizing longer DNA
pieces become cost effective in the future, our encoding scheme would be di-
rectly compatible with it. In fact, gBlock sequences are subject to a number
of constraints, including lack of high GC areas, repetitive stretches and toxic
sequence. Our strategy directly mitigates all of these issues as is, and is there-
fore fully compatible with gBlocks. Yazdi and colleagues also demonstrate
random access and editing, by using specialized address sequences and PCR.
Random access and ability to rewrite is a strength of address-based approaches
– though limited random access could be added to our scheme (by flanking
each packet with unique primer binding sequences, for instance) rewriting in
place is likely to be impractical. Thus, we consider address-free approaches
such as ours to be more suited for very long term, infrequently accessed, “cold
storage” for archival purposes, where the latency and cost of editing is less
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significant. Address-based systems, especially with rewrite capability such as
that shown by Yazdi et al., would be well suited to a more frequently accessed
storage tier above that utilizing ours.
Our strategy represents several important innovations over previous
work. Most importantly, we do not rely on address blocks to guide assembly
of the DNA sequence for decoding, but instead make use of the overlaps be-
tween packets of data. These overlaps can be used to construct a De Bruijn
graph and be assembled in a manner analogous to the well-studied problem
of genome sequencing and assembly. A primary advantage of this method is
that only standard assembly algorithms, not specialized software, are required
to perform the assembly. In addition, the different parts of the packet are
equally vulnerable to mutation. With an address scheme, mutations falling on
the address section can lead to the loss of the whole block, while mutations
falling on the data portion are far more limited in scope. In our approach, if
the packets tile the original sequence uniformly, it does not matter where the
mutations fall, provided they are sufficiently sparse. This greatly simplifies
the design of a single universal error correction scheme. Finally, the overlaps
act as additional mutation buffers. Our encoding has tunable redundancy that
already confers an error-correction capacity, but the added redundancy from
overlaps allows straightforward detection and correction of sequencing errors
and rare mutations as a result of the de novo assembly process. This “failsafe”
error correction protocol makes this strategy the most secure thus far for any
long term storage attempts.
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With address blocks, an important consideration is efficiency of storage:
within each packet, the address information and the encoded data compete for
space. The number of packets scales with the total size of the encoded digital
data, and the associated address block becomes larger when there are ever
more packets. An upper bound on the number of packets is the number of
possible unique sequences of that length (in reality this tends to be a gross
underestimation since many possible sequences are unsuitable for synthesis
and sequencing). Early on it was recognized by Goldman and colleagues, for
instance, that with 114 bp packets, 14 bp could be used for indexing to ob-
tain 88% efficiency; this imposes an upper limit of about 268 million packets
covering 6.7 Gbp of sequence (taking into account the four-fold redundancy).
For a similar level of redundancy, our approach could generate 114 bp packets
tiling the sequence with 85 bp overlaps, for a total of 231 million packets.
The upper limit on how much information can be stored would most likely
be determined by the limits of assembly software. Moreover, arbitrarily large
amounts of information can be stored regardless of this upper limit, if separate
pools of encoded DNA are physically isolated by storing them in their own in-
dividual containers. Alternatively, multiplexing is possible by flanking packets
pertaining to each encoded file with a unique pair of primer sequences, and
then selectively amplifying that subpool as needed (this also allows for random
access[127]).
Our overlap-based approach therefore allows for a simpler and more
straightforward partitioning of encoded data than relying on address blocks. It
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eliminates the need for parsing and interpreting address blocks when decoding,
as well as the concern over how to preserve the instructions for performing
this step correctly. The sizes of address blocks must be explicitly standardized
prior to encoding, which will impose an upper limit on how much data can
be encoded for as long as that standard is in effect. If the address blocks
are too small, large encodings will run out of address space and the encoding
standard will have to be changed often (leading to compatibility issues), but
if they are too big then small pieces of data will be encoded inefficiently. Our
approach sidesteps this dilemma; it is only necessary that sufficient overlap
exists between packets to enable assembly, and no space is “wasted” on address
blocks since the overlaps act as an additional safeguard of data integrity. The
information is partitioned efficiently regardless of its size, the upper bound
on capacity is very large, and no specific details of the partitioning need be
recorded, since simply attempting to assemble the overlapping pieces of DNA
(a step which would be obvious even if the encoding scheme is unknown) yields
the complete stream of encoded data.
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5.5 Conclusions
We have described the design and in silico implementation of a strat-
egy for encoding digital information into distributed DNA sequences and then
reassembling the original information irrespective of intervening errors. We
evaluated several key parameters, including the manner in which the sequence
would be partitioned into oligonucleotides, the cloning regimen necessary to
maintain a sufficient fraction of the original information for reconstruction
following dispersal, the read depth needed to ensure successful recovery, and
limits on how many mutations can be tolerated while still allowing complete re-
covery of the information. Our simulations demonstrate a successful round-trip
of information during long term storage in DNA, taking into account problems
that might be encountered during synthesis (the write phase) and sequencing
(the read phase).
The error correction method we have chosen, and the closely related
algorithm for codebook generation, facilitate tailoring the encoding to specific
applications. By reducing the minimum distance between code words, one can
reduce redundancy, thereby allowing the encoded data to fit into shorter DNA.
Conversely, when the integrity of the data is more important than the efficiency
of storage, the minimum distance can be set very high, thereby potentially
allowing recovery even if a large number of mutations are introduced.
By compressing our input data with LZMA, we remove correlations
between the statistical properties of the input data and those of the result-
ing DNA sequence. LZMA is a compression algorithm based on constructing
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a Markov model of the data that captures recurring patterns within it, and
then encoding the overall data in terms of this Markov model. To the extent
that patterns do exist, the resulting information is compressed and largely free
of patterns, resembling random data or uniform digital noise. Thus, LZMA
should allow us to produce uniform and non-repetitive DNA sequence from
even very skewed and / or repetitive inputs. By explicitly generating a code-
book with well-defined parameters, we should be able to further impose con-
straints on any resulting sequence output, such as requiring a GC composition
that would be optimal for synthesis and sequencing, irrespective of the com-
position or structure of the input data.
In our work we used a codebook of eight 4 bp blocks. In principle, it
is possible to obtain the same level of overall redundancy with longer blocks,
the minimum codeword distance being scaled up as appropriate. Two key
parameters for choosing the block size were performance (codewords for longer
blocks take more time to generate) and the expected distribution of mutations.
Longer codewords, with more distance between them, have a greater per block
mutation tolerance, even if the per base pair mutation tolerance remains the
same. Error correction functions only if the number of mutations within a
particular block remains below a threshold; that is, mutations must not be
too close to each other. If there is a tendency for mutations to occur in small
clusters, rather than being evenly distributed, longer blocks would likely be
preferable.
Though our primary interest was to develop the means of storing infor-
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mation in DNA, the process can be adapted to a number of other applications.
Herein we will discuss three of these: repurposing the codebook generator to
produce barcodes, using encoding for inactivation of toxic sequences and the
potential to use DNA-encoding to protect private information.
We designed our codebook generation algorithm to produce a set of se-
quences that are evenly spaced in sequence space. This encoding has similari-
ties to the mathematical concept of a “perfect code”[141] which refers to sets of
codewords optimally arranged in sequence space so as to provide a given level of
error correction, although our approach considers Levenshtein distances rather
than Hamming distances, and furthermore there are codewords we deliberately
avoid, so in practice our code is less than perfect. Though our purpose was to
encode information, an interesting property of the resulting codewords is to
lack bias and repetition, and therefore be distinct from one another. The rel-
atively small length makes them easy to synthesize and the lack of repetition
makes them easy to sequence. Overall, these properties also potentially make
them excellent DNA barcodes[143, 142, 144], and as such they can be readily
applied to a long list of biological techniques such as multiplexed NextGen se-
quencing[145], identification of genetic variants[146], construction of deletion
libraries[147] and high-throughput RNA profiling[148].
Another consequence of encoding is that output sequence has very little
resemblance to input. This can make the storage of difficult sequences more
tractable. For example, if a given DNA sequence is fragile or unusually prone
to mutation, encoding should allow it to be stored with high fidelity. Our cen-
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tromere simulations illustrate this principle - although centromeric sequence
is not per se toxic, it is very repetitive, impairing its faithful construction and
sequencing. In contrast, when encoded, the centromere data does not have
any obvious repeats or other unwieldy sequences. Encoding can be used to
not only preserve information, but also to prevent its ready expression in the
absence of decryption. Any biological sequence is rendered biologically un-
readable by our scheme for encoding, and this in turn suggests that biothreats
such as toxin genes or even entire pathogen genomes (e.g. genomes of infec-
tious viruses) that would otherwise be harmful in their ‘biologically readable’
form could potentially be encoded and stored over long periods, essentially
placing them in ‘deep storage’ for posterity.
Distinctly from previous work, we encode information such that there
is a specific codebook associated with each piece of information, which is also
necessary for later decoding. In this sense, our encoding method is analo-
gous to a symmetric key cryptography scheme, with the codebook as the key.
With short block lengths, it is conceivable that the codebook might be re-
verse engineered from the encoded sequence only by an exhaustive approach.
With longer block lengths, it would become extremely difficult to recover the
information without access to the codebook. This allows information to be
hidden from readers who do not possess the correct codebook, or simply to
prevent information from being accessed before an arbitrary amount of time
has passed (that is, the time needed for exhaustive reconstruction of the code-
book). These features render DNA encoding inaccessible and resilient in a way
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that far exceeds what can be availed via electronic encoding. While there may
be few applications for information privacy that can tolerate slower read-write
capabilities, it should be noted that mechanical, Enigma-like rotor cypher sys-
tems can be difficult and time-consuming to crack even with modern electronic
computers [26]. Thus, it is entirely possible that a nation state or corporate
enterprise might wish to hide (and retrieve on a leisurely scale) ‘trade secrets’
via the long term, difficult to break, and undegradable encoding strategies we
describe herein.
Finally, because of the Markov chain-based compression employed,
having access to part of the encoded DNA does not allow one to access
part of the original information. Decoding is only practical if the entire
sequence is present, since otherwise both assembly and decompression fail.
This all-or-nothing nature of the information round trip requires care to be
taken that a sufficient number of packets are retained throughout storage;
in our case we solve this by creating a redundant set of packets that allow
assembly even if a small number is lost. Subsets of the packets could also
be distributed to different recipients or locales, which would then be unable
to decode the information on their own without combining their respective
pieces of the DNA-encoded data. This strong message compartmentalization,
combined with the potential for multi-hundred thousand year digital file
storage capacities–a time-scale exceeding all known continuous human
civilizations–allows one to consider the prospect of securely preserving
information such that it outlasts even extreme, global catastrophic events.
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To summarize, we have demonstrated a strategy for encoding digital
information into DNA, which is highly parallelizable and has built-in error cor-
rection ability, and relies on an overlap-based assembly method fundamentally
different from the previously published approaches. We have demonstrated full
round trip read and write of the information, including simulated sequencing
of a cloned oligo pool, with recovery from simulated mutations.
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5.6 Methods
5.6.1 Test data
The Cat.jpg file was obtained by scaling down a color photo of a cat
(released into the public domain) and encoding with the Jpeg algorithm. After
adjusting the pixel size of the image to approximate our desired size, we then
fine-tuned the Jpeg compression level (ultimately we used level 86) so that the
resulting file size was about 10 kB. Cat-big.jpg was constructed similarly to
produce a 100 kB image. The random data file was obtained by creating a 10
kB file and populating it with random data piped from /dev/urandom on a
Unix computer. The centromere input was a text file containing part of the
sequence from human chromosome I (NCBI sequence NC 000001.11 positions
11,000–22,000). The flat file was constructed by pasting a large number of
0 s into a text file. In every case, the test data was wrapped in a tar archive
(which is a file format that can store one or more files without compression),
which is then used as the input for the DNA codec.
5.6.2 Codebook generation
The codebook is a table showing permissible blocks of DNA sequence,
and what numeric value each sequence maps to. Our algorithm (implemented
as Python code in the file make codewords.py) begins by generating all pos-
sible sequences of a given length (Table 1). This pool is filtered to remove
sequences with high repetitiveness (quantified by dividing the number of its
unique subsequences to the number of all of its subsequences, implemented in
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complexity estimation.py) and undesirable GC content (in our case set as less
than 40% or more than 60% GC). Of the remaining sequences, one is picked
at random and saved as a codeword. All sequences with Levenshtein distance
less than the defined threshold (in our case 3) are removed. Of the remaining
sequences, another one is picked at random to be the second codeword, those
with too small Levenshtein distance are pruned again, and the process is re-
peated until no further codewords can be produced. Sequential integer values
starting from 0 are then assigned at random to each codeword in the resulting
codebook. We generated a single codebook of eight 4 bp codewords and used
it for all of our experiments (Table 2).
5.6.3 DNA codec implementation
The DNA encoding-decoding scheme was implemented in Python
(dna read.py and dna write.py) to produce a codec which, given the code-
book, converts a digital file into a DNA sequence (encoding) and vice versa
(decoding). For encoding, the file is first read, compressed with LZMA (lzma
library of Python 3.5.2), converted into a byte array, which is equivalent to
the digits of a base 256 number. A base change operation is performed, to
change the base from 256 (the number of possible values a byte may have)
to 8 (the number of codewords in our codebook). The resulting array of
integers is converted into short DNA blocks according to the mapping in the
codebook, and concatenated into a single DNA sequence. To decode, the
entire DNA sequence is broken into 4 bp blocks, then each block is mapped
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back to an integer according to the codebook, producing a base 8 number. A
base change is performed from 8 to 256, and the resulting array of numbers is
converted into a byte stream and decompressed with LZMA.
5.6.4 Error correction
The error correction is applied by scanning through a DNA sequence
and checking each subsequent block against the codebook. If the block appears
in the codebook, then it is deemed correct. Otherwise, the block is deemed to
be mutated, and the Levenshtein distance from the observed block to each code
word is calculated. The block with the minimum distance is assumed to be
the original sequence before mutation. This was implemented in clean dna.py
and related files.
5.6.5 Partition of encoded DNA into packets
In order to accommodate eventual synthesis of the encoded DNA se-
quence into nucleic acid, it is broken up into short subsequences termed “pack-
ets” (implemented in split into packets.py). The packets are selected so that
each one is 200 bp long (selected because it is the longest length feasible with
current large-scale DNA synthesis technology), and they tile original sequence
such that each two adjacent packets overlap by a specified amount. For the
beginning and end of the sequence, shorter packets are produced to avoid lower
coverage of sequence ends.
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5.6.6 Sequencing simulations
We simulated NextGen sequencing of our encoded DNA and packets
using the ART sequencing simulator[149]. We simulated 150 bp-long reads
with the Illumina HiSeq 2500, this being a common, commercially available
method of sequencing. The read depth varied from 1x to 50x depending on
the particular experiment.
5.6.7 De novo assembly
Fastq files generated by the ART simulator were used for de novo contig
assembly with the Geneious assembler from the Geneious 9.1.2 software[96].
The parameters specified that the expected assembly was linear and not cir-
cular. The longest resulting contig was then taken as the assembled sequence.
5.6.8 Mutation simulation
To simulate mutations, we implemented a simple iterative algorithm
(mutate dna.py). In each iteration, the algorithm picks a random base pair
and changes it to a different, randomly picked base. This operation is repeated
as many times as needed.
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5.7 Supplementary Text
5.7.1 General estimates of error tolerance
In any round trip write-store-read experiment, we can group errors into
three classes:
• Errors arising during synthesis, with per nucleotide rate s′ = 1− s
• Errors arising during storage, with per nucleotide rate r′ = 1− r
• Errors arising during sequencing, with per nucleotide rate q′ = 1− q
These groupings are advantageous in that the parameters of one can
often be manipulated independently from the other two. For instance:
• Synthesis errors can be improved by using more sophisticated synthesis
technology or producing shorter pieces of DNA
• Storage errors are influenced strongly by duration of storage, storage
medium and temperature
• Sequencing errors depend on choice of sequencing technology and prep
For any given position in the encoded data, the fraction of DNA
molecules in the synthesized pool that carry the correct nucleotide at that
position will be s. After storage, this proportion will fall to s · r. The
proportion of sequencing reads covering this position that also correctly
report the unaltered bases will be p = s · r · q.
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5.7.1.1 Correcting errors by majority consensus
After processing sequencing data and obtaining c reads covering each
position, the probability of a majority of reads reporting the correct base is
given by the binomial distribution P = BCDF(c, k, p
′) representing probability
of no more than k successes from n trials with probability of success p′ = 1−p,
where k is (c+ 1)/2 rounded down.
Picking a modest estimate of c = 5, we get k = 3. In our simulations
we have determined that redundancy-based error correction can recover from
an error rate of up to P = 0.01 in the final assembled consensus sequence.
This implies a maximum threshold for the round trip error rate p′ ≈ 0.10. If
coverage is increased slightly to c = 10, then k = 4 and p′ ≈ 0.15. For much
higher but still reasonable c = 50; k = 24 and p′ ≈ 0.33. Note, however, that
this does not include the effect of errors on assembly.
5.7.1.2 Real world estimates of error rates
Synthesis errors tend to be on the order of 1% to 0.01%[150], although
they are often strongly influenced by certain parameters such as desired frag-
ment length (shorter pieces have less error) and yield (there is a trade-off
between fidelity and total yield). We can take s′ = 0.01 as an estimate eas-
ily achieved by even older technology. However it is clear that much higher
synthesis fidelities can be achieved — for example, in our case encoded infor-
mation is composed solely of a limited repertoire of n-mers, so synthesizing
DNA from pre-manufactured n-mers instead of monomers would not be tech-
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nically challenging and could improve the segment length several fold, albeit
with the potential to introduce segmental substitution error.
The experiment of Grass et al.[140] can be interpreted as a measurement
of r′. They report per nucleotide error rates on the order of 1% after simulated
storage for 2000 years. Thus we can take r′ = 0.01.
Sequencing error rates can vary substantially depending on the par-
ticular equipment and protocol used. Notably, statistical properties of the
sequence (such as repetitiveness) also have a strong effect, and our encoding
method minimizes problematic sequence features. Nevertheless, commonly
reported rates are on the order of 0.1-1%[151] and from this we can take
q′ = 0.01.
Based on the above, we can estimate p = s·r ·q = 0.99·0.99·0.99 ≈ 0.97
and correspondingly p′ = 0.03 for a reasonable expectation of the error rate
in practice, after storage for many centuries. This is well below the maximum
even for 5x coverage, which is p′ = 0.10. Thus, high-fidelity storage appears
to be very feasible using the method we propose, even on extremely long
timescales and modest technical resources.
Note that for the above calculations provide an estimate of
per-nucleotide errors, but it is difficult to precisely calculate true error
rates in actual usage due to the many, sometimes unpredictable factors
involved. For the above estimates, it is assumed that:
1. Assembly is successful. The likelihood of this is explored in the sections
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of our main manuscript titled “Library construction and long-term
packet-wise retention” and “Simulated recovery of information with
packet loss”.
2. There is no block-wise synthesis error (as would be the case if pack-
ets were synthesized from n-mers rather than individual monomers, for
instance).
3. There are no systematic errors or jackpot effects. Our main manuscript,
in the section “Encoding of digital data into DNA”, discusses the features
of our codec which enable mitigation of systematic errors.
Therefore, real world performance will likely be lower than these esti-
mates.
5.7.2 Details of Data in Table 5.6
5.7.2.1 Bancroft 2001
The phrase encoded was “IT WAS THE BEST OF TIMES IT WAS
THE WORST OF TIMES IT WAS THE AGE OF FOOLISHNESS IT WAS
THE EPOCH OF BELIEF”[124], which is 106 characters long. The authors
specify that they mapped values to uppercase letters and a space, a total of 27
possible characters. In this case, Shannon information would be 107. log2 27 =
509 bits.
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5.7.2.2 Church 2012
The publication reported encoding of 5.27 million bits in total. This
was stored on 54,898 sequences, each 159 bp long, for a total of 8,728,782 bp.
[125]
5.7.2.3 Goldman 2013
The numbers for total bits of information and total bases used were
taken as reported in the publication. [126]
5.7.2.4 Grass 2015
It was reported that 83 kbytes of information was encoded (83, 000 ·
8 = 664, 000 bits) and 4,991 segments of DNA, each 158 long, were produced
(4, 991 · 158 = 788, 578 bp of DNA).[140]
5.7.2.5 Yazdi 2015
While the total raw input information was given as 17 kbytes, this
study encoded information using a dictionary of words rather than traditional
byte-characters. We have therefore taken their own figure of 23,196 bits of
information for the word-based encoding (Table S1).[127]
It was reported that the total of bases produce was 32 kbp.
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5.7.2.6 This publication
The Cat.jpg image was 10478 bytes, or 8 · 10, 478 = 83, 824 bits. The
encoded DNA produced from this was 111,192 bp long.
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5.8 Abbreviations
cpo Clones per unique oligonucleotide
GC Guanine-cytosine (composition of DNA)
Jpeg Joint Photographic Experts Group (image compression standard and
the file format implementing it)
LZMA Lempel–Ziv–Markov chain algorithm (compression algorithm)
oligo Oligonucleotide
ORF Open reading frame
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Figure 5.1: A diagram of the encoding and decoding process. (Con-
tinued on next page.)
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Figure 5.1: The input data is first wrapped in a tar archive, to ensure a
uniform input format as well as combining multiple files into a single contigu-
ous data stream with a well-established method. The digital information is
encoded using a pre-generated codebook, producing one long single sequence
of DNA. This sequence is split into overlapping packets, each up to 200 bp
long, which are then synthesized as a complex pool of oligonucleotides. These
can be cloned into plasmids and transformed into cells, where they can be
maintained reliably for a very long time. To recover the information, the pop-
ulation of cells (or alternatively plasmids or lyophilized oligonucleotides) can
be sequenced with NextGen sequencing technology, and de novo assembly of
the resulting reads is performed. During assembly, some errors can be cor-
rected by simply considering the consensus of the contig, whereas systematic
errors (such as those arising during synthesis) can be corrected in silico using
the error correcting code. Finally, the codebook is used to decode the resulting
contig and recover the digital files.
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Figure 5.2: Digital data used for in silico experiments. A
300 x 200 pixel color photo of a cat, encoded with the Jpeg algorithm so
as to produce a files 10,387 byte file.
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Figure 5.3: Overall self-similarity of the encoded Hamming image.
Dot plot of the encoded Hamming image generated with dottup, using word
size 20 as the parameter. Positions where 20 bp of the sequence are self-similar
are marked with blue. Identical regions longer than 100 bp are marked with
red. The plot shows a lack of long stretches of repetition that could interfere
with assembly.
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Figure 5.4: Self-similarity at corners. Dotplots of the same encoded
DNA, showing only the ends of the sequence, generated with word size 10.
Short blocks of repetitive sequence are visible as blue blocks, these result from
header and terminator information utilized by the LZMA algorithm which is
less variable than the compressed data stream itself. Top left: Sequence head
vs. itself. Top right and bottom left: Head vs. tail. Bottom right: Sequence
tail vs. itself.
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Figure 5.5: Self similarity of flat file. Dot plot of the entire encoded flat
file, generated with dottup with word size 10, showing self-similarity within
the entire encoded DNA sequence.
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Figure 5.6: Total nucleotide composition of encoded DNA. Bars show
the relative fraction of each nucleotide within DNA obtained by encoding the
given digital data.
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Figure 5.7: Local composition. Nucleotide composition in sliding 100 bp
window for each sequence of encoded DNA.
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Figure 5.8: Total nucleotide composition error. Total deviation of
nucleotide composition from the expected 25% proportion. Shown here is sum
of error within each 100 bp window tiled along the encoded sequence, and
divided by the sequence length.
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Figure 5.9: Spurious ORFs in encoded sequence. Top: Histogram
showing the distribution of spurious ORFs observed in the DNA sequence
for the encoded Hamming image. Middle: Violin plot showing the length
distribution of spurious ORFs grouped by reading frame. Frames are marked
with a minus (-) if they are on the negative strand (ie. detected in the reverse
complement of the sequence). Bottom: Distribution of spurious ORF start
(grey) and stop (black) positions along the sequence.
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Figure 5.10: Mutation buffering by error correcting code. Light gray
line shows the effect of applying error correction on sequences mutated to
varying degrees. The mutation rate is shown in average mutations per block,
given that each block is 4 bp long. Shown here is the mean of 10 simulations
(middle line) with ±2.58σ band (shaded area), representing 99% confidence
interval. Bottom plot: Subset of the data corresponding to only lower mutation
rates.
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Figure 5.11: Distribution of oligos along the encoded DNA. Black bars indicate 200 bp oligos,
produced so as to tile the encoded sequence with 175 bp overlaps between two successive oligos. Blue
graph shows coverage of the DNA by oligos (uniformly 8x virtually everywhere). Only the beginning and
end of the sequence is shown here; but the parts shown here are representative of the entire sequence.
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Figure 5.12: Left: Fraction of base pairs in the longest assembled contig that matched the original
sequence after mapping. Right: Fraction of the original sequence that was present in the longest assembled
contig.
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Figure 5.13: Monte Carlo simulations of library construction from pools of oligos. A series
of simulated random draw experiments were performed for pools of 100 and 500 unique sequences; the
number of draws ranged from 1 to 30 times the number of unique sequences. For each combination of
parameters, 20 repeat experiments were performed, shown here as lines of identical color.
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Figure 5.14: Recovery of original sequence after simulated sampling of packet pool and
simulated sequencing. Each bar shows fraction of 20 simulated read-write experiments in which the
data after decoding matched the encoded data exactly. For black bars, the error correction capacity built
into the sequence was ignored, and the assembled contig was decoded as-is. For grey bars, the error
correction was applied and decoding was attempted after.
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Parameter Explanation Value
Word length Length of each codeword to be generated, also determines ci-
pher block size
4
Max mutations Maximum number of mutations that can be recovered from per
block. If this parameter is k, the algorithm generates code-
words such that the minimum Levenshtein distance between
them is 2k + 1.
1
Min. GC Minimum GC composition in each codeword 0.4
Max. GC Maximum GC composition in each codeword 0.6
Complexity Minimum complexity (used as a proxy for repetitiveness) of
each codeword
0.75
Table 5.1: Parameters used for codebook generation
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Codeword Value
accg 0
ctag 1
gact 2
tcga 3
agtc 4
gtta 5
taac 6
cggt 7
Table 5.2: Codebook
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Input data Explanation Rationale
Cat.jpg Color photo in jpeg format,
scaled down to 300 x 200 pixels
Example of real world data
Flat file A text file containing a string
of 10,340 zeros
Demonstrate performance
when given extremely repeti-
tive data
Random data 10 kb of random data obtained
from /dev/urandom on a Linux
computer
Demonstrate performance
when given data without any
statistical bias
Centromere Part of centromeric sequence
from human chromosome I,
retrieved from: https://www.
ncbi.nlm.nih.gov/nuccore/
NC_000001.11?report=
fasta&log=seqview&format=
text&from=11000&to=22000
Real-world example of repeti-
tive information
Cat-big.jpg Higher resolution (1125 x 750
pixels) version of Cat.jpg
Example of larger (100 kB) in-
put file
Table 5.3: Input data
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Data Size of file (bytes) Size of tar archive (bytes) Length of encoded DNA (bp) Rate
Cat.jpg 10,387 12,288 106,968 0.459
Flat file 10,340 11,776 1,792 26.286
Random data 10,240 12,288 112,044 0.439
Centromere 11,001 12,800 35,200 1.454
Cat-big.jpg 105,359 107,008 1,082,584 0.395
Table 5.4: Data before and after compression
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Parameter Value Explanation
Sequencer HiSeq 2500 Sequencing equipment to be simulated; we
chose a commonly used Illumina sequencer
Read length 150 Length of simulated reads
Read depth 1, 2, 5, 10, 50 How many reads to collect for a given position.
Higher numbers represent deeper sequencing
(with more reads covering the same sequence).
Table 5.5: ART simulator parameters
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Study Code Partition Data encoded
Shannon
information
(bits)
Total bases Rate
Error
tolerance
Bancroft 2001 Triplets of A,
C, T to upper-
case letters
Address based,
with indexes
also concate-
nated on a
dedicated key
molecule
107 character
English phrase
509 479 0.531 —
Church 2012 2 bases mapped
to each binary
digit
Address based Text, images
and source
code
5,270,000 8,728,782 0.302 12 of
22 cor-
rected
Goldman 2013 Huffman en-
coded, bases
mapped to
ternary digits
and rotated
Purely address
based assem-
bly, fourfold
redundancy
due to overlaps
between pieces
Text, PDF, au-
dio, images
5,165,800 17,940,195 0.144 Recovered
from
0.4%
Grass 2015 Based on
Reed-Solomon
code
Address based Text 664,000 788,578 0.421 Recovered
from
1%
Yazdi 2015 Word 6-tuple
mapped to
binary num-
bers and DNA
sequences
Address based Text 23,196 32,000 0.362 —
This study Block cipher
based on
Levenshtein
distances
Purely overlap
based
Text, images,
video, random
data
83,824 111,192 0.377 Recovered
from
1%
Table 5.6: Comparison of key publications
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Chapter 6
Conclusions and Future Directions
Yeast has long been among the most powerful tools in experimental
biology. In this thesis, I have described my attempts to push the boundaries
of investigatory power. I have done so in three main respects:
• By constructing and characterizing extensive humanizations, ecolizations
and plantizations of yeast I demonstrated the rapid applications of this
technique to investigate hypotheses about basic biology. These strains
have revealed important clues about the history of life on our planet
(such as the evolution of localization). They have also vindicated the
practical promise of humanized yeast: The idea that despite being a
very distant evolutionary cousin, yeast can still have genetic analogs for
human molecular function and dysfunction. The pink cell phenotype
observed in humanized and ecolized yeast iron chelatases is striking in
its resemblance to human porphyria, and an excellent example of how
humanized can be used to assay disease alleles and functional epistasis.
• By developing a practical, rapid method of ortholog swapping and com-
bination, I provided the tools for extension and generalization of the
humanized yeast idea to many other pathways and genes. The excit-
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ing practical benefit of humanized yeast strains is that they are a very
practical chassis for personalized medicine and on-demand profiling of
new human allelic variants without laborious human cell experiments.
Straightforward, streamlined experimental tools are vital if this is to
become a reality.
• By describing a method for digital information storage in yeast, I laid
the groundwork for expanding the use of yeast beyond even biology,
into information technology. Biological computing has long been a goal
of synthetic biology[152], but so far biological computing devices have
lagged decades behind electronic ones in terms of scale and speed. Al-
though biological circuits attract much attention, it may very well be
that the very first union of biology and computing will be in the realm
of data storage, not processing. At any rate, the idea of DNA as a dig-
ital archival medium has already managed to capture the imaginations
of industry researchers as well as academics[129].
An insightful review by Laurent and colleagues[153], frames the concept
of humanization in terms of degrees. The lowest, degree 0, is the study of yeast
which has not been humanized at all. Degree 1 is simply expressing human
genes in yeast with no regard for orthology or complementation, a classic
strategy of molecular biology. Degree 2 is humanization of specific positions
within genes. Degree 3 is humanization of individual genes[8, 37]. The highest,
degree 4, is humanization of entire pathways. At the time, few studies directly
addressed this last, most ambitious category. The work described in Chapter
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4 represents an early foray into humanization of the highest degree.
Having now arrived at the terminus of this taxonomy, I would like to
propose a slightly different view to complement that of Laurent et al.: The
notion of “resolution” in humanization. All humanization involves replacing
units of the yeast genome with corresponding (often orthologous) units of the
human genome (Figure 6.2). In the classic case, the units are genes, or rather
coding sequences. Therefore, there is an implicit assumption in this approach
that the salient unit of evolutionary selection is the gene. By going further
and considering the swapping of whole pathways and complexes, we can access
an alternative context where the evolution is thought to act on the genetic
module. Indeed, [8] shows that there are two different classes of modules with
regards to how evolutionary forces act on them. In one case, the module is
restricted from divergence, while in the other it is not. With pathway-level
humanization, we can query high-order genetic mechanisms, such as epistasis
and regulation within the pathway. However, another interesting avenue of
research would be to swap the yeast pathway with a hybrid one, which is a
mixture of genes from humans and a third species. This would enable yeast
to serve as a proxy for querying ortholog swapping from human to any other
species while retaining the ease of yeast experimentation.
In the opposite direction, it is possible to swap smaller units, such as
individual protein domains. Generalizing this, it would not be difficult to gen-
erate chimeras of yeast and human genes[154]. By surveying several chimeras
of the same gene, we can obtain residue-level information of swappability (Fig-
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ure 6.1). This information could potentially reveal foci of divergence: Indi-
vidual sites that account for much of the fitness cost or non-swappability of a
given ortholog. With chimeras of human alleles, human variation could also
be explored at a precise level.
The unique biology of yeast makes it a very tractable organism for the
experimentalist. Indeed, it must surely be one of the most studied organ-
isms on the planet. One might even wonder if yeast research is close to being
“done”. With the advent of CRISPR, other model organisms seem poised
to close this gap and become tractable to the same degree. However, those
same technologies also boost the utility of yeast even further. A wealth of
high-throughput studies has developed staggering know-how and infrastruc-
ture for investigation of global hypothesis about the whole of yeast genome
and proteome. With ortholog swapping, this power can be leveraged to gain
knowledge on the biology of humans and many other organisms. As we com-
plete our understanding of yeast as an organism of study, we enter the era of
yeast as a tremendous platform for the study of other organisms.
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Figure 6.1: DNA shuﬄing can be used to gain residue-resolution
of divergence. Many yeast/human chimeras are generated by mixing
pieces of yeast and human sequence with PCR. Each chimera is then used to
replace the yeast gene and the strain is characterized (such as by measuring
growth rate). The results can be synthesized to find those residues which when
humanized, cause the most significant impairment. For poor complementors,
these residues could account for the majority of the barrier to swappability,
and indicate divergent vs. conserved regions of the gene.
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Replaceability
Low Resolution:
- Whole pathway replacement
- Interactions, epistasis
Medium Resolution:
- Single replacement
High Resolution:
- Chimeric templates
- Domain replacement
- Divergence foci
Figure 6.2: All humanization involves replacing units of the yeast
genome with corresponding (often orthologous) units of the human
genome. Traditionally, the unit is a gene. More precisely, in our work, it
has been the coding sequence of each gene. Going to a “higher” degree affords
a broader look and provides information about epistasis. The unit is then
the “module”: A pathway or protein complex. However, it is also possible
to examine smaller units — these include the individual sites of degree 2,
but also humanization of domains and introduction of chimeras of human and
yeast sequence. A systematic survey of different chimeras for the same gene
could provide a residue-level readout of replaceability, and potentially identify
foci of divergence within the gene. Chimerizing human alleles could permit
deep functional scans of human polymorphism.
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